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Functional consequences of genetic variants are best studied in their endogenous 
chromosomal context. Gene editing by homology-directed repair can introduce such 
predetermined genetic changes into chromosomal DNA. In this thesis, I develop methods to 
generate tens to hundreds of genetic variants, expressed from a native chromosomal 
context, and simultaneously evaluate their phenotypic impact. This approach involves repair 
of Cas9-derived double strand breaks (DSBs) from oligonucleotide repair template libraries 
containing controlled levels of nucleotide heterogeneity. Cell populations are then purified 
based on a phenotypic assay and subjected to deep amplicon sequencing at the target site 
to link genotype with phenotype.  
 
In the first chapter, I developed a bioinformatics pipeline for the processing of Illumina 
sequencing reads containing nucleotide variants, and validate this pipeline in silico. As a 
proof-of-principle, in the second chapter I then introduced nucleotide variants across 8 
codons of a chromosomal GFP transgene in mouse embryonic stem cells. The functional 
impact of these variants was quantified, with the results benchmarked against an existing 
episomal dataset, and by in silico modelling of mutant protein structure. In the final chapter, 
I applied this pipeline to analyse a CRISPR deep mutational scanning dataset incorporating all 
possible amino acid substitutions within a region of β-catenin, a component of the Wnt 
signalling pathway, that is a mutational hotspot in many types of cancer. The functional 
impact of these clinically relevant variants was assessed using a fluorescent reporter of Wnt 
signalling. By combining the resulting functional scores with mutational signature data from 
genome sequencing of different tumour types, I finally dissect the relative contribution of 
mutational bias and natural selection to the different patterns of amino acid substitutions 






The genome is an organism’s complete set of DNA including all of its genes. The human 
genome consists of billions of nucleotides (A, C, G or T) and controls how the cells of an 
organism behave and function. Individuals have their unique set of genomic variations that 
make them unique, whilst they additionally acquire mutations throughout life due to errors 
in DNA replication and exposure to factors such as smoking and sunlight. These alterations 
underlie a wide variety of diseases including cancer. Understanding how genetic variations 
affect cell behaviour and diseases is crucial for improving medicine and biotechnology, 
although examining the effects of many genetic variations simultaneously remains difficult.   
 
In this thesis, a DNA editing tool called CRISPR-Cas9 is used to make thousands to millions of 
cells in a dish each carry a different change in its DNA, such that the effects of these mutations 
on the behaviour of these cells can subsequently be measured. To achieve this, Cas9 cuts the 
DNA of these cells, after which the specific genetic variant is copied into the genome from a 
small strand of DNA that we introduce into the cell together with Cas9. After this, the 
fluorescence of these cells is assessed, which is indicative of their fitness as a result of the 
mutation. After isolation of groups of cells with different levels of fluorescence, we can then 
read (‘sequence’) the genetic code to see which mutation corresponds with which 
fluorescence level.  
 
To analyse the sequencing data, programming scripts have been written and analysed to 
process the data and to subsequently make counts and graphs of nucleotide variants in the 
fluorescence groups. This methodology is first tested on cells that harbour a genetic element 
encoding for a green fluorescent protein (GFP) and subsequently applied to introduce and 
functionally assess single nucleotide variants introduced into GFP. The effects of many high-
quality genetic variants on GFP fluorescence are assessed and validated, demonstrating that 
our approach works. In chapter 5, the developed approach is used to examine β-catenin, a 
protein often mutated in cancer. The effects of 380 clinically-relevant mutations in β-catenin 
were measured, after which this information is used to explain why different cancer types 
carry certain mutations. Through this, we better understand the mechanisms through which 
this protein works and how different genetic changes in this protein cause cancer. The 
technique developed in this thesis allows for systematic screening of the effects of thousands 
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The human body is composed of trillions of cells (Bianconi et al., 2013) that all contain nearly 
the same genetic information, which is stored in deoxyribonucleic acid (DNA) molecules that 
are collectively known as the genome. The genome contains the essential information for 
the production of all the proteins necessary for the functioning, growth and reproduction of 
an organism. Each of these proteins is tightly regulated by complex, tissue-specific processes 
that allow for the formation of different cell types while harbouring the same genome.  
 
The last few decades have provided marvellous advantages in our understanding of our 
genome. The initial publication of the human genetic sequence by the Human Genome 
Project in 2001 revealed that there are approximately 19,000 coding genes and that most of 
the genome does not code for any functional elements and consists of repetitive stretches 
of code (Venter et al., 2001; Ezkurdia et al., 2014). In the subsequent years of research, 
scientists elucidated an astonishing amount about the function of genomic elements and 
showed the power of genomic maps by being able to map genes, regulatory elements, 
chromatin structures and conservation throughout evolution and between individuals 
(Lander, 2011). Although there is a high sequence similarity of approximately 99.9% between 
individuals (Altshuler et al., 2012), this means that there is still variation across roughly 6 
million single nucleotide sites. With the largest majority of these genetic variants not 
affecting functioning of the genome (Kimura, 1968), a major goal of 21st century genetics is 
to identify those that do.  
 
With the current ease and cost-efficiency of sequencing experimental and clinical samples, 
vast amounts of genomic data are available on the incidence of single nucleotide variants 
(SNVs) and on their coincidence with disease and traits. A thorough understanding of the 
molecular consequences and mechanisms through which these variants work is however 
often missing and impair our ability to assign a functional significance to them. The reason 
for this is that systematic introduction and interrogation of vast numbers of genomic variants 
in their endogenous context has largely been unfeasible.  
 
The discovery and development of CRISPR-based precise genome editing of eukaryotic cells 




the effects of genetic elements and sequence variations in their native genomic context to 
an unpreceded extent.  
 
In this thesis, I will investigate the possibility of developing a systematic approach for the 
interrogation of the phenotypic consequences of genetic variants in their genomic context 
using genome editing.  
 
1.1 The eukaryotic genome 
1.1.1 Elements of the genome 
Every organism is composed of cells, which are considered the basic units of life. Each cell 
stores its genetic information in deoxyribonucleic acid (DNA), which is a thread-like chain of 
nucleotides that in turn consist of a phosphate group, a deoxyribose sugar and a nitrogenous 
base (Watson and Crick, 1953) (see Figure 1.1A). Each strand of DNA is bound to a second, 
reverse strand of DNA, meaning that the two respective strands are going in opposite 
directions, from respectively 5’ end to 3’ end and vice versa. The hydrogen bonds between 
the two strands are formed between the nitrogenous bases of the respective molecules, 
which come in four types: adenosine (A), cytosine (C), guanine (G) and thymidine (T). 
Contrary to random occurrence, A will always pair with a T on the opposite strand (with two 
hydrogen bonds), as a C will similarly bind a G (with three hydrogen bonds). Thus, each strand 
of DNA is a template of the other.  
 
All organisms can be described as either prokaryotes or eukaryotes, depending on their 
cellular structure. Whereas prokaryotes (comprising both archaea and bacteria) have a 
single, circular strand of DNA and contain all their cellular components in the cytoplasm 
(Doolittle, 1996), eukaryotes have membrane-separated, compartmentalised structures 
including the nucleus, which contain their genomic DNA. Eukaryotes, including plants and 







Figure 1.1  Structure of DNA and the central dogma of biology (A) At its primary structure, 
DNA consists of two nucleotide strands that are wound together in a helix. Each nucleotide 
(see dashed box) consists of a deoxyribose sugar group (indicated by S) bound at its 5th 
carbon to a phosphate group (termed 5’ end) and to the phosphate group of a neighbouring 
nucleotide with its 3rd carbon (termed the 3’ end). Each nucleotide also has either a 
nitrogenous base, adenosine (A), cytosine (C), guanine (G) or thymidine (T), at the central 
part of the helix, with which it binds to the other strand. A always pairs with T, whereas C 
always pairs with G. While each strand is oriented from 3’ to 5’, the strands are bound anti-
parallel. Each turn of a DNA helix consists of 10.5 nucleotides. (B) A gene is a part of the 
genome that encodes for a functional transcript such as a protein. Expression of a gene is 
driven by a promoter 5’ upstream from the gene and contains individual coding segments 
(exons) that are intervened by non-coding sequences (introns) and is embedded between 
untranslated regions (UTRs) at the 5’- and 3’-termini. The number and length of exons and 
introns varies within and between genes. (C) For protein synthesis, DNA is transcribed into 
pre-mRNA, which is processed into mRNA by removal of intronic regions, after which the 
mRNA is transported from the nucleus to the cytoplasm, where ribosomes translate it into a 
chain of amino acids (polypeptide chain) by corresponding each three nucleotides (codon) 




1.1.2 Components of the cell and the central dogma 
Each protein is encoded by a gene, which is a genomic region containing the information for 
the synthesis of a protein-coding or non-coding RNA, of which the transcription is regulated 
by a promoter (Pesole, 2008). A typical eukaryotic gene contains individual coding segments 
(exons) that are intervened by non-coding sequences (introns) and is embedded between 
untranslated regions (UTRs) at the 5’- and 3’-termini (see Figure 1.1B). Approximately 19,000 
protein-coding genes are found in the human genome (Ezkurdia et al., 2014), making up only 
± 1.8 % of the total genomic sequence (Altshuler et al., 2012). These genes can be transcribed 
into RNA, which can subsequently be translated into proteins (see Figure 1.1C). This is known 
as the central dogma of molecular biology (Crick, 1970).  
 
RNA polymerase transcribes the full sequence of a gene from the DNA into pre-messenger 
RNA (pre-mRNA). In RNA, uracil (U) is used as a binding partner for A instead of the more 
stable thymidine T. After transcription, this pre-mRNA is processed and spliced to remove 
any redundant sequences such as introns, resulting in mRNA. This mRNA can now be 
transported out of the nucleus, after which it is captured and translated by ribosomal 
complexes into amino acid sequences that subsequently fold into three-dimensional protein 
structures. Each three-nucleotide sequence in an exon (codon) encodes for a specific amino 
acid. As there are (4 nucleotides * 3 three positions) 64 possible codons and 20 different 
amino acids, several codons encode the same amino acid and are known as synonymous 
codons (see Table 1-1).  
 
In addition to protein-coding genes, other genes may encode for RNAs that themselves fulfil 
a role in the cell (Morris and Mattick, 2014; Marchese, Raimondi and Huarte, 2017). For 
example, transfer RNAs (tRNAs) are short strands of RNA that function as homing beacons, 
necessary for the binding between a specific triplet codon on mRNA and the corresponding 
amino acids in ribosomes (Rich and RajBhandary, 1976). 
 
1.1.3 Codon usage bias 
Whereas it follows from the central dogma that synonymous codons should not alter the 





Table 1-1 DNA codon to amino acid translation table. Each three-nucleotide sequence 
(codon) translates into any of the 20 amino acids or into a stop codon (indicated in red), 
which terminates translation. Several codons can encode for the same amino acid (i.e. 
synonymous codons). 
 
are found at distinct frequencies in different organisms and even fluctuate widely in 
frequency between genes within the same genome, or more strikingly within the same gene, 
a phenomenon known as codon-usage bias (Ikemura, 1985; Sharp and Li, 1986; Plotkin and 
Kudla, 2011). Codon usage bias has a demonstrated effect on fitness and synonymous codons 
are hence under a nonnegligible selective pressure. Nucleotide changes due to codon bias 
can affect many processes including transcription (Zhou et al., 2016) and folding and stability 
(Presnyak et al., 2015) of an mRNA, whereby GC-rich mRNA sequences typically adopt strong 
secondary structures (de Smit and Van Duin, 1990; Kudla et al., 2009). On the translational 
level, initiation rates may be affected by different codons (in E. coli) (Kudla et al., 2009), whilst 
a resulting delay in translation at certain sites ensures correct folding of the protein 
(Sørensen, Kurland and Pedersen, 1989). Codon optimisation may thus hugely bias correct 
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TTT Phe TCT 
Ser 
TAT Tyr TGT Cys T 
Third nucleotide 
TTC TCC TAC TGC C 
TTA Leu TCA TAA Stop TGA Stop G 






CAT His CGT 
Arg 
T 
CTC CCC CAC CGC C 
CTA CCA CAA Gln CGA G 






AAT Asn AGT Ser T 
ATC ACC AAC AGC C 
ATA ACA AAA Lys AGA Arg G 






GAT Asp GGT 
Gly 
T 
GTC GCC GAC GGC C 
GTA GCA GAA 
Glu 
GGA G 




functioning of mechanisms at both the transcriptional and translational level, which together 
affect global translation efficiency and cellular fitness.  
 
The origin of differences in codon usage between genes in mammalian systems is still a point 
of debate. One underlying explanation is the observation that genes of different functional 
categories differ in their codon usage, providing evidence that the tRNA abundance in the 
cell types that these genes are expressed in is the largest determinant of codon usage 
between genes (Gingold et al., 2014). Concentrations of different isoaccepting tRNAs – i.e. 
those binding the same amino acid – can vary in a cell (reviewed in Quax et al., 2015). Highly-
expressed genes hence frequently display a large skew towards codons with higher tRNA 
levels, thereby enhancing their elongation rate (Plotkin and Kudla, 2011). However, there still 
remains debate on whether codon usage adapts to tRNA abundance and as tRNA 
concentrations are hard to determine, this hypothesis remains based on many assumptions 
(Laurin-Lemay, Philippe and Rodrigue, 2018).  
 
The most obvious pattern for the skew between genes in the same genome is the observation 
that in isochores (stretches >300kb with high uniformity in GC levels), both synonymous and 
non-synonymous codons are under constraints to reflect the GC composition (Bernardi, 
2000). A recent study further supported this by demonstrating that codon-usage biases are 
explained by a correlation in the GC-content between the third codon positions of a gene 
and adjacent untranslated regions (Pouyet et al., 2017), whereby the authors reasoned that 
this GC-content is largely driven by the variations in long-term recombination rates instead 
of expression, with regions with higher GC-content being more conserved. Furthermore, 
specific classes of genes are thought to fall within specific isochoric groups, e.g. housekeeping 
genes tend to be more GC-rich whereas genes important for development and differentiation 
tend to be AT-rich (Peden, 1999). It is hence postulated that GC-content is the major 
determinant of codon usage bias between genes (Rudolph et al., 2016).  
 
Codon usage bias affects many processes in fundamental and applied biology. For transgene 
or recombinant protein design, inter-species codon usage bias is a crucial consideration for 
correct expression (Gustafsson, Govindarajan and Minshull, 2004; Plotkin and Kudla, 2011). 




nucleotide changes found in oncogenes (Supek et al., 2014). Thus, synonymous mutations 
emphasise the complexity of the genome and the challenges associated with predicting the 
functional impact of sequence variants.  
 
1.2 Genomic variations 
Genomic variations occur naturally in the genome of all organisms and can lead to alterations 
in cell function and disease. They are the basis for natural selection, with successive cycles of 
mutations and selective amplification of the fittest variants causing populations to adapt to 
their environment over time. Advantageous traits that emerge and provide a survival 
advantage are thus passed on, whereas deleterious mutations and their hosts gradually 
disappear. 
 
Genomic variations are present in many forms, including substitutions, insertions, deletions, 
inversions and duplications and can vary from single nucleotide variations (SNVs) to large 
chromosomal rearrangements affecting several megabases (Feuk, Carson and Scherer, 
2006). Regions of the genome that have no functional role are typically more permissive to 
the accumulation of mutation (Wolfe, Sharp and Li, 1989), since there is no selective pressure 
against such variants. In contrast, variants in regions of biological significance are more likely 
to have a negative impact on the fitness of an organism and would therefore be depleted in 
such a region. In rare cases, a variant may positively influence viability and would thus be 
selected for. Therefore, all the genomic variants found in the genome are a result of selective 
pressure or a lack thereof.  
 
Variants occurring in the human genome, including their rate of prevalence, are described in 
the 1000-Genomes Project, which analysed over 2,500 haplotypes from 26 populations and 
comprises the total collection of allelic variants in the genome of an individual (Altshuler et 
al., 2012). Over 88 million genetic variants occurring in at least 1% of the population have 
been described, ranging from single nucleotide polymorphisms (SNPs), indels and other small 
variants to large structural variants spanning over 100,000 bases. Every human individual 
caries approximately 300 rare, protein-encoding variants (Tennessen et al., 2012), many of 





1.3.1 Single nucleotide polymorphisms 
Polymorphisms are genetic variants naturally occurring between individuals and are thought 
to comprise transient variations in a species that are either to be fixed or removed from a 
population over time. SNPs are variants found at a single nucleotide that occur in at least 1% 
of the population and comprise the most frequent type of sequence variation in the human 
genome, with over 84.7 million SNPs having been identified (Auton et al., 2015). It is 
estimated that 93% of all protein coding gene loci are within 5kb of the nearest SNPs and 
that there are on average 2 exonic SNPs per gene (The International SNP Map Working 
Group, 2001). Thus, a large numbers of SNPs are within close proximity to a gene and are 
expected to alter the gene’s function, by which it is not surprising that a large number of 
SNPs is associated with disease susceptibility. Besides Parkinson’s disease (Nalls et al., 2014) 
and sickle-cell anaemia (Ingram, 1956), a notable example is a missense mutation in BRCA1, 
which is carried by 10% of the female population and is thought to underlie breast cancer 
(Millot et al., 2012). In addition to SNPs, two or three consecutive polymorphisms frequently 
appear in tumours (Rosenfeld, Malhotra and Lencz, 2010). Thus, SNPs play a large role in the 
variations between humans.  
 
1.3.2 Single nucleotide variants 
In contrast to SNPs, which occur in at least 1% of the population, SNVs are variations that can 
occur at any frequency in the population. SNVs can accumulate in somatic cells throughout 
the lifetime of an individual and are a main driver of tumorigenesis (Goya et al., 2010). All 
cells in an organism are exposed to a continuous mutational burden proportional to their 
proliferation rate and age due to intrinsic infidelities such as the DNA replication and repair 
machinery (Stratton, Campbell and Futreal, 2009). For instance, over-activity of members of 
the APOBEC family of cytosine deaminases can cause C>U conversions that are typically 
repaired by base excision repair, which most often results in C>T conversions (Chen et al., 
1987; Powell et al., 1987; Seeberg, Eide and Bjørås, 1995).  
 
In addition to intrinsic factors, exposures to certain carcinogenic factors can result in 
accumulation of distinct mutations in specific tissues (Pfeifer, 2010). For example, ultraviolet 
radiation in sunlight is the most abundant factor in our environment but does not penetrate 




hence thought to be the result of excessive exposure to ultraviolet light (Ravanat, Douki and 
Cadet, 2001; Pleasance et al., 2010). In contrast, substitutions due to tobacco carcinogens 
are typically associated with C>A and CC>AA in lung cancer (Pfeifer et al., 2002).  
 
Due to the large array of sources of DNA damage, large numbers of SNVs are accumulated 
throughout the lifetime of an organism. In addition to the millions of SNPs that have been 
mapped over the last decades (The International SNP Map Working Group, 2001; Frazer et 
al., 2007; Altshuler et al., 2012; Auton et al., 2015), this rapidly complicates the association 
of these variants with traits or disease. The 1000-Genomes Project greatly aided our 
understanding of the genetic variants naturally occurring in the human genome. However, 
as a minimum of 90% of the human genome is thought to be functionally inactive (Keightley, 
2012; Scally and Durbin, 2012; Kellis et al., 2014), the bulk of these variants will have no 
functional impact on the fitness of the organism (Kimura, 1968). Other studies have 
described the patterns of SNVs that arise due to certain carcinogenic processes in mutational 
signatures (Stratton, Campbell and Futreal, 2009; Nik-Zainal et al., 2012; Alexandrov and 
Stratton, 2014), which further enhance our understanding of the sources and consequences 
of SNVs (mutational signatures are further discussed in Chapter 5). However, these are 
typically large association studies and do not systematically look at the effect of individual 
mutations, I will next showcase the methods typically used to study the effects of genetic 
variants.  
 
1.3 Genotype-phenotype relationships 
1.3.1 Forward genetic screens 
Historically, associations of genetic variants with a phenotype have been examined by 
forward genetic screens (reviewed in Schneeberger, 2014). Hereby, DNA-damaging agents 
are used for random mutagenesis of an organism with a well-defined genetic background, 
after which mutants that express a characterised phenotype of interest are selected. 
Subsequently, genetic mapping is required to elucidate the locus harbouring the causative 
genetic variant, after which the exact mutation needs to be isolated and characterised. 
Identifying the loci of knock-outs typically occurred by screening differences in amplicon size 
by polymerase chain reaction (PCR) (Wienholds et al., 2003), indicating a insertion or 




labour-intensive backcrossing to remove background mutations. Whilst for a long time it was 
the only approach to identify genes and mutations that underlie phenotypes, these forward 
genetic screens are costly and laborious. In addition, larger genes are more likely to be 
targeted by mutagenesis due to chance and these screens may thus be skewed.  
 
1.3.1.1 Transposon-mediated mutagenesis 
Transposon-mediated mutagenesis, i.e. the use of transposable elements to interfere with 
gene functions, often integrated through viral transduction, proved to be a more efficient 
forward genetic screening method than chemical mutagenesis in organisms such as 
Caenorhabditis elegans and Drosophila melanogaster due to higher mutation rates and lower 
lethality, although it had limited success in eukaryotes due to the lack of usable elements 
(Bellen et al., 1989; Spradling et al., 1995; Plasterk, 1996). Reconstruction of the Sleeping 
Beauty transposon however proved a successful method for insertional mutagenesis in 
higher eukaryotes (Ivics et al., 1997), especially because it only requires TA as its target 
sequence. The use of Sleeping Beauty-mediated mutagenesis in systematic screening 
however remained limited due to low transposition efficiencies (Luo et al., 1998), although 
some efforts addressed this limitation and demonstrated the use of this system in genome-
wide cancer gene screening (Dupuy et al., 2005). Other transposons such as the PiggyBac 
system have been developed and are now widely applied in genome-wide screening for 
cancer genes with TTAA specificity (Rad et al., 2010). Hence, for a long time, transposons 
provided an effective alternative to radiation and chemical mutagens for the introduction of 
mutations underlying forward genetic screens.  
 
1.3.1.2 Genome-wide association screens 
With the rise of next-generation sequencing technologies, genome-wide association studies 
(GWAS)  (and similarly familial studies) rapidly became a much-applied approach to link 
genetic variants with traits using samples from large human populations (reviewed in 
Visscher et al., 2017). GWAS is based on linkage analysis and narrows the window on where 
a variant may be located, aiming to identify alleles that are non-randomly and differentially 
distributed between populations with and without the phenotype of interest. It offers a good 
system to associate genomic variations with traits on a large scale, but does not explicitly 
identify the causative variant. For common diseases, these studies however provide limited 




informative as the association between the underlying molecular mechanism and phenotype 
is not always apparent. Experimental interrogations are thus still often required in addition 
to linkage analysis when validating larger number or co-occurring genomic variations.  
 
1.3.2 Reverse genetic screens 
In contrast to forward genetics, hypothesis-driven, reverse genetic screens start with the 
inactivation of a preselected gene, after which the function of the sequence is determined 
by the corresponding phenotype. Such ‘genotype-to-phenotype’ approaches thus start with 
prior knowledge of specific genetic elements to test the causal role of mutations herein. 
Next-generation sequencing technologies have greatly enhanced the speed with which 
random mutations can be mapped in classical forward genetic screens (Schneeberger, 2014), 
whereas reverse genetic screens improve the targeting scope by disrupting a known genetic 




The manipulation of endogenous RNA interference (RNAi) was first discovered in 
Caenorhabditis elegans (Fire et al., 1998) and proved an effective way to disrupt gene 
function. With RNAi, double-stranded RNA sequences equal to mRNA transcripts are 
introduced into a cell, where it is recognised as exogenous genetic material and activates the 
RNAi pathway, which subsequently targets homologous endogenous transcripts for 
degradation. The resulting gene knockdown is now widely used to screen for functions of 
transcribed genetic elements (Ketting, 2011) and libraries targeting thousands of genes are 
available and allow for genome-wide loss-of-function screening. Despite the success of RNAi, 
substantial off-target activity and imperfect on-target activity obscure interpretation of 
phenotypes resulting from RNAi screens (Jackson and Linsley, 2010), thus having similar 
restrictions as classical genetic screens. In addition, RNAi cannot replace classic genetic 
screens, as the phenotypic effects are transient and not heritable, although the latter can be 
advantageous when studying essential genes.  
 
1.3.2.2 TILLING 
As the mapping of mutations underlying a phenotype of interest was one of the main 




Genomes (TILLING) was quickly adopted as a general screening method after its publication 
(Till et al., 2003). TILLING is a reverse-genetic approach that allows for the creation of an 
allelic series of induced point mutations in a gene of interest. It was initially developed in 
Arabidopsis Thaliana (Till et al., 2003) and was later proven to work in other organisms 
including C. elegans (Gilchrist et al., 2006) and Danio rerio (Moens et al., 2008). TILLING is 
based on the introduction of point mutations in DNA with either ethylmethane sulphonate 
(EMS) or ethyl nitrosourea. A target gene or genetic region is PCR-amplified with fluorescent 
primers, after which denaturing and random reannealing of the amplicons occurs. If a mutant 
amplicon anneals with a wildtype or different amplicon, this reannealing will result in a 
mismatch. Digestion with an endonuclease (commonly Cel1 (Colbert et al., 2001)) cleaves at 
mismatch-specific nucleotide sites, after which gel electrophoresis of the digested amplicons 
reveals the approximate position of the mismatch. As point mutations are less disrupting 
than large rearrangements, TILLING allowed for a more targeted screening of genomic 
variants, including the detection of gain-of-function mutations. Thus, TILLING allowed for a 
more effective and robust screening of mutations in contrast to classical genetic screens, 
although it still required high arrays of amplicon screening and the pre-selection of genomic 
regions (Gilchrist and Haughn, 2010).  
 
1.3.3 Interrogating the effects of single nucleotide variants 
In addition to characterising or enhancing the function of a gene, targeted mutagenesis of a 
gene can also be used to study the structure of a protein and the functioning of individual 
fragments of a genetic element. While genome-wide screening methods (e.g. GWAS) can 
assess the function of the most common genomic variants, measuring the effects of 
(multiple) amino acid substitutions on protein structure and function requires setup to 
diversify the target sequence and screen for a desired phenotype.  
 
Alanine scanning, for example, systematically replaces all residues in a protein with alanine 
to assess their function (Cunningham and Wells, 1989). Alanine is used as a substitute as it 
does not introduce any electrostatic or steric effects, although it provides limited 
characterisation of sequence-function relationships and does not elucidate the effects of 





As genetic variants are typically found in (the vicinity of) regulatory elements, the potential 
genomic locations of such regulatory elements are often determined by DNase I footprinting 
and more recently DNase I hypersensitive sites sequencing (DNase-seq) (Crawford et al., 
2006; Boyle et al., 2008). As open chromatin regions are more accessible, DNAse I cleaves 
DNA in these regions more frequently, thereby leaving regions in a closed chromatin state 
intact. By sequencing and mapping the remaining DNA, regulatory elements appear from a 
depletion in sequence coverage. Such procedures are often used to narrow the window for 
finding causal variants. 
 
A detailed mechanistic and predictive comprehension of the biophysical relationship 
between sequence variants and protein function is underlying a wide number of biological 
and biotechnological principles. In addition, non-synonymous mutations in protein-coding 
sequences are thought to underlie ± 57 % of the disease-linked genomic variants (Stenson et 
al., 2017). To give meaning to genomic variants and to understand the consequences of each 
of these structural variants on the fitness and functioning of a cell or organism is crucial and 
comprises a large portion of the work of geneticists.  
 
Predicting the function of genetic elements and how genomic variants can affect a 
phenotype, e.g. protein function, can prove complex. For example, a variant in an exon far 
away from a binding site or active site can affect the functioning of a protein due to a change 
in thermodynamic stability or enzymatic activity of the protein (Spiller et al., 1999; 
Shimotohno et al., 2001; Freeman et al., 2011). Some highly conservative mutations (i.e. 
amino acid substitutions without a large change in biochemical properties) may be 
deleterious, neutral or hyperactivating (Fowler and Fields, 2014). Alternatively, a 
destabilising mutation can rescue or compensate for a destabilising mutation (Bloom et al., 
2005). Further contributing to the complexity of genotype-phenotype relationships, the 
effect of some mutations might require the presence of another, a phenomenon termed 
epistasis (Aita et al., 2002; Hayashi et al., 2006). If mutations have negative epistasis, their 
effects are less beneficial than expected from their effects when alone, whilst positive 
epistasis indicates that the effect of the mutations is synergistic, i.e. larger than the sum 




confidently predict the effects of such mutations on protein stability and thus require 
mutational data to discriminate between the predicted structures (Fowler and Fields, 2014). 
  
Several computational approaches have been developed to determine the impact of genetic 
variants. SIFT and PolyPhen (Polymorphism Phenotyping) are such tool that annotates coding 
nonsynonymous SNPs and predicts the effects of the subsequent amino acid substitutions 
(Adzhubei et al., 2010; Sim et al., 2012). Both base these predictions on evolutionary 
sequence homology and the physical properties of amino acids. Similarly, the CADD 
(Combined Annotation Dependent Depletion) tool scores SNVs based on their 
deleteriousness, but rather than giving an absolute score it ranks variants based on their 
predicting effects without a defined cut-off and is therefore less suitable for the analysis of 
small numbers of variants (Rentzsch et al., 2018). Whereas in silico predictions are a suitable 
method to obtain an initial prediction, they do not compete with in vitro and in vivo 
validations of these mutations.  
 
1.3.4 Deep mutational scanning 
Through the combination of next-generation sequencing (NGS) and single-cell analysis 
technologies, mutagenesis screenings can be performed to assess hundreds of thousands of 
unique variants in a protein on a large scale simultaneously. This process, known as deep 
mutational scanning (DMS) (Araya and Fowler, 2011), has been applied in several cases to 
study protein structures over the last years. Cells that express allelic variants of a protein-
coding gene (typically introduced from a plasmid or virus) are coupled to a phenotypic 
screen. However, in addition to isolating variants that harbour the phenotype of benefit as 
with directed evolution (see section 1.3.4), DMS can give meaning to genomic variants in 
order to interrogate the protein structure. The phenotypic screen in DMS enriches cells with 
the desired variant activity whilst cells that harbour a negative variant are depleted. By 
determining the number of variants present in both the starting pool and the screened pool 
by deep sequencing, an enrichment score can be calculated for each variant (see Figure 1.2). 
While alanine scanning can reveal the specific catalytic residues in the primary structure of a 
protein, DMS additionally reveals information on secondary and tertiary structure by 
elucidating advantageous mutations in a parallel screen. A wide range of selection schemes 




selection (Ge et al., 2010; Sarkisyan et al., 2016; Rocklin et al., 2017), selecting for protein, 
RNA and regulatory elements (reviewed in Araya and Fowler, 2011). Library synthesis that is 
required for DMS is further discussed in section 1.6.3. 
 
1.3.5 Directed evolution 
The present-day sequence of a genome is the product of millions of years of successive 
genetic change and selection for a certain phenotype, e.g. fitness. These Darwinian principles 
have been applied to yield desired phenotypes over thousands of years to breed animals and 
plants with desired phenotypes. With the onset of molecular techniques, evolution can be 
applied in a directed fashion on the level of single cells or even single molecules rather than 
an entire organism. Hereby, successive rounds of mutagenesis and phenotypic selection are 
applied to yield a desired phenotype, e.g. protein function, which is the underlying principle 
of directed evolution (see Figure 1.3) (Romero and Arnold, 2009).  
 
Directed evolution is an application of DMS and are performed by introducing different 
modifications in the genetic element of interest. The pool of cells bearing these different 
mutations can subsequently be exposed to a phenotypic screen on the protein level, such as 
catalysing a reaction or interactions with other proteins, to select for more beneficial 
phenotypes. Repetitive cycles allow for rapid evolution and the selection of a desired 
phenotype, thereby allowing for the optimisation of existing properties and evolution of 
proteins towards new goals.  
 
As even for a small protein of 100 amino acids there are more possible amino acid sequences 
(20100) than there are atoms in the universe (1080) (Smith, 1970), there is a tremendous 
spectrum of proteins that can be engineered through directed evolution that are not found 
in nature. While most polypeptides do not encode a stable protein (and even more unlikely 
a protein with the desired phenotype) (Govindarajan and Goldstein, 1997; Taverna and 
Goldstein, 2002), studies have shown that most random amino acid substitutions are 
tolerated (Guo, Choe and Loeb, 2004; Bloom et al., 2005). This is an important given for 
evolution as single nucleotide mutations, the most frequent mutation type occurring 
naturally, in genes important for fitness would otherwise always lead to a lower fitness and 






Figure 1.2 Deep mutational scanning generates large-scale mutational data Deep 
mutational scanning relies on both high-throughput mutagenesis and high-throughput 
sequence analysis and allows for systematic structural analysis of protein variants. Starting 
with an initial pool, sequence variants are introduced at equal rates through mutagenesis, 
creating a heterozygous library of sequence variants. These sequences are then subjected to 
a phenotypic screen (e.g. survival) by which selection is imposed. By assessing the frequency 
of each variants in the pool before and after screening, a functional score can be calculated 
(bottom). Mutations that are enhancing fitness have a functional score larger than 1, 
whereas mutations that have a negative effect on fitness have a value between 0 and 1. 
 
 
Figure 1.3  Directed evolution to yield desired phenotypes With directed evolution, the aim 
is to yield an enhanced or novel phenotype (e.g. enzyme activity or fluorescence) by 
sequential rounds of sequence diversification and selection for a desired phenotype. First of 
all, a suitable parent or target sequence (gene) and suitable phenotypic screen need to be 
selected. The target sequence is diversified, such that different clones each harbour a 




These can be retargeted to further diversify the sequence and enhance the phenotypic 
selection until the desired phenotype has been met.  
 
neutral or deleterious and only 0.01 - 1% is beneficial (reviewed in Romero and Arnold, 2009), 
directed evolution screens are most optimal by introducing only a single or two changes per 
cycle, by which the desired phenotype is often met after only five to ten cycles (Romero and 
Arnold, 2009). 
 
Directed evolution has become a common tool for acquiring proteins or genetic elements 
with an optimised or novel function. Besides the eventual optimised product, it can also 
improve our understanding of genetic and protein structures. 
 
1.3.6 Saturation mutagenesis   
For the generation of sequence libraries used in directed evolution or DMS, in situ 
mutagenesis through chemical agents was initially the gold standard. However, limitations 
included the targeting specificity and on-target efficacy. As an alternative, saturation 
mutagenesis provides a sophisticated approach through which a variant library of all possible 
amino acids at a particular site in a genetic sequence is constructed. Many approaches have 
been developed to achieve this, including the treatment of PCR fragments with chemicals or 
error-prone PCR amplification to introduce nucleotide mismatches (Myers, Tilly and 
Maniatis, 1986; Cunningham and Wells, 1989). These DNA sequences are subsequently 
cloned into a plasmid backbone and introduced into mammalian cells by episomal or viral 
gene transfer. Saturation mutagenesis is often used to construct libraries which are 
subsequently used in directed evolution experiments in single cell organisms including 
budding yeast (Saccharomyces cerevisiae) and bacteria (Escherichia coli) (Derbyshire, Salvo 
and Grindley, 1986; Zheng, Baumann and Reymond, 2004; Reetz et al., 2010), though its 
application in higher organisms has been limited due to the difficulty of introducing and 
comparing genetic variants at large scale.  
 
1.3.7 DNA library synthesis 
In addition to saturation mutagenesis, several other strategies can be used to synthesise 
diverse repair template libraries in order to perform directed evolution. Gene synthesis can 




diversity at the nucleotide or codon level, whilst reducing costs and improving throughput 
(Wan et al., 2017). Gene synthesis allows to minimise bias and can as such create libraries 
with equal proportions of codon variants, or avoid the introduction of stop codons or 
multiple non-consensus codons.  
 
Nucleotide sequences can be synthesised in bulk and can be integrated into the genome 
through several techniques, which are further discussed in sections 1.4 and 1.5. Whilst single-
stranded oligodeoxynucleotides (ssODNs) typically yield increased genomic integration rates 
compared to dsDNA donors (Chen et al., 2011; F Ann Ran et al., 2013; Renaud et al., 2016), 
these strategies are less commonly used for library diversification and require alternative 
DNA repair mechanisms. For oligonucleotide synthesis, deoxyribonucleotide triphosphates 
(dNTPs) are sequentially coupled to the growing oligonucleotide chain in the order required 
by the sequence of the product, typically up to 200 bp (Stemmer et al., 1995). In order to 
yield diversity, partially degenerate oligos are used in some studies, whereby during 
particular cycles of the synthesis, a number of possible dNTPs are mixed and incorporated at 
equal rates during synthesis, such that any of the nucleotides gets incorporated at random 
at the specified sites, whilst at other positions a fixed nucleotide gets incorporated. Instead 
of completely random codons, most often the complete set of standard amino acids is 
encoded using NNK or NNS codons, where K represents G or T and S represents C or G, as it 
lowers the probability of a premature stop codon and simultaneously induces a more 
uniform distribution of the 20 standard amino acids, compared to the distribution induced 
by the NNN codon (Patrick and Firth, 2005).  
 
A similar process is oligonucleotide doping, whereby mixed base composition at specific sites 
are yielded by skewing the rate towards one dNTP, such that the other dNTPs are 
incorporated at much lower rates than with degenerate oligonucleotides. The disadvantages 
of degenerate oligonucleotides and oligonucleotide doping are that due to the random 
nature, (1) the co-occurrence of multiple mutations is likely and (2) there will be a skew 
towards codons that require only one or two nucleotide changes, thereby resulting in an 
unequal representation of codons in the library. The latter is advantageous as it reflects 
patterns of human mutations, while it simultaneously reduces the proportion of protein 





DMS has proven its applicability in a wide range of systems and is a suitable way to scan 
protein structures and the effect on both mRNA transcription and protein translation in 
several ways as discussed in section 1.1.3. Although plasmids and viral vectors provide a 
suitable way to drive directed evolution or DMS, transient expressions are not always able to 
capture the subtleties and complexity of cell regulation (Gibson, Seiler and Veitia, 2013). 
Genetic variances are hence best studied in their native sequence and epigenetic context, 
with the presence of endogenous transcription factors and normal expression levels the cell 
is found in. Hence, I will next discuss how genetic variants can be introduced into their 
genomic context and the historical context of mutagenesis.  
 
1.4 Genome editing 
1.4.1 Mutagenesis through radiation and chemical agents 
Long before the discovery of the DNA double-strand helix, scientists pioneered ways to 
introduce mutations into the genome. When the term ‘mutation’ was coined as a process of 
‘discontinuous heritability’ by De Vries (De Vries, 1914), he envisioned the induction of 
directed mutations, which would provide man with ‘unlimited power over nature’. After that, 
the field of genetics underwent rapid development through the discovery of heritable 
principles such as chromosomal crossing and genetic mapping (Sturtevant and Morgan, 
1923), but their attempts to induce mutations with ether or ethanol remained unsuccessful. 
Indeed, the chemical nature of mutations remained a major and controversial question in 
the field until Hermann J. Müller discovered that X-rays had a mutagenic effect in Drosophila 
(Muller, 1927). Muller realised as a first that, in addition to inheritance and variability, genetic 
changes can spontaneously arise and passed on to subsequent generations, a fundamental 
insight for evolution. Whereas the previous decades of Drosophila work across the globe 
discovered approximately 200 mutations, Muller’s first experiments with X-ray-induced 
mutations allowed him to find half of that number in less than two months (Carlson, 2007). 
This work greatly changed the concept of genetics, realising that our heritable material could 
be altered by man, therewith placing evolution in his control. Shortly after, Müller’s 
collaborator Altenburg elucidated that ultraviolet (UV) radiation similarly induced alterations 





Later, Delbrück, Timoféeff-Ressovsky and Zimmer concluded from experiments with X-rays 
that the gene might have a defined structure which could be decoded (Timoféeff-Ressovsky, 
Zimmer and Delbrück, 1935). This discovery subsequently lead to the establishment of the 
first phage group, considered the birth of molecular biology (Friedberg, 2002), which 
discovered that both X-rays and UV radiation could induce viral resistance in bacteria by 
increasing the mutation rate (Luria and Delbrück, 1943). In the same years, in addition to 
radiation, many chemical mutagens were discovered and thus provided initial means to alter 
the DNA prior to its discovery (reviewed in Auerbach, 1949). 
 
1.4.2 Recombinant DNA 
Recombinant DNA technologies in the 1970s provided scientists with the ‘technical ability to 
join together, covalently, DNA molecules from diverse sources’ and provided huge advantages 
in the manipulation of DNA molecules (Singer and Soll, 1973). Recombinant DNA allowed for 
the interrogation of genetic function out of their native context and through the 
manipulation of homologous recombination (HR, further discusses in section 1.6) (Capecchi, 
1989), exogenous DNA sequences with homology to the donor site could be integrated into 
the genome. Despite this technological breakthrough, the extremely low success rate of 
integration (1 in 106 - 109 cells) restricted the scale onto which these techniques can be 
applied. The use of the non-pathogenic adeno-associated virus type 2 (AAV) to transduct 
mammalian cells with recombinant DNA increased the rate of successful integration of DNA 
over 1% (Hermonat, Muzyczka, PNAS 1984), making it one of the most powerful methods for 
DNA manipulations for decades.  
 
Similar approaches have proven more successful in other approaches, species and cell types. 
For example, manipulations of DNA in Saccharomyces cerevisiae were relatively effective 
compared early on in the field of genetics due to the use of shuttle vectors which were not 
effective in mammalian systems (Sikorski and Hieter, Genetics, 1989). Similarly, the chicken 
DT 40 B cell line has been a popular due to the ease of genetic manipulations exceeding any 
other mammalian cell line (Winding, Berchtold JIM 2001). The genetic editing of mouse of 





1.4.3 Genome editing 
In the past two decades, developments in the field of genome editing have allowed for the 
introduction of site-specific modifications in a genetic sequence in its endogenous context 
(Carroll, 2008). Genome editing enables specific and precise mutagenesis through the 
recruitment of DNA-binding factors that create a double-strand break (DSB) at the target site. 
The outcome of the subsequent, endogenous DNA repair mechanisms will be determinant 
for the eventual result of the genome editing strategy used, which is further discussed in 
section 1.6 (Bibikova et al., 2003).  
 
Technologies that can conveniently insert, delete and alter the nucleic sequence in a precise 
manner in either cells or whole organisms allow for the dissection and reconstruction of 
cellular networks in a wide range of applications. In biotechnology, the combination of 
genetic building blocks with genome editing tools allows for the development of disease-
resistant crops or the production of biofuels. Within medicine, genome-manipulating tools 
allow for the repair of genetic alterations that underlie diseases or for the discovery of novel 
drug targets by selectively knocking out a single or multiple genetic element.  
 
The tethering of the nuclease domain of the FokI restriction enzyme to the DNA-binding 
domain of eukaryotic transcription factors known as zinc-finger proteins (ZFP), known as  
zinc-finger nucleases (ZFNs) (Bibikova et al., 2003; Porteus and Carroll, 2005; Urnov et al., 
2010; Wood et al., 2011), gave birth to the first tools to yield site-specific DSBs (see Figure 
1.4A). Soon after, fusion of the same FokI nuclease domain to transcription activator-like 
effector (TALE) domains gave rise to the modular transcription activator-like effector 
nucleases (TALENs; Figure 1.4B) (Boch et al., 2009; Morbitzer et al., 2010; Miller et al., 2011; 
Wood et al., 2011). Due to its nickase activity, the FokI domain requires dimerization in order 
to induce DSBs in both ZFN and TALEN approaches, thus requiring two separate binding 
events, which greatly enhances the targeting specificity.  
 
The ZFP domain of a ZFN monomer contains a tandem array of up to six Cys-His2 fingers that 
each recognises a 3bp DNA region (Wolfe, Nekludova and Pabo, 2000). In TALENs, a single 
TALE repeat binds to a single base pair of DNA (Boch et al., 2009). Due to design efficiencies, 





Figure 1.4 ZFNs and TALENs allow for precise introduction of genomic disruption Both ZFNs 
and TALENs utilise a non-specific FokI cleavage domain, which requires dimerisation in order 
to introduce a double-strand break in the spacer region (grey dashed box). ZFNs consist of 
DNA binding subdomains (i.e. fingers, 12-31 repeats), which each recognises a specific 
nucleotide triplet. By using two pairs of different fingers, ZFNs specifically introduce a break 
at the target site. Similarly, TALENs consist of subdomain that bind to specific single 
nucleotides, thereby having an increased programmability over ZFNs. TALENs can entail up 
to 18 repeats, thus recognising 36 nucleotides specifically, whereas ZFNs can be built from 
up to six fingers, recognising 24 nucleotides. 
 
recognised nucleotide sequence being much easier to predict in silico, TALENs are highly 
programmable and considered to be advantageous over ZFNs or the less frequently used 
homing endonucleases (Smith et al., 2006) for introducing targeted DSBs, but as a single TALE 
repeat (each repeat 33-34 amino acids in size) is needed for each target nucleotide, TALENs 
with single site specificity are larger and somewhat harder to deliver than ZFNs.  
 
Genome editing with ZFNs and TALENs revolutionised the field of genetics, as precise editing 
of the genomic sequence had become scalable (compared to previous approaches) and 
efficient compared to recombinant DNA. However, as the construction of TALENs is still 
costly and requires labour-intensive protein engineering for each retargeting, it still limited 
the application of genome editing at a large scale.   
  
1.5 Genome editing using CRISPR-Cas9 
The adaptation of the bacterial CRISPR-Cas9 system from Streptococcus pyogenes (SpCas9) 
to eukaryotic cells provided large improvements in both efficiency and ease of design of 




examine the background of the CRISPR-Cas system and its manipulation for precise genome 
editing.  
 
1.5.1 CRISPR-Cas systems mediate adaptive immunity in bacteria 
Many bacterial genomes encode clustered regularly interspaced short palindromic repeats 
(CRISPRs), which are transcribed and processed into short RNAs that guide CRISPR-associated 
(Cas) proteins to cleave foreign nucleic acids of invading viruses or plasmids (or close 
relatives) that have previously been encountered (Ishino et al., 1987; Jansen et al., 2002; 
Barrangou et al., 2007; Garneau et al., 2010), thereby functioning as an adaptive immune 
system against these invaders (see Figure 1.5A).   
 
Upon phage infection, CRISPR arrays in the bacterial host can acquire new repeat-spacer 
sequences that match the infecting virus, thereby guiding Cas proteins to cleave the foreign 
DNA upon a subsequent infection by the same or closely related viral strain. Only cells with 
these newly acquired sequences will survive infection with this agent, meaning that the 
spacer content of CRISPR arrays reflects the phages and plasmids it has been exposed to 
previously (Barrangou et al., 2007; Doudna and Charpentier, 2014). This genetic memory 
allows the bacteria to rapidly develop an immune response to the agents it reencounters.  
 
CRISPR-Cas systems are classified in three types (I, II and III), which use characteristic 
mechanisms to recognise and cleave the foreign DNA (Makarova et al., 2011). Cas proteins 
require a CRISPR RNA (crRNA) that specifically recognises a foreign phage or plasmid DNA 
sequence and therewith guides Cas cleavage (Brouns et al., 2008). Cas type I and II systems 
require an additional protospacer-adjacent motif (PAM) adjacent to the crRNA binding site 
on the invading DNA (Mojica, García-Martínez and Soria, 2005). Whereas type I and type III 
systems utilise a complex of multiple proteins for the cleavage of target strands, type II 
systems only require a single Cas protein (Gasiunas et al., 2012; Jinek et al., 2013), making 
these systems convenient for genome engineering.  
 
The type II Cas9 system in Streptococcus pyogenes (SpCas9) is the best studied system and 
consists of two nuclease domains: HNH and RuVC-like (see Figure 1.5B) (Tang et al., 2002; 




Vergnaud, 2005). The HNH domain of Cas9 is used for the cleavage of the DNA strand that is 
complementary to the sgRNA sequence, whilst the RuVC domain cleaves the adjacent strand 
at the same site to produce a blunt ended DSB.  
 
As mentioned, for the recognition of the target strand, the crRNA requires a PAM sequence 
directly adjacent, typically NGG, further guiding the Cas9 nuclease to introduce a DSB 
between three and four nucleotides upstream of the PAM. In order for Cas9 to bind to the 
target site, it requires a dual RNA complex of the crRNA and another small trans-activating 
crRNA (tracrRNA) (Jinek et al., 2012).  
 
1.5.2 CRISPR-Cas9 system for highly efficient, targeted editing of genetic sequences 
Through codon optimisations, the CRISPR-Cas9 system was optimised for the use in 
eukaryotic cells and proved its ability to cleave specified target strands in human cells (Cong 
et al., 2013; F Ann Ran et al., 2013; Jinek et al., 2013; Mali et al., 2013). This discovery 
promoted genome editing from a technical possibility to a more practical reality that could 
be routinely used by allowing highly efficient, programmable nucleases to be designed and 
assembled in a quicker and more efficient manner. The crRNA and tracrRNA were engineered 
into a single guide (sgRNA) that still contains both the 20-nt recognition sequence at its 5’-
end and a more complex structure allowing for the binding of Cas9 on the 3’end (see Figure 
1.5B). In contrary to laborious protein engineering necessitated by TALENs and ZFNs, the 
targeting of CRISPR-Cas9 can be adjusted to any genomic sequence adjacent to an NGG PAM 
by altering the 20-nt target sequence, making it a convenient two-component system for 
genome editing applications.  
 
1.5.3 Alternatives to using SpCas9 for genome editing 
Since the emergence of CRISPR-Cas9 as a targetable genome editing tool in a wide variety of 
species, genome editing became available for the wide audience and has been modified to 
be repurposed to allow for a wide range of applications. Besides SpCas9, which limits editing 
to a region containing the NGG PAM motif, a wide variety of optimised Cas9 proteins have 
broadened the scope of PAM sequences that can be targeted (summarised in (Komor, Badran 





Figure 1.5 CRISPR is an adaptive immune system in bacteria and can be utilised for precise 
genome editing (A) In bacteria, the CRISPR locus contains clusters of both repeats (black 
diamonds) and spacers (coloured squares), which are preceded by a leader sequence (L) and 
a CRISPR-associated (Cas) operon. Upon viral infection (1), the Cas complex cleaves the viral 
genome and incorporates these new spacers into the CRISPR locus (2). After transcription of 
the CRISPR repeat spacer, the crRNA is cleaved into small crRNAs (3). Upon a novel infection, 
the crRNA recognises the viral genome (4) and binds with a 20-nt spacer directly adjacent to 
a protospacer adjacent motif (PAM). Through this binding, a tracrRNA (not shown) and the 
Cas complex can bind, after which Cas9 inactivates the foreign DNA through cleavage (5). 
Figure adapted from Barrangou et al., 2015. (B) The CRISPR-Cas9 system from S. pyogenes 
has been adapted to allow precise genome editing in eukaryotic cells, requiring a single guide 
RNA (sgRNA) and Cas9 protein. This sgRNA contains a 20nt protospacer (pink) that binds to 
a complementary sequence adjacent to an NGG PAM, whilst the rest of the sgRNA allows for 




cleavage on respectively the PAM-distal and PAM-adjacent strand, 3 nt upstream of the NGG 
PAM. Figure adapted from Ran et al., 2013. 
 
identified to have RNA-guided DNA cleavage activity in eukaryotic cells, amongst which Cpf1 
notably requires a TTTN PAM at the 5’ rather than the 3’ end of the protospacer and induces 
staggered rather than blunt DSBs (Zetsche et al., 2015). These variants to SpCas9 greatly 
broaden the scope and allow for more specific targeting to regions not accessible when 
restricting to an NGG motif, although SpCas9 remains the most frequently used nuclease.  
 
A series of variant Cas9 proteins (xCas9) was similarly developed through directed evolution 
to recognise a broader range of NG PAMs (instead of the conventional NGG sequence), 
thereby expanding the targeting space of targeted nucleases (Hu et al., 2018). These proteins 
can function in different contexts including DNA base editing showing lower off-target 
activity, but is outcompeted in recognising NGH PAMs in vitro by a recently published SpCas9 
variant (Nishimasu et al., 2018). Such advances in evolving and engineering Cas9 enzymes 
improve the applicability of genome editing in context difficult to target with conventional 
spCas9.  
 
One limitation in the application of CRISPR-Cas9 for therapeutic purposes is the cleavage at 
genomic regions other than the targeted site, known as off-target effects, to which several 
solutions have been found. Firstly, truncation of the sgRNA can limit off-target DSBs, which 
is hypothesised to be due to the resulting decrease in tolerance for mismatches(Tsai et al., 
2015). Secondly, the delivery of pre-constructed Cas9:sgRNA ribonucleotide protein 
complexes (RNP) rather than plasmid expression results in a shorter, more transient effect, 
thus preventing Cas9 to linger around for too long and exert off-target activity (Lin et al., 
2014). By reducing the interaction between Cas9 and the substrate DNA, it was also possible 
to ensure Cas9 only cleaved the intended target (Slaymaker et al., 2015). Additionally, 
whereas Cas9 by default creates a blunt double-strand break, interference with either of the 
nuclease domains, SpCas9 (HNH (Cas9N863A) or RuVC (Cas9D10A) (see Figure 1.5B)), results in 
the development of two nickase (Cas9n) variants that create a single-stranded DNA break on 
either the target or complementary strand (F. Ann Ran et al., 2013; Mali et al., 2013), thus 
requiring the independent binding of two different nickases in order to create a double 




to be recruited to Cas9-induced DSB sites and can therefore be allowed to specifically identify 
off-target sites (Richardson et al., 2018). These approaches reduce potential off-target 
effects and thus further enhance the applicability of CRISPR-Cas9 as an editing tool in 
mammalian cells.    
 
1.6 DNA damage repair in genome editing 
As genome editing tools including CRISPR-Cas9 merely create lesions in the target DNA, the 
mutational outcome wholly relies on the subsequent response in the host cell. DNA-based 
genomes have developed in an environment set for aerobic metabolism and photosynthesis 
(Blankenship and Hartman, 1998; Falkowski et al., 2005). As such, from the early stages of 
evolution, organisms already had to cope with DNA-damaging factors such as UV light and 
reactive oxidative species. Still in dividing mammalian cells today, an estimated average of 
ten DNA double-strand breaks (DSBs) occur per cell daily (Chang et al., 2017). As cells cannot 
function with sustained DNA damage, evolution would not have been possible without the 
development of systems to dampen the most harmful effects of DNA damage. It is therefore 
not surprising that a wide array of DNA damage response (DDR) pathways can be found in 
eukaryotes, whereby each DDR pathway targets specific types of damage and errors. In this 
section, the main DDR pathways thought to act during CRISPR-Cas9 genome editing will be 
reviewed. However, much of our knowledge of these pathways comes from studies of DNA 
damage induced by agents other than genome editing nucleases and their relevance to 
CRISPR mutagenesis is thus still a very active area of research to this day (C. D. Richardson et 
al., 2016; Brinkman et al., 2018).  
 
1.6.1.1 Double-strand break repair 
Like most other genome editing tools, Cas9 typically creates a DSB at the target site, after 
which the subsequent DNA-repair machinery of the cell determines the outcome of editing. 
These DSBs can be highly damaging to a cell and can result in translocations, inversions or 
fragmentation of the DNA, especially when used with multiple sgRNAs (Canver et al., 2014; 
Boroviak et al., 2017; Kosicki, Tomberg and Bradley, 2018). As such, cells aim to minimise 
eventual scarring of the DNA by deploying either of the two major repair pathways: non-
homologous end-joining (NHEJ) or homology-directed repair (HDR), in which the former does 
not use a homologous template and the latter does. Each of these are subdivided into 





1.6.1.2 Non-homologous end joining 
In the absence of a homologous repair template, localised DSBs are repaired through 
canonical/classical NHEJ (c-NHEJ), which is the primary pathway for DSB repair. After 
detection of the break, the Ku70/Ku80 heterodimer and DNA-PK catalytic subunit (DNA-PKcs) 
stabilise the two ends of the break by forming the DNA-PK holoenzyme (see Figure 1.6A) 
(Meek, Dang and Lees-Miller, 2008). The DNA-PK holoenzyme recruits factors necessary to 
trim (nucleases) or fill in (polymerases) the termini after which these get directly ligated with 
DNA ligase IV and Xrcc4 (Li et al., 1995; DiBiase et al., 2000; Wang et al., 2001).  Hence, c-
NHEJ often leads to insertions or deletions (indels) at the target site, or in rare cases 
translocations. However, perfectly repaired DNA is indistinguishable from DNA that has 
never been broken and thus cannot be measured post hoc, and successive cycles and 
cleavage and perfect repair could underlie a grossly overrated rate of errors. Published data 
has suggested that most Cas9-induced breaks are actually repaired via error-free repair 
(Bhargava et al., 2018), whilst the accuracy of rejoining is still a major point of debate and 
has been disputed by others (Brinkman et al., 2018). The vast majority of c-NHEJ repair of 
CRISPR-Cas9-induced breaks that can be measured through mutations typically results in 
indels not extending 20bp in length (Koike-Yusa et al., 2014; Tan et al., 2015; van Overbeek 
et al., 2016), although large indels up to 25 Mb have been observed (Birling et al., 2017; 
Kosicki, Tomberg and Bradley, 2018). This application of genome engineering is convenient 
in knock-out screens of genes, as indels in an exonic sequence often result in frameshifts or 
premature stop codons (Rouet, Smih and Jasin, 1994).  
 
In addition to c-NHEJ, alternative end-joining (alt-EJ, including microhomology-mediated end 
joining (MMEJ)) repair refers to repair events that are independent of c-NHEJ factors such as 
Ku proteins and is instead mediated by PARP1 and DNA polymerase q (Pol q) following 
resection of the 5’ ends of the break (see Figure 1.6B) (Howard, Yanez and Stark, 2015). Alt-
EJ is considered highly mutagenic and its frequency increases as a result of the loss of c-NHEJ, 
a feature it shares with HR and SSA (discussed in the next section). One hallmark of alt-EJ is 
microhomology, although this is not absolutely essential for alt-EJ (Bennardo et al., 2008) 
and can also be used by c-NHEJ (Pannunzio et al., 2014). In general, alt-AJ is considered 
important for completing repair of aborted HR initiation events, e.g. in the absence of a sister 




However, as mentioned before, the relative contribution of each DDR pathway remains 
largely uncharacterised.    
 
1.6.1.3 Homology-directed repair 
HDR comprises at least three sub-pathways: single strand annealing (SSA), synthesis-
dependent strand annealing (SDSA) and homologous recombination (HR) (see Figure 1.6B-
D). In contrast to NHEJ, HDR typically involves many more protein factors and extensive 
resection of the DNA ends to uncover sequence homology (Lieber, 2010); whereas NHEJ 
requires <4 bp homology, SSA requires >20 bp and the most conservative pathways (i.e. HR 
and SDSA) require >100 bp in length (reviewed in Chang et al., 2017). HDR is the preferred 
pathway over NHEJ to minimise eventual scarring of the DNA. However, as with much of the 
work in the DNA repair field, it is important to note here that much of this work has been 
performed in S. cerevisiae and the extent to which these findings can be extrapolated to 
other species (and their specific cell types) remains to be determined. Furthermore, whereas 
HDR is an umbrella term covering SSA, SDSA and HR, in relation to genome editing, the 
abbreviation HDR is typically used for the introduction of an exogenous sequence. 
 
During all HDR pathways, 5’-end resection results in 3’ ssDNA overhangs, which are protected 
from further resection and secondary structure by Replication Protein A (RPA) (see Figure 
1.6). RPA mediates the formation of a protein complex at the 3’-end including Rad51, Rad52 
and BRCA2, after which Rad51 scans the rest of the genome for homology (Mehta and Haber, 
2014). With help of Rad54, Rad51 catalyses homology-search, strand-pairing and strand-
exchange.  
 
SDSA requires a single DNA strand to find its complementary strand, which is used as a 
template for DNA polymerase for incorporation. A holiday junction is then formed from the 
3’-end, invading the homologous template (see Figure 1.6C), after which DNA polymerase 
resynthesises the strand.  
 
HR is highly regulated and also requires homology on the sister chromatid or exogeneous, 
double-stranded DNA donor as a template in genome editing experiments (see Figure 
1.6D)(Bothmer et al., 2017; Kan et al., 2017). In contrast to SDSA, it forms a double holiday 





Figure 1.6 DNA double-strand breaks can be repaired through different repair mechanisms 
When a double-strand break (DSB) occurs in a cell, different mechanisms result in different 
repair outcomes. (A) Ku70 and Ku80 proteins are typically present at high abundance and 
form heterodimers that bind at the DSB, where they form a DNA-PK holoenzyme that 
stabilises the two ends of the break together with DNA-PK catalytic subunit (DNA-PKcs). Once 
stabilised, these ends are either trimmed or filled in by respectively nucleases or DNA 
polymerases (not shown), after which XRCC4 and Ligase 4 together directly ligate the ends. 
NHEJ typically results in short (<10bp) insertions or deletions. In case Ku proteins do not bind 
to the DSB ends, both of the 5’ ends are resected, creating free sticky ends, which are 
stabilised by capping with RPA proteins. The restricted ends then allow for SDSA, HR or SSA 




chromatid, reanneals the resected strands, leading to frequent or the loss of genetic 
information. One form of alt-EJ, MMEJ, can involve microhomology to guide the reannealing 
of the broken strands. (C) SDSA involves a set of proteins including Rad51, which bind to one 
of the free 3’ ends and allows to search for homology, either on the sister chromatid (in red) 
or an introduced DNA template. Through the formation of this single Holliday Junction by 
Rad51 and co-factors, the homologous template sequence is copied in, after which the strand 
is ligated. In the meanwhile, the other 5’ end is resynthesised. (D) Similar to SDSA, HR invades 
the sister chromatid, but contrastingly forms a double Holliday Junction., thereby copying in 
the sister chromatid on both strands. In addition to synthesis, a cross-over between the two 
sister chromatids can occur, through which the sister chromatid is also altered (not shown). 
(E) With SSA, a homologous region on the same strand (in cyan) is used by Rad52 to re-ligate 
the two strands together, thereby creating 3’ overhangs, which are resected by nucleases, 
after which a ligase reattaches the strands. SSA results in the loss of information initially 
present between the two homologous regions. (F) The Fanconi Anemia (FA) pathway is 
involved in the repair of interstrand crosslinks (ICL) and stalled replication forks. Upon 
binding of FA-associated proteins including FANCA to the damaged site, these factors recruit 
and activate (ubiquitinate) FANCD2 and FANCI, which in turn can recruit other DDR factors. 
 
hence be utilised to yield precise indels or substitutions by the introduction of repair 
templates with homology to the target sites.   
 
Contrastingly to SDSA and HR, which both require Holliday Junctions and a sister chromatid 
or exogenous template with homology, SSA promotes annealing between interspersed 
stretches of homologies placed on the same chromosome (see Figure 1.6E), resulting in the 
loss of the intermediate sequence, and thus results in the loss of genetic information 
(Ceccaldi, Rondinelli and D’Andrea, 2016). In mammals, SSA is suppressed by other repair 
pathways and hence serves as a back-up pathway, and as such is considered to be suitable 
for repair of regions with tandem repeats (Dueva and Iliakis, 2013). Contrastingly, it has to 
be noted that SSA in S. cerevisiae is highly efficient (Ivanov et al., 1996), illustrating the 
difficulty in generalising research findings from one system to another.  
 
The Fanconi Anemia (FA) (see Figure 1.6F) pathway is a fourth DDR mechanism involving 
homology, which recently gained increased interest due to its involvement in single-strand 
template repair (SSTR) from ssODNs (Richardson et al., 2018). SSTR is a poorly defined 
mechanism thought to be similar to SDSA, although using a single-stranded rather than a 
double-stranded template and being Rad51 independent (Gallagher and Haber, 2018). 
Normally, FA is associated with interstrand crosslink repair and stalled replication forks 




ssODN mimics a stalled replication fork (Richardson et al., 2018). Recruitment of FA-
associated core proteins promotes the localisation of the FANCD2/FANCI heterodimer to 
Cas9-induced DSBs, where it is proposed to act as a ‘traffic light’ as to whether a DSB should 
be repaired through SSTR (Richardson et al., 2018). As these are very novel findings and 
hypotheses, further investigations should elucidate the involvement of the FA pathway in the 
repair of DSBs from ssODNs. 
 
1.6.1.4 Ratio of NHEJ to HDR 
As sister chromatids are not produced until S phase, in a normal situation (i.e. when no 
exogenous homologous DNA template has been introduced) HDR can only take place in S or 
G2 phase in mitotic cells (Saleh-Gohari and Helleday, 2004). Whilst DNA damage in non-
dividing, terminally differentiated cells gives rise to DNA damage repair, proliferating cells 
first stall the cell cycle at different checkpoints in order to repair DNA damage prior to cell 
division (Zhou and Elledge, 2000). As Ku proteins are typically present at high abundance in 
cells and prevent extensive restriction of the DNA-ends, repair through NHEJ is typically 
favoured (Mimitou and Symington, 2010). This skew towards NHEJ is likely to be a time 
constraint on damage control, as NHEJ is a rapid mechanism (several minutes), relatively 
error-free (Wang et al., 2001) and thus limits the time that a DSB exists and thus the amount 
of additional damage occurring in the genome. 
 
Cells in G1 favour NHEJ over HDR by more than 50-fold, whereas in other cell cycle phases 
this ratio is estimated to be closer to 4:1 (Beucher et al., 2009; Chang et al., 2017) (Chang et 
al., 2017). Therefore, the rate of HDR differs between cell types and is typically out-
numbered by NHEJ, typically resulting in HDR efficiencies < 5% after cleavage with Cas9 
(Komor, Badran and Liu, 2017). This is currently a major limitation in the field of precise 
genome editing. Several chemical approaches are shown to have positive results on 
increasing the HDR to NHEJ ratio, for example, by using Scr7 to inhibit a DNA ligase (Lig4) 
necessary in NHEJ (Vartak and Raghavan, 2015) or by enhancing Rad51 involved in HDR using 
a dsDNA template (Pinder, Salsman and Dellaire, 2015), although these processes themselves 
are cell type and  cell state dependent and are hence not broadly applicable. Further 





1.6.2 Single-stranded break repair  
By default Cas9 creates a blunt double-strand break, but interference with either of the 
nuclease domains, SpCas9 (HNH (Cas9N863A) or RuVC (Cas9D10A) (see Figure 1.5B)), results in 
the development of a nickase (Cas9n) variant that creates a single-stranded DNA break on 
either the target or complementary strand (F. Ann Ran et al., 2013; Mali et al., 2013). Damage 
to a single base can result naturally from several sources of DNA damage including ROS and 
chemicals inherent to cell metabolism, making this by far the most common form of DNA 
damage in a cell (Swenberg et al., 2011). Whereas DSBs pose a complex challenge as both of 
the DNA strands are broken, the information required for correct repair of a nick is present 
on the intact strand. Several repair pathways are present to approach specific types of single-
stranded breaks, although not mentioned in detail in this thesis.  
 
The repair of a single-stranded nick is at a high-fidelity relative to DSB repair, with Cas9n 
creating genomic disruptions at lower frequencies than wildtype Cas9 (Hsu, Lander and 
Zhang, 2014). The use of two sgRNAs in opposite orientation at close proximity (paired 
nickases) however creates DSBs with sticky ends due to 5’ resection (F. Ann Ran et al., 2013; 
Mali et al., 2013), which are thought to promote annealing with homologous strands when 
PAM sequences are outwards-oriented in case of a Cas9D10A-induced paired nickases resulted 
in a 5ʹ overhang (Bothmer et al., 2017). Inwards-oriented, 3ʹ overhangs induced by Cas9N863A 
theoretically create the same result, but the kinetics of Cas9-binding as such are thought to 
result in recognition of the breaks as two separate nicks rather than a single DSB (Bothmer 
et al., 2017).  
 
1.6.3 Effects of different donor templates on HDR 
To utilise HDR following Cas9-induced breaks to yield specific modifications or large 
integrations at the target sites, a homologous donor template is required. While historically 
double-stranded DNA (dsDNA) with long homology-arms (500 - 1000nt) was often used as 
the donor template in CRISPR-Cas9 editing (Byrne et al., 2014), it is considered inefficient in 
many cell types and requires Rad51-dependent HR, which is only active in S/G2/M phases 
(Chen et al., 2011).  
 
More recent studies demonstrated that single-stranded oligodeoxynucleotides (ssODNs) 




whilst also reducing toxicity and being effective at lower molarities (Miura et al., 2015; 
Yoshimi et al., 2016). In some cases, their use can increase HDR efficiencies up to 500-fold 
compared to dsDNA donors (Ferenczi et al., 2017). ssODNs are typically used to introduce or 
modify sequences up to 200 bp, using 30-60 nt homology arms (Jacobi et al., 2017). Long, 
single-stranded DNA (ssDNA) donors have more recently also shown their utility in 
introducing long stretches of DNA, without the need for long homology arms (Yoshimi et al., 
2016). In fact, perhaps surprisingly, longer homology arms in ssODNs were shown to reduce 
HDR efficiencies (Paix, Schmidt and Seydoux, 2016) and are optimal at 30-40 bp (Liang et al., 
2017).   
 
When using paired nickases with outwards facing PAMs, efficiencies are enhanced up to 60% 
by binding of ssODNs to the strand opposite to the PAM (i.e. the strand complementary to 
the sgRNA) improve HDR efficiencies (Christopher D. Richardson et al., 2016). The same study 
showed that asymmetric donor DNA with a longer PAM-proximal than PAM-distal homology 
arm (optimally 91-nt against 36-nt) even further enhances HDR efficiencies, indicating that 
the first-created 5’ overhang created by the D10A paired nickases binds to the ssODNs, which 
is consistent with the hypothesis that ssODNs are copied in through SDSA rather than 
through direct integration (Liang et al., 2017; Paix et al., 2017), although a very recent study 
identified the FA pathway to be the pathway crucial for integration of ssODN (Richardson et 
al., 2018). Their findings indicate that single-stranded DNA templates are incorporated in a 
Rad51-independent, FA-dependent manner, which indicates that Rad51-dependent SDSA 
cannot be the main repair pathway for ssODN-mediated repair.   
 
In addition to the use of ssODN and the means discussed in section 1.6.1.4, other ways to 
improve HDR efficiencies have been sought after. For example, as degradation is thought to 
deplete the ssODN pool before DNA cleavage by Cas9 has occurred, elongating of the half-
life of ssODNs by phosphorothioate-modification has been reported to increase HDR 
efficiencies, especially for long inserts (Renaud et al., 2016). Another study demonstrated 
that Cas9-induced breaks can incorporate ssODN sequences without the need for HDR, 
termed homology-independent targeted integration (Suzuki et al., 2016), although the rates 
for this are still considerably low (± 5%). Hence, precise editing efficiencies are slowly 





In the meantime, as our knowledge of CRISPR–Cas9 gene editing and DNA repair is increasing, 
it is becoming apparent that the picture is not as clear and straightforward as we thought. 
With time, it will become more evident which of the combinations of nuclease and donor 
template are most suitable for each application, although at this stage single stranded donors 
appear to be most advantageous for many applications. Similarly, increasing our knowledge 
of the molecular mechanisms underlying precise genome editing may allow the outcome of 
cellular DNA repair pathways to be manipulated. 
 
1.7 Genotype-phenotype screening with CRISPR-Cas9 
As precise genome editing through CRISPR-Cas9 has become feasible in a wide range or 
targets and has shown to be easy to repurpose due to its modularity, it has been applied in 
many ways to study the effects of genomic variants on phenotypes. Hereafter I will discuss 
several means by which Cas9 is exploited for screening purposes.  
 
1.7.1 Genome-wide screens mediated by CRISPR-Cas9 
When a Cas9-induced double-strand break results in a frameshift or premature stop codon, 
this often results in a destabilised protein or nonsense-mediated decay of the mRNA 
transcript. As both of these processes result in similar gene-knockout, CRISPR-based genome-
wide knockout screens (CRISPRi) rapidly developed into the gold standard for the gain-of-
function and loss-of-function screening of gene functions as it proved more effective than 
traditional RNAi, as in the latter non-sense mediated decay (NMD) of the target RNA is not 
always entirely efficient (Shalem et al., 2014; Wang et al., 2014; Zhou et al., 2014).  
 
Moreover, a nuclease-deficient Cas9 variant (dCas9) for targeted recruiting of the Cas9-
bound proteins to a target site without inducing a cut has been developed (Qi et al., 2013), 
which can also be used in genome-wide screens without introducing permanent destabilising 
mutations (i.e. transient) when coupled to a transcriptional repressor or activator (Qi et al., 
2013; Konermann et al., 2015). Hence, Cas9 can be utilised in a broad spectrum of 
applications to perform genomic interrogations, although these screens – as discussed in 
section 1.3 – only allow for loss of function or overexpression phenotypes, and not the 





1.7.2 Saturation mutagenesis using CRISPR-Cas9 
The advantage of using saturation mutagenesis in combination with Cas9-based genome 
editing is capturing the native context of the genetic element in contrast to episomal 
introduction or random integration. Site-directed mutagenesis of mouse and human 
enhancers using CRISPR-Cas9, whereby all individual nucleotides in the genomic region are 
disrupted through NHEJ, allows for the screening of functional mutations in non-coding 
genetic elements. By disrupting sequences within an enhancer in its endogenous context, 
essential elements can quickly be distinguished from other nucleotides (Canver et al., 2014). 
Such site-directed mutagenesis using Cas9-induced indels is an effective approach to study 
the function of genetic elements, with targeting efficiencies up to 88% in Drosophila (Bassett 
et al., 2013), although up to ± 40 % is typically reached in mammalian cells (Canver et al., 
2014; Wu et al., 2017). Whilst effective in non-protein-coding functional elements, structure 
assessments of protein-coding genes are less suitable as for reasons mentioned in section 
1.7.1, for which edits resulting in substitutions and hence not leading to frameshift mutations 
are more suitable.  
 
1.7.3 Base editors 
For the introduction of single nucleotide substitutions with Cas9, HDR was long thought to 
be the best approach since NHEJ frequently leads to indels. However, as the process of HDR 
can be inefficient in certain (non-dividing) cell types (Saleh-Gohari and Helleday, 2004), 
recent developments in the field of genome diversification have circumvented this process 
and resulted in Cas9n or dCas9-mediated base editors (BEs) (Hess et al., 2016; Komor et al., 
2016). The most-used third generation of BEs recruits a single-strand-specific cytidine 
deaminase such as APOBEC that induce a C>U conversion in a 5-nt window at the PAM-distal 
end of the protospacer without introducing DSBs (Komor et al., 2016). The addition of an 
uracil glycosylase inhibitor impedes base excision repair (BER), thereby favouring the 
permanent C>T conversion. Finally, by introducing a nick on the unedited strand, the DNA 
repair process resects the G-containing DNA strand and repairs it using the edited strand as 
a template. By directed evolution of RNA adenosine deaminase, a seventh generation of BEs 




conversions in target DNA (Gaudelli et al., 2017), thus allowing for all base transitions when 
combined with third generation BEs. 
 
Comparable approaches to BE include (1) CRISPR-X, which involves dCas9 linked to MS2 RNA 
hairpins that recruit an MS2-binding protein fused to a hyperactive variant of activation-
induced cytidine deaminase (AID) to the target site (Hess et al., 2016), (2) AID fused to a ZFP 
or TALE (Yang et al., 2016) and (3) an AID ortholog (PmCDA1) directly fused to dCas9 or nCas9 
(Ma et al., 2016; Nishida et al., 2016). Base editing is hence becoming a frequently-used 
method for both the introduction of precise genome edits and targeted genome 
diversification.  
 
As base editing rates are typically much higher than HDR rates, it has been used in recent 
DMS approaches (discussed in section 1.3.4). In addition, as no DSBs are introduced, there is 
typically no loss or gain of nucleotides. Therefore, BE is very effective for applications aiming 
to yield specific nucleotide changes. However, as the targeting window typically covers only 
a few bases adjacent to an NGG PAM motif (except CRISPR-X), its applicability is best suitable 
for the introduction of precise edits. Later studies addressed some of these issues by altering 
PAM compatibilities (Kim et al., 2017) and enhancing on-target specificity (Rees et al., 2017), 
although (intentionally) retaining a small window and only a single base conversion per 
experiment and as such has a limited applicability in DMS. As APOBEC requires ssDNA as a 
substrate, APOBEC-mediated diversification will probably remain limited to the protospacer 
region. In addition, xCas9 and spCas9-based base editing have been developed to broaden 
the range of targets and contexts in which these principles can be applied, as are discussed 
in section 1.5.3. 
 
1.7.4 Nucleotide diversification through Cas9-guided polymerases 
A very recent study describes an alternative to BE by guiding an error-prone, nick-translating 
DNA polymerase to a target site by Cas9n, thereby extending the targeting window up to 350 
nt (Halperin et al., 2018). This system, termed EvolvR, induces a nick at a specific site, after 
which the polymerase displaces the strand downstream of the nick. The window length, 
mutation rate and substitution bias are controlled by the fidelity and processivity of the 




fold, its activity has so far only been demonstrated in E. coli and is thus not yet available for 
mammalian cells.  
 
1.7.5 Deep mutational scanning using CRISPR-Cas9 and multiplex HDR 
DMS (discussed in section 1.3.4) combined with CRISPR-Cas9 and multiplex HDR allows for 
broadening of the targeting region by using repair template pools that are saturated with 
(nigh to) all possible nucleotide variants without the loss or gain of nucleotides. Several 
studies have been published, of which I will list several here to give an overview of 
accomplishments and limitations.  
 
Findlay and colleagues were one of the first to publish results on DMS with CRISPR-Cas9, 
demonstrating the assessment of the effects all possible SNVs across 6 nucleotides in an exon 
of BRCA1 on transcriptional abundance, through the use of CRISPR-Cas9 and multiplex HDR 
using a pool of repair templates harbouring all possible variants (Findlay et al., 2014a). They 
subsequently applied this approach to assess the effects of mutations in a conserved region 
of DBR1 on proliferation, thereby proving its efficacy in assessing the phenotypic 
consequences of SNVs. The HDR libraries used for this study were plasmids with long (2 x ± 
750 bp) homology arms to the target sites, generated using partially degenerate 
oligonucleotides, as explained in section 1.3.7. Despite their HDR rates comprising only ± 1-
3 % in human embryoid kidney (HEK293T) cells, their repair templates introduced silent 
mutations that created PCR primer binding sites, such that they selectively amplified reads 
from loci that had undergone HDR, thus compensating for low HDR frequencies.  
 
Similarly, CRISPR-Cas9-based mutagenesis was used to perform screenings for SNVs in BRC-
ABL1 underlying drug resistance (Ma et al., 2017). Here, instead of degenerate 
oligonucleotides, a cassette ligation strategy (i.e. the ligation of several fragments with 
overhanging sequences)in a bacterial cloning plasmid was used to create library diversity 
including PCR, ligations and bacterial transformations, although this approach limited its 
targeting window to 30 nt. In the murine cancerous B-cell (Ba/F3) line they achieved 8% HDR, 
which for dsDNA donors is on the higher end. A recent study utilised site-directed 
mutagenesis with help of CRISPR-Cas9 in engineering antibodies in murine naïve B-cells 




degenerate codons (explained in section 1.3.7). Elegantly, they were able to achieve HDR 
efficiencies up to 36% by knockout of 53BP1, thereby disfavouring NHEJ. 
 
One of the most elaborate studies describing Cas9-mediated DMS thus far interrogated the 
functional impact of 9,833 variants in the DNA-binding domain of TP53, the most frequently 
mutated gene in cancer (Kotler et al., 2018). As libraries, synthetic ssODNs 200 nt in length 
were rationally designed to contain all possible single and dinucleotide (e.g. TT > CC) changes, 
premature stop codons, amino acid substitutions and deletions and commonly occurring 
SNVs across 1,160 nucleotide sites, and cloned into plasmid backbones. This study elucidated 
selective pressure on specific mutations in both evolution and tumorigenesis and derive a 
fitness score per mutation that corelates with their incidence in tumours. Interestingly, the 
authors identified SNPs appearing to be neutral in isolation, but which exhibited positive 
synergistic effects when cooccurring with other missense mutations, emphasising the merit 
of in-depth scanning of mutations.  
 
Similarly, all possible TP53 variants were screened by Giacomelli et al. through parallel 
introduction of all possible amino acids and a stop codon at each codon position (Giacomelli 
et al., 2018). Through massive parallel sequencing, it was determined that >99.8% of all 
mutant alleles were generated and assessed using 150-base oligonucleotides with 30 bases 
of complementary sequences flanking a 90-base variable region. Lentiviral transfection in 
isogenic cells with respectively p53WT and p53NULL allowed for the analysis of LOF alleles and 
depletion of alleles with wildtype-like activity. Their comprehensive study was related to 
transcriptional reporter assays, evolutionary conservation and mutational signatures found 
in tumours, making this study a comprehensive landmark in the field of DMS. 
 
Finally, two recent paper describes the use of saturation genome editing to assay nearly 
4,000 SNVs (96.5% of all possible SNVs) across 13 exons of the BRCA1 tumour suppressor 
gene (Findlay et al., 2018; Starita et al., 2018) to identify over 400 non-functional missense 
variants and 300 SNVs that disrupt expression. BRCA1 is essential in the haploid cell line 
HAP1, and their relative enrichment over time was hence used as proxy for their effect on 




mutation destroying the PAM, thereby preventing recleavage of edited alleles. With 
knockout of LIG4, a protein involved in NHEJ, increased HDR rates by 3.6-fold up to 75%.  
 
These studies show that CRISPR-Cas9 with multiplex HDR can be used to generate 
endogenous libraries of sufficient size for both DMS and directed evolution, allowing for an 
unpreceded throughput and precision when combined with NGS. In contrast to base editors, 
where one type of base conversion can be achieved per experiment in a small window, 
saturation mutagenesis with multiplex HDR can achieve all possible single nucleotide or 
codon changes across a much larger window. Several techniques such as selective PCR and 
inhibitory drugs are deployed to improve HDR frequencies, reaching up to 36% (Mason et al., 
2018). As advances in the field of CRISPR-Cas9 progress, repair outcomes can be skewed to 
favour HDR over NHEJ, thus increasing the yield of possible variants that can be screened.  
 
1.8 Thesis Objectives 
There is a wide abundance of targets and approaches for DMS, which have proven powerful 
in providing a high-throughput screen for the phenotypic consequence of mutations 
frequently observed in nature. At the time of initiation of our study, none of the above 
screening methods were developed and published. In this thesis, I will therefore develop an 
experimental and data analysis pipeline to perform DMS using CRISPR-Cas9 and multiplex 
HDR in endogenous genes, which will provide a benchmark for oncogenic mutations found 
in b-catenin. The overall aims of this thesis are as follows:  
• To develop experimental and bioinformatics pipelines to perform deep mutational 
scanning on single nucleotide and amino acid changes in chromosomally encoded 
genes with CRISPR-Cas9.  
• To validate this approach for the assessment of single nucleotide variants using 
genomically-integrated green fluorescent protein (GFP) in mouse embryonic stem 
cells.  
• To utilise our approach to assess the effects of amino acids substitutions in an 
endogenous gene to provide a benchmark for SNVs observed in tumours by using b-













2.1.1 Embryonic stem cell culture 
The RCNβH-B(t)-GFP cell line used in Chapter 4, also known as the RCN(t)-GFP cell line was 
previously characterised as an E14-derived mouse embryonic stem cell line with a single copy 
random integration of a pCAG-Gfp transgene with uniformly high GFP expression and 
fluorescence (Chambers et al., 2007) (see Figure 4.2A). Mouse embryonic stem (ES) cells 
were retrieved from liquid nitrogen by rapid thawing in a 37°C water bath, after which they 
were resuspended in 9ml pre-warmed E14 media (GMEM (Life Technologies), 15% fetal calf 
serum, 1% L-glutamine, 1% penicillin/streptomycin (P/S), 1% sodium pyruvate, 1% non-
essential amino acids, 0.1% β-mercaptoethanol and 0.2% LIF-conditioned media) and 
pelleted by centrifugation (at 300 x g for 5 minutes) to remove DMSO. These cells were 
cultured at 37°C with 5% CO2 in pre-gelatinised culture flasks. Cells were passaged by 2x PBS 
wash and trypsinisation for 3 minutes at 37°C. 10 volumes of pre-warmed media were added 
to the cell-containing trypsin, after which the suspension was spun down at 300 x g for 5 
minutes. Cells were then resuspended in E14 media and resuspended at approximately 1.0 x 
105 cells/cm2. For cryopreservation, cells were frozen at 4.0 x 106 cells / ml by adding 500μl 
of CryoStor® cell cryopreservation media CS5 (Sigma-Aldrich) to 500μl cell suspension at 8.0 
x 106 cells/ml and stored at -70°C in a polystyrene box for 24 hours prior to long term storage 
in liquid nitrogen at -150°C.  
 
2.1.2 Plasmid construction and validation 
For targeting of cells with CRISPR-Cas9 (see section 4.2.6), sgRNA sequences (see Table 2-1B) 
were designed using the online version of the Azimuth sgRNA design software (Doench et al., 
2016) and cloned into plasmids utilising overhangs with sequence similarity to BbsI 
restriction site according to standard protocol (F Ann Ran et al., 2013). For targeting 
experiments with Cas9 nickases, sgRNAs were cloned into pX335-U6-Chimeric_BB-CBh-
hSpCas9n(D10A). For targeting with wild-type Cas9, sgRNAs were cloned into pSpCas9(BB)-
2A-Puro (PX459) V2.0.  
 
Plasmids were transformed into subcloning efficiency DH5α-competent Escherichia coli (E. 
coli) (Invitrogen). Cells were thawed on ice and 50µl of cell-suspension was mixed with 2µl of 
ligated plasmids and incubated for 3 minutes on ice. Cells were heat-shocked for 30 seconds 




Catabolite repression (SOC) media. The cell suspension was then incubated for 1 hour at 37°C 
while shaking at 400rpm before being spread on a LB-plate with 50µg/l ampicillin and left 
overnight at 37°C for selection of successful transformation. 
 
Individual E. coli clones were picked from plates, transferred to 5ml LB medium with 50µg/l 
Ampicillin and left at 37°C while shaking at 225rpm overnight. Plasmids were extracted using 
the Plasmid Spin Miniprep Kit (QIAGEN) following manufacturer’s instructions. Successful 
cloning of sgRNAs was confirmed by Sanger sequencing of the plasmid sequences using 
primers ‘CRISPR_plasmids_U6_FP’ and ‘CRISPR_plasmids_RP’ described in Table 2-1A.  
 
2.1.3 sgRNA validation using CEL1 surveyor assay 
For assessment of cleavage of target DNA by Cas9 using specific sgRNAs (see section 4.2.4), 
mutation rates were assessed by the Surveyor nuclease assay (F Ann Ran et al., 2013) with 
several modifications. ES cells were transfected as described in section 2.1.6, after which 
genomic DNA extracted as described in section 2.1.8. After amplification of the target locus 
by PCR using ‘GFP_CEL1’ primers (see Table 2-1A) and reannealing of amplicon sequences, 
cleavage of mismatch DNA was performed by 7µl celery extract purified by Gillian Taylor. 
Bands were subsequently separated by standard gel electrophoresis on 2.5% (w/v) TBE 
agarose gels and stained with SYBR Gold (1 : 10,000, Thermo Fisher) for 45 minutes while 
agitated before visualisation. 
 
2.1.4 ssODN repair template synthesis 
ssODN repair templates used in Chapter 4 (described in  
Figure 4.3) were designed to be 100 nt in length with incorporation ratios of 94% for the 
genomic homology consensus nucleotide and 2% for each of the remaining nucleotides, or 
97% and 1% for the respective classes, as further described in section 4.2.2 and synthesised 
by IDT. This resulted in four ssODN classes as described in Table 2-1C. 
 
2.1.5 UltraRT construction 
To synthesise long (820 bp) double-stranded repair templates with variable regions, 100nt 
ssODNs were used as a template. Two pairs of Ultramer primers 200 nt in length (see Table 
2-1A) were designed with homology to the GFP locus (depicted in figure 4.16) and used in a 




template DNA, 1 μM GFP_Ultra_F1 , 1 μM GFP_Ultra_R1 and 2X Phusion® High-Fidelity DNA 
Polymerase Master Mix (New England Biolabs) was prepared and placed in a thermal cycler 
(Tetrad) optimised to: initial denaturing 95°C 2 minutes, then 10 cycles of: second denaturing 
95°C 30 seconds, annealing 55°C 30 seconds, extension 72°C 1 minute, before final extension 
72°C 5 minutes. Correct band size (460 bp) of PCR products was subsequently separated by 
standard gel electrophoresis on 1.5% (w/v) TBE agarose gels, after which the product was 
cleaned with the QIAquick PCR Purification Kit (QIAGEN). The final product was used in a 
second PCR reaction at 0.5μM, with 1μM GFP_Ultra_F2, 1 μM GFP_Ultra_F2 and 2X Phusion® 
High-Fidelity DNA Polymerase Master Mix (New England Biolabs) at the same thermocycler 
protocol as the first reaction. After the second reaction, bands of 820bp were confirmed on 
agarose gels and extracted using the QIAquick Gel Extraction Kit (QIAGEN) before being used 
as repair templates for homology-directed repair. 
 
2.1.6 Cell transfection 
For transfection, cells were grown to 70% confluency to ensure logarithmic growth, after 
which 2.0 x 106 cells were seeded in a pre-coated well of a 6-well plate with 2ml of media. 
For transfection with paired Cas9 nickases, 2μg plasmid DNA (0.5 μg pSUPER.retro.puro and 
0.75 μg px335 plasmid with sgRNA8 and 0.75μg px335 plasmid with sgRNA17) was added to 
100μl Optimem (Invitrogen), after which 6μL FuGENE® HD (Promega) was added and mixed 
by pipetting. The FuGENE reagents pack the target DNA in vesicles that fuse with the 
cytoplasmic membrane, thereby delivering the vectors directly into the cell. For transfection 
with Cas9 nucleases (i.e. wtCas9), the 2 μg plasmid DNA consisted of 0.5 μg 
pSUPER.retro.puro and 1.5 μg px459 plasmid with the respective sgRNA (sgRNA8, sgRNA17 
or sgRNA100, see Table 2-1B) After 10 minutes of incubation at room temperature the 
mixture was added dropwise to the well and cells were incubated with the mixture for 24 
hours at 37°C. The media was then replaced by media containing 1.6μl/ml puromycin (Gibco) 
which was incubated for 24 hours, selectively killing cells that had not been transfected, after 
which this media was replaced by fresh media. Cells were cultured for 8 days post-
transfection before being separated by fluorescence activated cell sorting (see section 2.1.7). 
 
2.1.7 Fluorescence-activated cell sorting 
Prior to fluorescence-activated cell sorting (FACS), cells were trypsinised as described in the 




subsequently stored on ice prior to sorting. Cells were subsequently analysed and sorted on 
the FACSAria™ (Becton Dickinson) cell sorter into respectively three populations based on 
GFP fluorescence. The GFP negative population was defined as the profile matching that of 
GFP-negative E14 embryonal stem cells, whereas GFP positive cells were those 
corresponding with untransfected RCN(t)-GFP cells. All cells falling in between these two 
populations were considered as intermediate.  
 
2.1.8 Genomic DNA extraction 
Genomic DNA was extracted from pelleted cells (centrifuged at 300 x g for 5 minutes) using 
the DNeasy Blood & Tissue Kit (QIAGEN) according to SOP. Quantification of DNA was 
performed using the Qubit Fluorometer (ThermoFisher) combined with the Qubit dsDNA BR 
(High Sensitivity) Assay Kit (ThermoFisher). 
 
2.1.9 Digestions 
The GFP target site was amplified in a 25 μl reaction with 1 μM ‘GFP_157bp_F1’, 1 μM 
‘GFP_157bp_R1’, 50 μg genomic template DNA and 2X Phusion® High-Fidelity DNA 
Polymerase Master Mix (New England Biolabs) yielding a 157 bp product, which was 
subsequently placed in a thermal cycler (Tetrad) optimised to: initial denaturing 95°C 2 
minutes, then 30 cycles of: second denaturing 95°C 30 seconds, annealing 58°C 30 seconds, 
extension 72°C 30 seconds, before final extension 72°C 3 minutes. Correct band size (460 bp) 
of PCR products was subsequently separated by standard gel electrophoresis on 1.5% (w/v) 
TBE agarose gels, after which the product was cleaned with the QIAquick PCR Purification Kit 
(QIAGEN). Subsequently, 1 μg of PCR amplicon was digested in a 50 μl reaction volume with 
1 μl restriction enzyme (PsiI (New England Biolabs) or BsaXI (New England Biolabs), 
respectively) and 2X CutSmart® Buffer (New England Biolabs) for 2 hours at 37°C. Bands were 
subsequently separated by standard gel electrophoresis on 2.5% (w/v) TBE agarose gels and 
stained with SYBR Gold (1 : 10,000, ThermoFisher) for 45 minutes while agitated before 
visualisation.  
 
2.1.10 Sequencing library preparation for genomic samples 
For preparation of genomic samples for next-generation sequencing on the Illumina MiSeq 
platform, genomic loci were amplified and tagged in a two-step PCR as described in the 




from 50 μg genomic DNA in a 25 μl reaction volume was performed using 2X Phusion® High-
Fidelity DNA Polymerase Master Mix (New England Biolabs) with 3% DMSO and forward and 
reverse primers with Illumina adapters (see Table 2-1A, GFP_157bp_Illumina) at 0.5 µM in a 
thermocycler (Tetrad) with cycling parameters to standard protocol at 20 cycles. For direct 
sequencing of ssODN template pools, ‘GFP_Oligo_Illumina_FP’ and ‘GFP_Oligo_Illumina_RP’ 
were used. Clean-up using AmPure XP beads (Beckmann Coulter) was performed to standard 
protocol.  
 
PCR amplicons were indexed by a second PCR round using Phusion® High-Fidelity DNA 
Polymerase Master Mix (New England Biolabs) with 3% DMSO and custom forward (i7) and 
reverse (i5) Nextera indexing primers (see Table 2-1D) at 0.25 µM with cycling parameters to 
standard protocol at 8 cycles. Indexed PCR amplicons were then quantified using the Qubit 
Fluorometer (ThermoFisher) and Qubit dsDNA BR (Broad Range) Assay Kit (ThermoFisher), 
and analysed by the Agilent 2100 Bioanalyzer system using high-sensitivity chips by the 
Wellcome Trust Clinical Research Facility. After quality control, samples were pooled 
equimolarly at 5 µM and sequenced by Edinburgh Genomics on the Illumina MiSeq platform 
at 150bp paired-end. Remaining template DNA was stored at -80°C 
 
2.1.11 Determining in silico structure of GFP  
The query GFP sequence was used to search for identical or related GFP structures using a 
BLAST (Altschul et al., 1997) search against the Protein Data Bank (PDB) (Berman et al., 2006) 
at the RCSB-PDB server (see section 4.2.14). Several GFP structure hits were returned from 
which the GFP crystal structure with the highest resolution (PDB ID: 2WUR; resolution 0.9 Å) 
was selected for analysis. Residue-specific solvent accessibility calculations were performed 
using ASAView (Ahmad et al., 2004). Structure visualisation and analysis was conducted using 
PyMOL (http://www.pymol.org/; Schrödinger LLC, USA).  
 
FoldX version 3b6 (Schymkowitz et al., 2005) was used to predict energetic impact of 
mutations on protein stability, computed by subtracting the energy of the wild-type from 
that of the mutant (ΔΔG) in each case. In brief, the ‘RepairPDB’ option was used on PDB ID 
2WUR (FoldX --command=RepairPDB --pdb=2wur.pdb) prior to mutating the 
residue using the ‘Mutate residue’ option under YASARA version 14.12.2 (Krieger, Koraimann 




298 K; Ionic strength: 0.05 M; VdW design: 2. The resulting ΔΔG reported is the average of 
three runs. Typically, FoldX predicted ΔΔG values larger than 1.6 kcal/mol are considered 
highly significant and correspond to severely destabilising mutations (99% confidence 
interval), as they correspond to twice the standard deviation of the error in FoldX, while 
energy changes of > 0.8 kcal/mol are still considered significant (one standard deviation; 95% 
confidence interval) (Guerois, Nielsen and Serrano, 2002; Schymkowitz et al., 2005; Rakoczy 
et al., 2011; Kiel and Serrano, 2014). 
 
2.2 b-catenin  
All the experimental work performed on β-catenin, laying out the fundament to the 
bioinformatic work performed in Chapter 5, was entirely done by Anagha Krishna and Derya 
Özdemir from the Peter Hohenstein lab.  
 
2.2.1 TCF/LEF cell line  
mESCs with a TCF/LEF:: H2B-GFP reporter activity as described in (Ferrer-Vaquer et al., 2010) 
was used as the parental cell line for saturation editing of β-catenin. Cells were cultured on 
gelatin-coated plates in 2i media as described in section 5.2.4.  
 
To generate a β-catenin heterozygous knockout, the TCF/LEF cell line was transfected with a 
PuroDtk selection cassette (pLCA.66/2272 plasmid; (Chen and Bradley, 2000)) and wtCas9 
(pSpCas9(BB)-2A-Puro (PX459) V2.0) with integrated sgRNAs targeting intron 1 to intron 6 of 
the β-catenin-encoding gene CTNNB1 (see Table 2-1B, CTNNB1_intron1_g1 and 
CTNNB1_intron6_g2), which were introduced through HDR in order to replace this fragment 
with a PuroDtk selection cassette using puromycin (Gibco) positive selection for 24 hours 
(schematic can be found in Figure 5.2). Clonal cell lines were then validated for heterozygous 
knock-in by PCR and Sanger sequencing. 
 
2.2.2 Repair plasmid construction 
Double-stranded DNA oligonucleotides 200 bp in size containing all possible codon 
substitutions across 20 amino acid sites (L31-G50 of CTNNB1), BbSI restriction sites and PAM-
synonymous mutations were synthesised by Twist Bioscience (see Table 2-1). To integrate 
the oligonucleotide library into a vector, a double-stranded backbone vector was generated 




5' and 3' β-catenin homology-arms using Gibson assembly. Double-stranded DNA 
oligonucleotides library were subsequently cloned into the previously generated β-catenin 
backbone vector by Golden Gate cloning (i.e. simultaneously and directionally assemble 
multiple DNA fragments into a single piece of DNA and validated by Sanger Sequencing.  
 
2.2.3 Transfection 
On day 1, 2.0 x 108 heterozygous knockout cells were cultured in 2i and transfected with the 
pooled targeting vectors, wtCas9 (pSpCas9(BB)-2A-Puro (PX459) V2.0) and sgRNAs targeting 
the PuroDtk selection cassette (see Table 2-1B, CTNNB1_PKO_5’_g2 and 
CTNNB1_PKO_3’_g1). On day 3, media was changed to ES media containing LIF but without 
the 2i inhibitors to remove interference with Wnt/β-catenin signalling. FIAU negative 
selection was performed on this same day for 48 hours. On day 5, cells were FACS-sorted 
(see section 2.1.7) into 6 equally log-spaced bins based on GFP fluorescence (p2-p7). 200,000 
cells were collected before sorting to make up the unbiased pool. 
 
2.2.4 DNA extraction and PCR amplification  
DNA from the unsorted cells and each FACS-isolated bin (p2-p7) was isolated using the using 
the DNeasy Blood & Tissue Kit (QIAGEN) and quantified using the Qubit Fluorometer 
(ThermoFisher, see Table 5-1 for quantities) combined with the Qubit dsDNA BR (High 
Sensitivity) Assay Kit (ThermoFisher), after which it was used for further PCR amplifications. 
An initial PCR was performed with a forward primer outside the homology arms 
(Betacatenin_F1), to prevent amplification of random integration, and a handle-specific 
reverse primer (Betacatenin_R1), to selectively amplify clones that have undergone HDR 
from the template vector (see Table 2-1A for primer sequences). Next, amplicons from the 
first round of PCR were digested with DpnI (ThermoFisher) to get rid of any residual vector. 
The DpnI-digested PCR product was analysed on an 0.8% agarose gel after which correct band 
sizes were gel-eluted to further avoid amplification due to residual vector. This was followed 
by a second round of PCR (using the gel eluted first round amplicon as template) with an 
indexed forward primer (Betacatenin_F2; just outside the region of interest) and a primer 
(Betacatenin_R2). In parallel, another PCR was performed (referred to as HRM in Chapter 3) 
using the pooled DNA with the forward primer outside the homology arms (a described 




second round PCR step was performed. An overview of primer orientation can be found in 
figure 5.2a. 
 
Second round PCR products were cleaned using AmPure XP magnetic beads (Beckmann 
Coulter), quantified using the Qubit Fluorometer (ThermoFisher) and Qubit dsDNA High 
Sensitivity Assay Kit (ThermoFisher). Samples were diluted to a concentration of 5nM and 
pooled, after which the integrity and concentration of the amplicons were checked using 
Bioanalyzer 2100. The pooled sample was sequenced by Edinburgh Genomics using 150bp 
paired-end MiSeq. 
 
2.2.5 CTNNB1 mutational likelihood analysis 
Mutational likelihoods (discussed in section 5.2.16) were calculated by Ailith Ewing as 
follows. Tumour and normal (i.e. patient-derived non-tumour tissue) sequences were aligned 
to the reference exome (GRCh38), after which any mutations that occur in the tumour but 
not the normal were considered SNVs. Mutations were screened for by four SNV callers: 
MuSE, Mutect2, VarScan 2 and SomaticSniper (Larson et al., 2011; Koboldt et al., 2012; do 
Valle et al., 2016). Only mutations that had been called by at least 2 callers were considered 
for further analysis. Samples were then filtered to only include those with a mutation in the 
analysed b-catenin region. Then, for the purposes of calculating relative frequencies and 
probabilities, non-synonymous mutations (i.e. missense and nonsense) were excluded in an 
effort to make these mutations mostly selectively neutral. Finally, all mutations in their 
trinucleotide context were counted across each of the tumour type to calculate their 




Table 2-1 Oligonucleotide sequences 
(a) PCR primer sequences 
   




first round PCR all 
samples 
Betacatenin_F2 Mm_CTNNB1 ATGGCCATGGAGCCGGA 










second round PCR all 
















































ACTT CEL1 assay 
GFP_CEL1_RP Mm_GFP 
CGTCCTCCTTGAAGTCGA











































































(b) sgRNA sequences   
Name Target locus Sequence 
gRNA8 Mm_GFP GCCGTCGTCCTTGAAGAAGA 
gRNA17 Mm_GFP CCGCGCCGAGGTGAAGTTCG 
gRNA100 Mm_GFP CAACTACAAGACCCGCGCCG 
CTNNB1_intron1_g1 Mm_CTNNB1 GATGGAGTTGGACATGGCCA 
CTNNB1_intron6_g2 Mm_CTNNB1 CAGGTGGGATGCAGGCACTG 
CTNNB1_PKO_5’_g2 Mm_CTNNB1 TAGAGCCCACCGCATCCCCA 




(c) ssODN donor templates. N1-N4 represent consensus nucleotides at 94% and the non-
consensus nucleotides at 2%, whereby consensus in N1=A, N2=C, N3=G, N4=T.   










































































(d) Nextera indexing primers and barcode sequences. In ‘Index 1’ and ‘Index 2’ reads, the 
adapter sequences are constant, whereas the barcode region (indicated with [i7] and [i5], 
respectively), are specific for each sample, thereby allowing for multiplexing of samples on 
the Illumina MiSeq platform.  
Index 1 Read CAAGCAGAAGACGGCATACGAGAT[i7]GTCTCGTGGGCTCGG 
Index 2 Read AATGATACGGCGACCACCGAGATCTACAC[i5]TCGTCGGCAGCGTC 

































3. Development and optimisation of a bioinformatic 
pipeline for the assessment of single nucleotide 





3.1 Introduction  
3.1.1 Illumina MiSeq platform 
Next-generation sequencing (NGS) technologies such as Illumina and IonTorrent have 
provided powerful tools to determine the sequence diversity of short DNA fragments. Due 
to cost effectiveness, fast-turnaround time and lowest error rate (Laehnemann, Borkhardt 
and McHardy, 2015), the Illumina MiSeq platform is considered one of the gold standards for 
the analysis of amplicon sequences. Illumina platforms rely on a chip-based bridge 
amplification procedure followed by sequencing-by-synthesis (SBS) using reversible 
terminator nucleotide dyes (Bentley et al., 2008). Sequencing templates are fixed on a flow 
cell, after which solid-phase bridge amplification produces up to 1000 copies in a very close 
proximity (cluster generation) (see Figure 3.1A). Each cycle, the SBS technology adds a single 
fluorescently-labelled, reversible terminator-bound dNTP to the 3’-terminus of the sequence 
(see Figure 3.1B). The fluorophore is sequentially illuminated by a green laser for G and T and 
a red laser for C and A, after which imaging through different filters determines which 
nucleotide is incorporated. Removal of the fluorophore and 3’-terminator allow for the next 
cycle to commence. Successive cycles in parallel clusters can read millions of DNA fragments 
each up to 300-bp in length. As this technology will be used in the projects discussed in the 
subsequent chapters, the technical aspects and pitfalls of Illumina sequencing will here be 
discussed in more detail. 
 
3.1.2 Illumina sequencing errors 
Whereas Illumina sequencing allows for the analysis of large sets of data, sequencing errors 
resulting in incorrect output reads can occur. Overlapping emission spectra of the 
fluorophores and limitations of the detection filters used to distinguish signals cause G and T 
as well as C and A intensities to strongly correlate. As a result, the dominant sources of error 
on the Illumina platform are substitution-type miscalls (Schirmer et al., 2015). In addition, 
lagging of molecules can occur by the incomplete removal of the 3’-terminator, or the 
skipping of nucleotides through the incorporation of dNTPs without an effective 3’-
terminator. The number of affected sequences increases with each cycle, resulting in an 
exponential decline in confidence of base calling towards the end of a read (Cox, Peterson 
and Biggs, 2010). Several errors inherent to the Illumina platform cause specific patterns of 




coverage is low. Conveniently, each base (i) in Illumina-derived reads is assigned an 
estimated error probability (pi) represented as an ASCII-encoded Phred quality score 
calculated as Qi = -10 log10 pi. This score thus gives an estimated probability of an error at that 
position, with a per base quality score (PBQS) of 10 indicating a probability of 1 in 10 in 
incorrect base calling (90% accuracy), PBQS of 20 indicating a probability of 1 in 100 (99%) 
etc., with a PBQS of 20 typically being used as a cut-off for low quality bases (Margulies et 
al., 2005; Altshuler et al., 2012). 
 
Quality scores provide a key measurement for read errors as they are rarely associated with 
PBQS above 21 (Kozich et al., 2013). Library preparation and sequencing primers are however 
thought to be the largest source of sequencing errors and as read quality scores do not reflect 
these errors, the confidence of bases is therefore thought to often be overestimated 
(Laehnemann, Borkhardt and McHardy, 2015; Schirmer et al., 2015).  
 
Illumina’s paired-end (PE) sequencing mode can generate reads from both ends of the target 
DNA. If the DNA fragment is shorter than twice the read length, i.e. if there is overlap 
between the forward and reverse reads, these read pairs can be merged into a single larger 
fragment. In addition, bases that are overlapped by both forward and reverse read can 
furthermore be deployed to correct sequencing errors and yield higher quality sequence 
output. Therefore, designing amplicons to have overlapping PE reads for the bases key in an 
analysis greatly improves the confidence of calling these bases. 
 
On the MiSeq platform, sequencing error rates increase substantially towards the distal end 
of a read and are significantly higher in the reverse read when doing PE sequencing; the 
overall substitution rate is known to be higher in reverse reads (1.07%) compared to forward 
reads (0.64%), whereas the insertion and deletion rates are approximately 4.2 x 10-2 % and 
2.2 x 10-2 % (i.e. 100-fold less frequent than substitutions) for both reads (Schirmer et al., 
2015). The false discovery rate (FDR) of a single nucleotide substitution in a mate pair hence 






Figure 3.1  Schematic overview of sequencing-by-synthesis on the Illumina platform (A) 
Sequencing on the Illumina platform relies on immobilised probes on the flow-cell surface to 
which the adapter sequence (orange) of the single molecule template bind. Polymerases 
extend from the 3’-end of immobilised probes, after which the original template is removed 
by denaturing. The distal end of newly synthesised sequences (blue) binds to adjacent 
probes, thus performing bridge amplification. Clusters are formed through multiple cycles of 
annealing, extension and denaturation. After bridge amplification, the reverse strands are 
washed off, leaving only the forward strands, which can then be used the sequencing. (B) 
Each cycle, the complement to the single-stranded template molecule that is annealed to the 
cluster is extended by a single nucleotide with a fluorophore attached to its 3’-end. Next, the 
unincorporated dNTPs are washed off, after which sequential excitation with a green and red 
laser allows for the identification of the incorporated nucleotide (A, C, G or T). The 
fluorophore is then uncoupled from the 3’-end nucleotide, after which a new cycle can 
incorporate a new dNTP. After the desired read length is achieved, the same process is 
performed for the reverse of the reads.  
 
Whilst slightly different, substitution and indel rates reported by another study are within 
the same range at respectively 0.25% and 9.1 x 10-2 % (Laehnemann, Borkhardt and McHardy, 




sequence motifs such as long homopolymer stretches, GC-rich regions and around inverted 
repeats, either due to altered enzyme preference or through backfolding during synthesis 
(Nakamura et al., 2011; Quail et al., 2012; Ross et al., 2013). Because of high sequence 
similarity, amplicons are more susceptible to these motifs underlying the miscalling of 
substitutions, while in the calling of single nucleotide variants (SNVs) such systematic biases 
can result in high false positive rates. Hence, appreciating the various sources of sequencing 
errors are important when analysing sequencing data.  
 
3.1.3 Motivation for study 
The sheer volume and complexity of sequencing data generated by the MiSeq platform 
imposes a requirement for bioinformatic tools to facilitate downstream analyses. Sequences 
of poor quality can greatly impact the calling of sequencing variants and need to be identified 
and removed prior to analyses to minimise the FDR of nucleotide variants. Many hardware- 
and software-based correction methods have been developed to address errors in Illumina-
derived sequencing data including quality trimming, error-correction and read overlapping. 
However, despite the availability of correction methods, most experimental biologists often 
lack a supportive bioinformatics infrastructure and often have to employ such software 
packages and pipelines, which results in computational inefficiency and inconsistencies 
between studies.  
 
With the development of CRISPR-Cas9-based genome editing tools (F Ann Ran et al., 2013; 
Jinek et al., 2013), nucleotide diversification methods have become more readily available, 
while the demand for a convenient analysis pipeline for such amplicon data sets increases 
too. As discussed in the introduction, CRISPR-Cas9-induced breaks introduced at the target 
site will be repaired by either (error prone) end-joining or HDR (i.e. incorporating genetic 
information from an exogenous repair template) and are often used to yield specific 
outcomes. Several bioinformatics pipelines have been developed for the analysis of amplicon 
sequencing data from CRISPR (Güell, Yang and Church, 2014; Boel et al., 2016; Pinello et al., 
2016; Park et al., 2017; Wang et al., 2017), but lack sufficient depth for the analysis and visual 
representation of the results. CRISPR-DAV is more sophisticated at visualisation (Wang et al., 
2017), but was not available at the initiation of this study and is not easily customised to 




For the nucleotide diversification experiments on GFP (chapter 4), repair from an ssODN 
donor template through HDR will introduce a six-nucleotide invariant region and random 
nucleotide substitutions across 24 bases. A 157-bp region that will cover these sites will be 
amplified and will hence allow nearly full overlap of forward and reverse reads. The dataset 
is however expected to contain a variety of wildtype (including perfectly repaired alleles) 
sequences, sequences with inserts or deletions and reads containing the HDR core with 
additional mutations. As only HDR-derived reads are of interest, these reads need to be 
filtered based on the core sequence, whilst SNVs introduced by CRISPR-Cas9 and multiplex 
HDR need to be distinguished from sequencing errors. 
 
In this chapter, I will therefore develop and optimise a bioinformatics pipeline to facilitate 
the processing of MiSeq-derived sequence libraries to detect and analyse pre-defined editing 
outcomes. These scripts will be tested on artificially-generated reads, representing a range 
of expected DNA repair outcomes, and will be provided in a step-by-step protocol for the 
utilisation of this bioinformatics package, which has been made publicly available. The 
package will subsequently be benchmarked on experimentally-derived data set from a 
genome editing project of SRSF1 and demonstrate that it can be used to filter and analyse 
CRISPR-Cas9-induced mutations. This pipeline will lay the groundwork for analysis of 
empirical data in the subsequent chapters.  
 
3.2 Results 
3.2.1 Generation of artificial datasets  
Optimisation of the data analysis pipeline required a data set containing sequences with pre-
determined levels of variations and read quality. Artificial sequences were therefore 
generated based on the 157-nt reference sequence of the GFP amplicon used in chapter 4, 
sequenced with 150-bp PE on the MiSeq platform (see Figure 3.2A). Besides sequences with 
full consensus to the wildtype reference, additional sequences were generated containing 
nucleotide substitutions, deletions, insertions or ambiguous bases ranging from a single up 
to 15 mutations per sequence. As HDR-derived reads were expected to contain an invariable 
6-nt sequence different from the wildtype sequence, sets of reads containing this 6-nt HDR 
core (respectively ‘CGCGCG’ for VarSil and ‘TTATAA’ for VarStop, further discussed in section 




substitutions mimicking the expected HDR-derived reads. From all these sequences, read 
pairs with variable PBQS for individual bases were then constructed and written to paired 
FASTQ files. The dataset furthermore contained a fixed number of reads with mismatched 
bases between the forward and reverse read to mimic sequencing errors. 
 
The script ‘GFP_dummygeneration.py’ is publicly available on the GitHub repository 
‘deepmutationalscanning’ (https://github.com/mkelder/deepmutationalscanning) and by 
adjusting the parameters at the start of the script, the pipeline can be used to generate 
sequences based on other FASTA sequences, sequences of different lengths or different 
numbers of mutations or output reads. 
 
Thousands of unique reads were generated per mutation for either the VarSil or VarStop 
class, resulting in a total of 128,240 unique mutant reads in the final pool (see Table 3-1A). 
The sequence identifiers for each read contain information on the mutations it harbours with 
respect to the reference sequence, allowing for convenient analysis of reads dropping out at 
each stage of the pipeline (see Table 3-1B).  
 
3.2.2 Trimming low quality bases using Trim Galore!  
During preparation of Illumina sequencing libraries, short adapter sequences are typically 
attached to the sequence reads to allow for (1) binding to the Illumina flow cell using a 
universal adapter and (2) barcoding using sample-specific index adapters to allow for 
multiplexing of several libraries on a single flow cell (see Figure 3.2A). Whereas these adapter 
sequences are typically removed by the sequencing facility prior to data manipulation, this 
process may be incomplete and may obscure subsequent data analysis. Therefore, adapter 
trimming is often performed before further data-analysis. 
 
Some tools such as FastQC (Andrews, 2010) allow for quality control with per-base and per-
sequence quality profiling, while other methods for quality filtering such as Trim Galore! 
(Krueger, 2015) and Trimmomatic (Bolger, Lohse and Usadel, 2014) trim posterior bases with 
low quality scores and subsequently use ad hoc norms to filter reads with a minimum number 
of high-quality bases (Bokulich et al., 2012). Average quality scores are calculated over a 




is trimmed until the average quality score is above a given threshold and the end of the read 
is trimmed if the average quality score falls below the threshold. 
 
Trim Galore! includes FastQC as well as adapter trimming from the 3’-end of reads using 
Cutadapt. By default, it uses the first 13-bp of Illumina standard adapters 
('AGATCGGAAGAGC') for trimming, whereas other adapter sequences can manually be 
added. Trim Galore! is also able to remove low-quality bases, which (as mentioned in section 
3.1.2) typically occur towards the end of a read.  
 
Trim Galore! was used in its default settings for PE sequences, whereby bases are trimmed 
with a Phred score under 20 (p-value of FDR < 0.01) and auto-detects the Nextera adapter 
sequences used in this data set. By default, Trim Galore! is extremely stringent in adapter 
removal, removing sequences that have as few as 1-bp overlap with the adapter. As the used 
Nextera adapter sequences (‘CTGTCTCTTATA’) and the target amplicon sequence have a 3-
nt homologous overlap, the stringency –s of overlap between adapter and read sequence 
was increased to 4 (see Table 3-1). As the pipeline will filter out short sequences further 
downstream, no size selection other than the default minimum fragment size of 20-bp was 
introduced. Final parameters: trim_galore --stringency 4 --paired 
"$FILE1" "$FILE2" 
 
As is shown in Table 3.1c, different characteristics determine whether reads pass through 
the pipeline. Trim Galore! passes all reads regardless of the number of edits (within the 
assessed range of 1-15 edits). Once reads are aligned, reads with more than 6 missense bases 
(reflected by the “substitution”, “silent” or “stop” categories), reads with more than 3 
insertions or deletions (reflected by the “insertions” or “deletions” categories), reads with 
ambiguous bases (i.e. reads with “N” bases, reflected by the “ambiguous” category) or reads 
with non-consistent reads between the read pairs (considered read errors, reflected by 






Figure 3.2 Overview of data analysis pipeline for the detection of HR-introduced mutations 
(A) Schematic representation of the GFP amplicon sequences tagged with Illumina adapters. 
In grey the amplicon-specific PCR sequence is depicted, whilst orange and blue represent the 
Illumina-specific sequences added to the distal ends of each amplicon. The sequences in light 
orange and light blue are constant Illumina-specific sequences, whilst the i5 and i7 index 
adapters (indicated in dark) are 8-nt sequences that are variable between libraries, thereby 
allowing for the multiplexing on a single sequencing lane. Sequences highlighted in pink are 
the Nextera-sequences recognised and trimmed by Trim Galore! Below, the 157-nt amplicon 
sequence for GFP is depicted (discussed in more detail in 
Figure 4.3), indicating the 100-nt region of interest in black font and the variable and core 
sequences highlighted in green and purple, respectively. The 6-nt VarSil or VarStop variants 
of the HDR core (purple text) differ respectively 1 and 6 nucleotides from the wildtype core 
and thereby allow for distinguishing the HDR-derived reads. (B) Overview of the steps 
involved in processing Illumina-derived sequencing reads. A full manual on the stepwise 





Table 3-1 Overview of GFP dummy sequences and mapping parameters (A) Breakdown of read classes in the GFP dummy dataset A total of 152,360 
reads were artificially generated to represent all possible editing outcomes in the deep mutational scanning project of GFP. Thousands of reads were 
generated for each type of mutation or read error. (B) Mapping efficiencies as a result of different BowTie2 parameters By default, 95,982 (74.8%) 
out of 152,360 of the dummy reads mapped. After optimisation, this number was increased to 104,493 (68.6%), mapping all reads with mismatches 
to the reference with 150M. For each parameter, the best setting (i.e. with the highest number of mapped reads are highlighted in green. Optimal 
parameters were determined to be bowtie2 --threads 8 --phred33 --local -M 3 --rg-id 3 -x GFP_WT.fasta -1 
dummy_1.fastq -2 dummy_2.fastq -S out.sam (C) Number of reads passing each stage, broken down by mutation type. Wildtype reads 
and reads with substitutions (random or in the 6-nt core (‘stop’ and ‘silent’)) generally pass through all filtering stages, whereas reads with insertions, 
deletions, ambiguous bases or read errors are lost in the alignment or read-merging stages. Abbreviations: Sub = substitutions; Ins = insertions; Del 
= deletions, Amb = ambiguous, WT = wildtype (i.e. no mutations)  
(A)  
Total 





                
128,240  
              
24,120  
          
24,120  
          
24,120  
          
12,000  
          
10,000  
             
2,000  
                             
36,000  

























95982 1 97015 2 100776 1 95982 5 99616 10 99616 1 99865 C 0 1 104043 0 0 0 104325 
  2 99865 3 99807 2 95982 6 99779 11 99616 2 99865 L 95265 2 103751 0.1 104325 1 104493 
  3 100849 4 98728 3 95982 7 99779 12 99616 3 99865 S 104043 3 103681 0.25 104167     
  4 101445 5 97833 4 95982 8 99779 13 99616 4 99865 G 104241 4 103499 0.5 104043     
  5 101450 6 96644 5 95982 9 99807 14 99616 5 99865     5 103381 1 103247     
  6 101491         10 99811 15 99616           2 101943     
  7 101546         11 99811               3 98555     
  8 101439         14 99811               4 98627     
  9 101438         17 99811               5 89095     
  10 101430         20 99811                       
  20 96655         25 99811                       












Total Sub Ins Del Stop Silent Amb WT 
Read 
Errors Sub Ins Del Stop Silent Amb WT 
Read 
Errors 
Adapter and Quality Trimming 
   
128,240  100.00 100.00 
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-     100 
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100  
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Amplicons were designed to only slightly exceed the length of a single 150-bp read, such that 
the overlap of both reads greatly reduces the base calling error rate. Genuine nucleotide 
variants in the dummy read set are expected to occur at rates higher than error rates. With 
quality trimming and quality control during the merging of reads already being implemented 
in the pipeline, several levels of noise reduction were already implemented. As error 
correction modules such as BayesHammer largely focus on indel errors and additionally often 
call low-frequency substitutions as false positives, these additional corrections were deemed 
to only interfere with the introduced nucleotide variances and were therefore not applied. 
 
3.2.3 Optimising read alignments using BowTie2  
After trimming of the raw reads, alignment to a reference genome is required for 
downstream variant calling and comparison between sequence individual reads and 
samples. Several alignment tools including Burrows-Wheeler Aligner (BWA) (Li and Durbin, 
2009) and BowTie2 (Langmead and Salzberg, 2012) are available for the mapping of reads in 
fastq format, the output format of most sequencers. Choosing an appropriate aligner can 
have drastic results on the accuracy of mapping. Spliced Transcripts Alignment to a Reference 
(STAR) (Dobin et al. Bioinformatics 2013) and other aligners are available but typically allow 
for alignment of reads other than amplicons, e.g. transcriptome data. As Bowtie2 allows end-
to-end alignment that involves all read characters and is often used in the mapping of 
amplicon sequences, BowTie2 was used for the pipeline.  
 
The BowTie2 parameters were optimised to correctly align the most possible reads in the 
pipeline. Bowtie2 outputs alignments in Sequence Alignment/Map (SAM) files, which, 
besides the sequence name, nucleotide and PBQS sequences, contain several fields 
describing information on the alignment. The FLAG is a bitwise number indicating whether a 
read and its mate mapped and in which order. Each reads also contains a CIGAR string that 
is used to indicate which bases align (either a match/mismatch) with the reference, are 
deleted from the reference, and are insertions that are not in the reference. As a readout for 
mapping efficiencies, the proportion of reads that were mapped with full consensus to the 






By default, Bowtie2 performs end-to-end read alignment, aiming to align every read 
character. Running Bowtie2 in --local mode allows for some characters to be soft clipped (i.e. 
ommitted) from the ends in order to achieve the greatest possible alignment score. It does 
hence not require the entire read to align from one end to the other. It was found that reads 
with single or multiple substitutions throughout the sequence were frequently soft clipped, 
thereby misaligning to the reference. It was hence decided that --local mode would not be 
optimal for the pipeline. 
 
Bowtie2 runs multiple rounds of alignment and scores each alignment based on the similarity 
of the read sequence to the reference, from which the alignment with the highest alignment 
score is chosen. The score is determined by subtracting penalty scores for each difference 
(mismatch, gap, insertion), for which different parameters can be set to optimise alignments. 
All parameters were tested, which elucidated that a mapping penalty (--mp) of 4 and read 
and reference gap penalties (--rdg and –rfg) of 9 were yielding the highest number of 
reads mapped with full consensus (see Table 3-1B). In --local mode, it was found that a 
matching bonus (--ma) of 4 was optimal, whilst this is 0 by default in end-to-end mode with 
a low mapping score. Changing the ambiguous penalty (--np) or effort options (-D and -R) 
did not change how well sequences mapped. Configuring the minimum score using the 
function options had a big impact on the mapping efficiencies. Overall, constant and linear 
functions were giving very low mapping efficiencies, whilst natural log increase using --i 
G,1,0.25 was shown to give to highest yield of mapping sequences.  
 
Whilst the majority of the indels were correctly indicated by the CIGAR string with the 
optimised conditions, a small fraction (0.8%) of reads with indels at the periphery of the 
sequence were mapped with full consensus (150M). This may be due to the repetitive nature 
of the sequence, but since all of these mutations were outwith the central region covered by 
the repair template, within which mutations of interest reside, this would not pose an issue 
in downstream analysis. Final parameters that were used: ‘bowtie2 --threads 8 --
phred33 --no-mixed --mp 2 -i G,1,0.25 --rdg 9,3 --rfg 9,3 -N 1 
--rg-id 3 -x [REFERENCE.FASTA]-1 [INPUT.MATE1.fastq] -2 





The optimised BowTie2 parameters align Illumina-derived read pairs and allow up to 6 
missense substitutions or 5 insertions or deletions to be mapped by BowTie2. For this reason, 
the majority of reads containing the 6-nt HDR core did not pass this stage. Therefore, reads 
were additionally mapped to the reference sequences containing the HDR core (respectively 
TTATAA and CGCGCG, discussed in sections 3.2.1 and 4.2.2) and finally combined the reads 
mapping to any of the three reference sequences into a single SAM file.  
 
3.2.4 Concatenating reads into single amplicons 
Reads processed by Bowtie2 are mapped in pairs, with each member of the pair expressed 
in separate lines of the output SAM file. PE sequencing greatly reduces the number of 
sequencing errors as each nucleotide covered by both mates is independently called twice 
as mentioned in the introduction. To further process amplicon sequences and correctly call 
single nucleotide mutations in downstream analysis, overlapping of forward and reverse 
reads into a single consensus contig was desired.  
 
Several read merger scripts exist including FLASH (Magoč and Salzberg, 2011), PANDAseq 
(Masella et al., 2012) and PEAR (Zhang et al., 2014). Mergers such as FLASH and PEAR look at 
the maximum number of overlapping bases without taking the PBQS into account and hence 
do not perform any error correction. PANDAseq utilises PBQS but typically has issues with 
the merging of shorter fragments (i.e. amplicons) as it assumes all reads can be merged. None 
of these was therefore considered to be suitable for the merging of short fragments with 
high nucleotide variety, so a custom script was written to overlap sequences from both 
forward and reverse reads, utilising the base quality scores and CIGAR strings present in the 
SAM files generated by BowTie2.  
 
At the start of the merger script, the read length (for the assays in this study 150-bp) and 
total amplicon sequence length covered by both the forward and reverse read (in case of GFP 
157-bp) are determined. The script sets up empty read and Phred score sequence of the 
amplicon length and fills these in with ambiguous characters (‘-’ and ‘!’, respectively). As we 
sought to minimize the FDR of SNVs, only read pairs in which both reads map to the reference 




passed. Nucleotide sequences and Phred scores are read and copied into these new 
sequences, skipping positions in case the CIGAR string indicating a deletion while indicating 
an ‘I’ when there is an insertion, thereby retaining the amplicon length. When the forward 
and reverse read are scanned, the script compares both sequences in the overlapping region 
and writes high-quality consensus bases (i.e. Phred scores exceeding 20, corresponding with 
a p-value > 0.01) whilst assigning the highest of the two Phred scores. In case two conflicting 
nucleotides are called at high quality at the same position, the base with a Phred score above 
20 or the one with the highest quality with a minimum difference of 5 in the Phred score, 
corresponding to half a log, is used. In case the two conflicting nucleotides are called at high 
confidence, it was considered an ambiguous nucleotide. As the deep mutational scanning 
projects require high confidence nucleotides in order to call SNVs, reads containing a 
deletion, insertion or ambiguous nucleotide in the region of interest (100-nt in case of GFP) 
are discarded at this stage. While stringent, these settings pass reads of the highest quality 
and minimise the FDR. These settings can however easily be adjusted at the start of the script. 
 
Contigs written to the final output file are hence of very high quality and of full amplicon 
length, containing only mismatches. It was found that none of the reads containing deletions 
and insertions, indicated in the read names of the dummy sequences, have passed to this 
stage, thereby leaving only reads with wildtype sequences and substitutions. Contigs that 
contain conflicting or low-quality nucleotides are sorted into a separate output file.  
 
For convenience, the output files containing the merged reads are remapped to the 
reference sequence to yield an output in SAM format. As at this stage, sequences do not 
contain insertions or deletions with respect to the reference, BowTie2 is here used at its 
default settings using bowtie2 --local -x [REFERENCE.FASTA] –U [MERGED 
INPUT] –S [OUTPUT.SAM]  
 
3.2.5 Selecting and filtering reads with desired read outcomes  
The remapped, high-quality contigs are at this point ready for analysis of nucleotide 
variances. As the sequences of interests are only those derived from HDR, those reads that 
contain the 6-nt HDR core that is unique for these sequences were filtered out. As the two 




(‘TTATAA’) experiments, the script was set up in a dynamic fashion to bin reads based on 
having the expected HDR, wildtype (‘CGCGCC’) or other core sequence at the specified 
positions into separate files (discussed in section 3.2.1 and 4.2.2).  
 
All dummy reads that were initially generated with HDR cores were correctly sorted into the 
HDR bin, confirming that the developed pipeline works efficiently at processing and isolating 
relevant reads. Whilst no additional sequences were found in this bin when selecting the 
STOP core sequence, a fraction of the reads containing substitutions in the wildtype read 
were found in the HDR bin. All these reads contained a C>G substitution converting a 
wildtype core sequence to a VarSil HDR core sequence. Whilst false positives through this 
specific mutation could theoretically also occur in experimentally-derived reads, it was 
reasoned that the developed bioinformatics pipeline cannot account for such a false positive. 
However, assuming that the proportion of HDR-reads will be sufficiently high in the 
experimental setup, such low frequency events were not expected to adversely affect 
downstream analysis. Indeed, missense mutations arising from a 1-nt substitution are very 
rare following NHEJ (van Overbeek et al., 2016). Assessment of the proportion of VarSil cores 
in negative control samples should be performed to assess the FDR of this SNV in 
experimental samples.  
 
3.2.6 Assessing frequencies of non-consensus nucleotides per repair template and 
in pool 
After the isolation of contigs containing the 6-nt HDR core, these sequences can be used to 
count nucleotide frequencies at each position. A Python script was written to allow for a wide 
range of sequences to be processed and allow for the configuration of the reference and 
coding sequence, reading frame and region of interest at the start of the script. The script 
loops through all reads and counts nucleotide frequencies at each position, whilst also 
translating the nucleotide sequence to amino acids and highlighting any amino acid 
substitutions. It outputs both a tabular file of nucleotide frequencies at each position and a 






In addition, whereas nucleotide substitutions in an exonic region will often affect protein 
stability through a change in amino acid sequence, the script additionally translates SNVs to 
amino acid substitutions. It outputs a list with the SNVs and amino acid substitutions per 
read, allowing for the analysis of amino acid substitutions occurring in a sample.  
 
Analysis of the nucleotide frequencies in the dummy sequences demonstrates that non-
consensus nucleotides are equally occurring as is expected by the random nature of their 
origin (see Figure 3.3A). Processing a file containing dummy files with mostly nucleotide 
substitutions in two banks of 12-nt flanking the HDR core (i.e. the predetermined variable 
regions in the experimental setup of GFP) shows that these are also correctly processed and 
represented in the tables generated by pipeline (see Figure 3.3B). Some non-consensus 
nucleotides in the variable region were represented at a lower rate around 2%. To assess 
whether these mutations were misaligned, a grep search was performed to assess their 
frequencies. This assessment showed that these substitutions were occurring at a lower 
frequency in the generated dataset and that the read alignment is therefore not biased 
against these mutations. These findings indicate that the pipeline processes contigs with no 
bias towards specific nucleotide substitutions.  
 
3.3 Step-by-step user guide for the use of the bioinformatics pipeline 
A step-by-step user guide to the pipeline developed in this chapter (for schematic see Figure 
3.2B) is provided in this section. In addition to the bioinformatic analyses described in the 
previous sections, additional (optional) scripts were provided to count and visualise 
nucleotide variants. Whilst these scripts have been optimised for the analysis of amplicon 
sequences derived from the GFP experiment, they can be adapted for the analysis of other 
amplicon sequences with predefined outcomes following the protocols laid out in this 
section.  
 
3.3.1 Introduction to pipeline 
The bioinformatics pipeline and supporting scripts described in this user guide are publicly 
available in the Github repository previously discussed 
(https://github.com/mkelder/deepmutationalscanning) (Dabbish et al., 2012). The 
‘Pipeline.sh’ Shell script contains all the modules necessary for full analysis of amplicon 




functions independently and can as such be turned on or off at the start of the script (line 
20-26), whilst the essential modules 1-5 are essential for subsequent analyses: 
 
Essential modules: 
Module 1: Adapter and quality trimming  
Module 2: Aligning reads to reference  
Module 3: Merging paired reads into a single contig  
Module 4: Remapping reads into SAM files  
Module 5: Sorting contigs based on core sequence   
 
Optional modules:  
Module 6: Determining mutation frequencies in wildtype reads   
Module 7: Filter HR reads with single nucleotide change  
Module 8: Assessment of nucleotide frequencies and mutations (recommended) 
Module 9: Assessment of amino acid codon frequencies  
Module 10: Plotting non-consensus nucleotide frequencies    
Module 11: Compare amino acid changes between samples 
Module 12: Plotting sequence logos  
 
3.3.2 Pipeline configuration 
Prior to the analyses, several reference files need to be in place in order for the scripts to 
function correctly:  
• Ensure all provided scripts are placed into the /analysis directory, whilst ‘Pipeline.sh’ 
is positioned in the working directory. 
• Place the FASTQ files compressed in the GNU zip (i.e. the standard output format of 
the MiSeq platform, indicated by the .gz file extension) in the working directory. 
• Place the reference FASTA file, containing the sequence name in the first line in 
format “>SEQUENCE_NAME” and the reference sequence in the second line, in the 
working directory. 







Figure 3.3 Dot plots of non-consensus nucleotides across nucleotide positions in dummy 
reads (A) Dot plot of non-consensus nucleotides at each position across the amplicon 
sequence. As nucleotide substitutions are generated randomly, there is no enrichment for 
specific nucleotide variants. In the centre, nucleotide variants representing the VarSil or 
VarStop core are enriched. (B) Dot plot of non-consensus nucleotides in dummy reads with 
non-consensus nucleotides enriched in the two banks of twelve nucleotides on either side. 
This shows that the developed pipeline is capable of detecting and visualising specific 
nucleotide variants. Non-consensus nucleotides occurring at reduced frequency in the 
variable region were underrepresented in the initial dataset (see previous page). Nucleotide 






Grid engine options can be indicated at the start of the script and are by default at 4 Gb in 8 
cores, with an expected run time less than 10 hours. Indicate the working directory in ‘DIR’ 
(line 13), reference file name in ‘FASTA’ (line 14) and toggle SILENT/STOP in ‘HRCORE’ (line 
15) of the file. Finally, indicate which of the scripts should be turned on/off in the analysis 
(line 20-26). 
 
For GFP, these configurations are sufficient to execute the full script from the command line 
by executing ‘sh Pipeline.sh’ or by submitting the script to the cluster through ‘qsub 
Pipeline.sh’. Alternatively, modules of the script can be copied to the command line for 
manual execution of the scripts. Throughout the pipeline, intermediate files will be placed in 
the respective folders, whereas output files are stored in the analysis folder. For the analysis 
of amplicons other than GFP, individual scripts require manual configuration. Each of the 
scripts is therefore explained below with instructions for configuration. 
 
3.3.3 Module 1: Adapter and quality trimming  
This module will run Trim Galore! (a wrapper for Cutadapt and FastQC) on the list of files in 
‘filenames.txt’ in the working directory, which will automatically be generated based on the 
unzipped ‘.fastq’ files in the directory. In PE mode, the first two files in ‘filenames.txt’ are 
paired, then the next two etc.. The Trim Galore! command does not require configuration for 
the analysis of other amplicons but can be adjusted for its stringency or adapter sequence as 
explained in the Trim Galore! manual (Krueger, 2015). After trimming, summary reports will 
be written to .txt files in the /analysis directory. 
 
3.3.4 Module 2: Aligning reads to reference sequence 
This module will run the BowTie2 aligner on the list of files in ‘filenames_trimmed.txt’ in the 
target directory using the FASTA file set at the start of the script, which will automatically be 
generated based on the ‘.fq’ files in the directory. Read pairs will be aligned to the FASTA 
reference sequence input at the start of the ‘Pipeline.sh’ script and outputs aligned reads in 
a SAM file. BowTie2 parameters were extensively optimised in section 0 and are suitable for 
a wide range of amplicon sequences but can be adjusted in the BowTie2 command line as 
can be read in the scripts manual (Langmead and Salzberg, 2012). Alignment summaries will 




3.3.5 Module 3: Merging reads into single contig  
This module merges forward and reverse reads into a single contig of a predefined amplicon 
length. When the forward read and reverse read are scanned, the script compares both 
sequences in the overlapping region and writes high-quality consensus nucleotides (i.e. 
Phred scores higher than 20, corresponding with a p-value for FDR < 0.01) whilst assigning 
the highest of the two Phred scores. For further details, see section 3.2.4.  
 
Adjust parameters in 'M3.Merge_Reads_To_Contig.py' to configure this merger script for 
amplicons other than GFP. Set read length by parameter ‘ReadLen’, amplicon length by 
‘AmpLen’ and toggle stringency ‘Stringent’ for the inclusion of indels and ambiguous 
nucleotide.  
 
3.3.6 Module 4: Remapping reads into SAM files  
Module 4 remaps the merged contigs to the reference sequence provided in the FASTA file. 
This module utilises the default parameters for BowTie2 and does not require any 
adjustments. 
 
3.3.7 Module 5: Sorting contigs based on core sequence    
This module sorts sequences based on their core sequence into three classes: NOHR (i.e. 
wildtype), HR and AMB (ambiguous or other). The HR core sequence will be based on the 
HDR core provided at the start of the ‘Pipeline.sh’ script. With this script, the proportions of 
predefined outcomes are hence measured and will be printed on the command line. 
 
Reference sequence will be based on the predefined FASTA file, whilst core sequences 
(‘HRcore’ and ‘NOHRcore’) and positions (‘coreStart’ and ‘coreEnd’, with respect to the start 
of the amplicon sequence) can be adjusted at the start of the script ‘M5.Sort_SAM.py‘.  
 
3.3.8 Module 6: Check mutation frequencies in WT reads   
This script is optional and can be toggled on/off at the start of ‘Pipeline.sh’. It assesses the 
proportion of wildtype reads with full consensus to the FASTA reference sequence, thereby 




of read errors. Similar to module 5, HDR core positions (‘coreStart’ and ‘coreEnd’) can be 
adjusted at the start of the ‘M6.Filter_WT_mutations.py’ script. 
 
3.3.9 Module 7: Filter HR reads with single nucleotide change  
This script is optional and can be toggled on/off at the start of ‘Pipeline.sh’. Reads identified 
as having an HDR core in module 5 are analysed and further divided based on having either 
(1) no mutations, (2) a single mutation in the variable region and no additional mutations in 
the peripheral regions, (3) mutations in the peripheral regions but not in the variable regions, 
(4) multiple mutations in the variable region or (5) a single mutation in the variable region 
with additional mutations in the peripheral regions. Absolute read counts for each class are 
printed in the console, whilst reads from class 2 are written to ‘.HRunique.HR’ files and reads 
from class 4 to ‘.moremuts.HR’ files. Similar to module 5, HDR core positions (‘coreStart’ and 
‘coreEnd’) can be adjusted at the start of the ‘M6.Filter_WT_mutations.py’. 
 
3.3.10 Module 8: Counting nucleotide frequencies and mutations  
This script can be toggled on/off at the start of ‘Pipeline.sh’ and is optional, although highly 
recommended, as it scans through the HR reads and counts the number of non-consensus 
nucleotides at each position. It outputs a tabular file (‘.NTcount’) containing a summary of 
the absolute counts and proportions of each nucleotide at each position. This includes an 
overview of the reading frame and reference numbers of nucleotides and amino acids to the 
larger genomic open reading frame (ORF).  
 
In addition, nucleotide substitutions are translated into amino acid substitutions. A list of 
reads with their respective nucleotide and amino acid substitutions (both with respect to the 
wildtype and HDR core sequence) are listed in a separate file (‘.mutations’).  
 
This script requires several parameters to be configured. ‘ReadingFrame’ is the nucleotide 
frame (1, 2 or 3) use to translate the nucleotide sequence into amino acids, based on the 
amplicon reference sequence. ‘outputstart’ is the nucleotide position in the amplicon 
reference sequence from which the output should start reporting (inclusive), set at 0 to 
inactivate and thus output from the start of the amplicon reference sequence. ‘outputstop’ 




reporting (inclusive), set at 0 to inactivate and thus output to the end of the amplicon 
reference sequence. ‘seqstart’ is the start nucleotide of the amplicon reference sequence 
relative to a larger reference sequence (e.g. the GFP ORF) for reporting nucleotide and amino 
acid mutations. 
 
3.3.11 Module 9: Assessing amino acid codon frequencies  
This script is optional and can be toggled on/off at the start of ‘Pipeline.sh’. It scans through 
all HDR reads and, based on the provided reading frame, makes counts for all possible codons 
at each position and writes it into a tabular summary file (‘.codoncount’). Parameters are the 
same as those used in Module 8.  
 
3.3.12 Module 10: Plotting non-consensus nucleotide frequencies  
This script is optional and can be toggled on/off at the start of ‘Pipeline.sh’. This module plots 
non-consensus nucleotide frequencies for all HR reads. It creates non-consensus nucleotide 
dot plots (as seen in Figure 3.3) and stacked bar plots based on the nucleotide frequencies in 
the ‘.NTcount’ file generated in module 8. These graphic representations are output as PDF-
files in the analysis directory. 
  
Parameters are optimised for GFP amplicons but can be adjusted for other amplicon 
sequences. This however requires the adjustment of values in the section starting at line 41 
for the boundary of nucleotides to report on. In addition, parameters in code lines 53 
onwards can be adjusted for the tuning of nucleotide positions for the limits of the variable 
region indicated by the dashed lines in the plot.  
 
3.3.13 Module 11: Compare amino acid changes between samples 
This script is optional and can be toggled on/off at the start of ‘Pipeline.sh’. It analyses the 
‘.mutation’ files generated in module 8 and outputs a tabular summary of the frequencies of 
amino acid substitutions, whilst additionally looking up the corresponding DDG value for the 
effect of these amino acid substitutions on GFP (discussed in more detail in section 4.2.14). 
These summaries are created for both the residues in the variable positions specifically 






3.3.14 Module 12: Plotting sequence logos  
This script is optional and can be toggled on/off at the start of ‘Pipeline.sh’. It translates all 
nucleotide sequences in the HR file into an amino acid multiple sequence alignment (‘.AAs’) 
in the AA directory and subsequently creates sequence logos in PDF-format the analysis 
directory. Parameters are the same as those used in Module 8.  
 
3.4 Use Case: Detection of HDR-derived reads in SRSF1 targeting 
As an initial assessment of how the established bioinformatics scripts perform on real data, 
albeit not from a deep mutational scanning experiment, the pipeline was utilised to assess 
HDR efficiencies in the repair of point mutations in SRSF1 by CRISPR-Cas9 and HDR. The 
experimental design was conducted by Fiona Haward and Andrew Wood, and cell culture 
was entirely performed by Fiona Haward. SRSF1 is part of a serine/arginine-rich protein 
family of pre-mRNA splicing factors that is capable of nucleocytoplasmic signalling. The aim 
of this work is to study the physiological relevance of the cytoplasmic functions of SRSF1, by 
knocking in a nuclear retention signal (NRS) to create a SRSF1-NRS fusion protein that 
prevents the nucleocytoplasmic shuttling of SRSF1. In addition, a small T7 epitope tag was 
added, allowing for several biochemical analyses on the SRSF1 protein.  
 
After several attempts to isolate homozygous clones through CRISPR-Cas9 (see Figure 3.4A), 
only a single viable clone with homozygous knock-in (clone 11) was obtained in mESCs. This 
clone however contained two single base deletions on one allele, resulting in frameshifts that 
inactivate the NRS (see Figure 3.4B). These results suggest that there is a strong selection 
against the obstruction of SRSF1 shuttling in mESCs. To test this, a CRISPR-Cas9-based assay 
was designed to assess changes in the frequencies of HDR-derived alleles during the 
retargeting of SRSF1-NRS-T7 clone 11. This assay was based on the premise that, if 
homozygous SRSF1-NRS-T7 alleles had a negative impact upon cell fitness, the frequency of 
HDR-derived alleles should decrease in the population over time. 
 
Repair of the monoallelic single base pair deletions in the C-terminus and NRS of this clonal 
cell line was attempted by CRISPR-Cas9-mediated HDR. Fortunately, the 5’ deletion created 




leaving the other allelic copy with the correct insert unaffected. Cells were transfected with 
wtCas9, sgRNA and a modified ssODN with a silent nucleotide substitution destroying a 
BamHI restriction site, which was utilised to distinguish both allelic copies after successful 
repair. Transfected cells were edited for 24 hours and subsequently enriched by FACS for GFP 
fluorescence. Cells were harvested for gDNA extraction before targeting (T0) and at multiple 
time points post-transfection (T1-T7, timepoint being 2 days apart) to assess whether there 
was a temporal reduction in presence of the desired knock-in see Figure 3.4C). The target 
site was amplified by PCR and subsequently deep-sequenced on the Illumina MiSeq platform.  
 
In order to account for any proximal sequence modifications (especially in the terminal exon 
of SRSF1, i.e. the 5’ portion of the insert) that could produce a compensatory mutation, the 
maximum PE read length of 300-bp was used to amplify across the entire C-terminal region, 
resulting in an amplicon of either 434-bp (unedited allele 1) or 436-bp (allele 2 or repaired 
allele 1) product. The bioinformatics pipeline developed in this chapter will be utilised to 
assess the frequency of successful HDR outcomes. This will furthermore assess the wider 
applicability of the pipeline.  
 
3.4.1 Experimentally-generated reads are efficiently mapped to the reference 
As the maximum difference between the expected repair outcomes (i.e. allele 1 unrepaired, 
allele 1 repaired and allele 2) is two single base pair deletions and a single base substitution, 
reads were mapped to a single reference sequence of repaired allele 1. For the proportions 
of allele 1 (either unedited or repaired), these were either represented as part of the entire 
sequencing pool or as proportion of all allele 1 reads by normalising to the number of allele 
2 reads, as allele 2 was unaffected by CRISPR-Cas9 editing. Across all samples, on average 
73.88% ± 0.07 of the reads mapped (see Table 3-2), with the highest proportion (85.0%) 
found in the T0 (i.e. unedited) sample as expected. An interrogation of unmapped reads 
showed that these predominantly comprise short (47 – 62 bp, similar to  
CCTGTAGATGTTAGGCGCCAGGGGATATTCCCCACGCCTGCAATTCAACACTTTAGCCCCTT) reads 
that have little (10%) sequence similarity with the reference or the Nextera adapters, whilst 
a BLAST search for the sequences did indicate a 86.7% similarity to the Srsf1 gene, with 8 A>C 
substitutions with respect to the reference (Altschul et al., 1997). As this number of missense 
mutations is higher than the threshold (6 missense bases), this is in line with the stringency 







Figure 3.4 Schematic of SRSF1 editing strategy and sequencing outcomes (A) For the tagging 
of SRSF1 with an NRS and T7 sequence, mESCs were transfected with a Cas9-GFP plasmid, 
sgRNA and an ssODN containing the tag sequence and homology arms to the SRSF1 site. GFP-
positive cells were enriched by flow cytometry and harvested at different time points after 
transfection and sequenced across the target site. (B) A single clone (Clone 11) was found to 
harbour a homozygous knock-in of the SRSF1-NRS-T7 construct but with two single base pair 
deletions on allele 1. This allele was specifically targeted with Cas9 and a ssODN containing 
the construct but with a silent mutation destroying a BamHI site, thereby allow to distinguish 
repaired allele 1 from allele 2. (C) Schematic overview of time points at which cells were 
harvested, which represent 2-day intervals. This schematic was adopted from the Ph.D. thesis 
of Fiona Haward. (D) Frequency of unedited allele 1 and 2 over time post-transfection. 




allele 1 sharply drops in the first two days after targeting, after which the frequency remains 
constant. This indicates that allele 1 but not allele 2 is targeted by CRISPR-Cas9. (E) Frequency 
of perfectly repaired HDR copies of allele 1. After editing, a sharp increase in the frequency 
of repaired copies of allele 1 is observed, indicating repair by HDR. Although some 
fluctuations are observed, this frequency gradually decreases in the time after editing, 
indicating a negative selection against perfectly repaired SRSF1-NRS-T7. (F) Frequency of 
copies of allele 1 containing full consensus and indels. Whereas there is a sharp drop-off in 
frequency of copies with full consensus, an inverted correlation is observed in the frequency 
of reads that have undergone NHEJ. This indicates that the majority of the copies of allele 1 
undergo NHEJ.   
 
of GFP reads can also be used for mapping different amplicons of a different length.  
 
3.4.2 Perfect repair of SRSF1 is selected against in mESCs 
For the merging of forward and reverse reads, parameters were optimised as described in 
the user guide to construct a 436-bp amplicon from 300-bp reads whilst allowing possible 
insertions/deletions to be included. Reads with bases that were not consistently called 
between both reads of a pair (i.e. read errors) were discarded. On average, 69.4 ± 3.04 % 
pairs merged with full consensus between forward and reverse reads.  
 
Module 5 of the pipeline was configured to isolate reads based on the expected editing 
outcomes, i.e. allele 1 unrepaired, allele 1 repaired, allele 1 with indels, unaffected allele 2 
and anything else. Editing efficiencies were determined by assessing the frequency of 
unrepaired allele 1 and allele 2, which was close to 1:1 at T0 (see Figure 3.4D). The proportion 
of allele 2 remained broadly constant over the time, confirming that that allelic copy was not 
targeted by Cas9. In contrast, the proportion of unrepaired allele 1 dropped drastically from 
40% to 15% in the first two days post-targeting, indicating a targeting efficiency 
approximating 62.5% (i.e. 100% - 15% / 40%). These results show that Cas9 specifically 
targeted a single allelic copy of SRSF1, which can be detected by the developed pipeline.  
 
As mentioned in the introduction, cleaved DNA can be repaired by either NHEJ, leading to 
small insertions or deletions at the target site, or by HDR from the introduced template 
donor, which should result in the desired outcome with repair of both of the point mutations 
and the destruction of the BamHI restriction site through a silent G>A mutation. Assessment 
of the frequency of HDR shows that HDR reads increased to 2% in the first day after 
transfection (T1) (see Figure 3.4D and Table 3-3), which corresponds with 6.7% when 




Table 3-2 Mapping efficiencies for SRSF1 samples 
Sample Total reads Aligned reads Aligned % 
T0 (unedited) 928,541 789,301 85.00% 
T1 1,089,775  679,475 62.35% 
T2 1,134,650  769,863 67.85% 
T3 818,138  600,841 73.44% 
T4 415,908  302,323 72.69% 
T5 640,925  480,758 75.01% 
T6 919,511  640,531 69.66% 
T7 295,590  251,311 85.02% 
 
been successfully repaired by HDR. Notably, the rate of HDR-reads decreases gradually over 
the first six days after transfection to frequencies similar those seen prior to transfection (i.e. 
T0). This demonstrates a strong negative selection against a homozygous SRSF1-NRS-T7 cells. 
 
Reads that matched neither the unrepaired or the 31-nt fully repaired length representing 
perfectly repaired allele 1 were considered as NHEJ reads (see Figure 3.4E and Table 3-3). 
These reads inversely increased with the decrease in unrepaired copies of allele 1 and 
plateaued after T2, demonstrating that the majority of reads targeted by CRISPR-Cas9 are 
repaired by NHEJ. However, as a considerable number of reads fell into this class in the 
unedited sample, a closer examination revealed that these reads harboured additional 
nucleotide substitutions in the target region whilst the two restored nucleotide insertions, 
indicating that the initial pool was not entirely monoclonal or that errors originating from 
library preparation were at considerable levels. Regardless, the increase in NHEJ reads in the 
transfected pool indicates that these scripts can be used to detect rates of editing in these 
samples.  
 
The analyses of the SRSF1 dataset shows that the developed pipeline can be utilised to 
analyse experimentally generated datasets with amplicon and read lengths different from 
those that the pipeline was initially designed for. By merely adjusting the parameters of the 
pipeline, the proportions of predefined CRISPR-Cas9 editing outcomes can be measured in 





Table 3-3 Read proportions of SRSF1 targeted editing of allele 1 Samples were harvested before editing (T0) and at 7 different time points after 
editing (T1-T7). Read proportions were determined by filtering reads for the occurrence of two base pair deletions (allele 1, unedited), repaired 
deletions but with a G>A substitution (allele 1, repaired by HDR), no deletions and no G>A substitution (allele 2) or other, which was classed as NHEJ. 
Proportions of reads were represented as either part of the read 1 pool (i.e. normalised to the unaffected allele 2) or as part of the total sequencing 
pool. After targeted, the proportion of both perfectly repaired allele 1 (HDR) and NHEJ increased largely, indicating editing. The proportion of 
perfectly repaired allele 1 decreases over time after transfection, indicating selection against this allele.  
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142,351  85.4% 30% 
                                                                                           
702  0.3% 0.14% 
                                                            
65,842  6.03% 13.32% 
                               
166,688  33% 375,583 
T1 
                           
63,836  39.6% 15% 
                                                                                      
3,143  2.0% 0.72% 
                                                            
206,832  47.56% 58.41% 
                               
161,053  37% 434,864  
T2 
                           
34,489  20.0% 7% 
                                                                                      
2,202  1.3% 0.45% 
                                                            
283,350  57.51% 78.75% 
                               
172,670  35% 492,711  
T3 
                           
27,383  21.0% 7% 
                                                                                      
1,936  1.5% 0.50% 
                                                           
225,019  58.52% 77.48% 
                               
130,200  34% 384,538  
T4 
                           
12,971  20.6% 7% 
                                                                                           
628  1.0% 0.32% 
                                                      
116,962  60.45% 78.39% 
                                  
62,926  33% 193,487  
T5 
                           
24,971  26.4% 8% 
                                                                                      
1,125  1.2% 0.37% 
                                                            
186,965  60.77% 72.42% 
                                  
94,624  31% 307,685  
T6 
                           
34,701  24.3% 8% 
                                                                                           
755  0.5% 0.18% 
                                                         
231,772  56.54% 75.16% 
                               
142,712  35% 409,940  
T7 
                           
20,985  25.3% 8% 
                                                                                           
558  0.7% 0.22% 
                                                         
146,923  58.46% 74.00% 
                                  







In this chapter, I developed and optimised a bioinformatics pipeline to analyse amplicon 
sequencing libraries with pre-defined outcomes generated on the Illumina MiSeq platform. 
These scripts were optimised on artificially generated sequences resembling all expected 
read outcomes and read errors based on the GFP experiment conducted in the following 
chapter, with the aim to distinguish SNVs introduced by CRISPR-Cas9 and multiplex HDR from 
sequencing errors. The analysis of data derived from an experiment aiming to repair 
monoallelic single nucleotide deletions in an SRSF1-NRS-T7 construct shows that this pipeline 
can conveniently be adapted to quantify pre-determined read outcomes in MiSeq-derived 
reads. Together, this data analysis pipeline provides a standardised and solid foundation for 
the analyses of multiple datasets in the subsequent chapters. 
 
3.5.1 Read errors need to be prevented through adequate experimental design 
Before being able to evaluate nucleotide variants in the dataset, several steps were required 
to ensure the exclusion of low-quality reads and to minimise the FDR by addressing the 
sources of error inherent to sample preparation and sequencing on the Illumina platform. 
One publication suggests that PCR, rather than sequencing, is the largest source of 
substitutions, insertions and deletions (Schirmer et al., 2015). The Illumina MiSeq platform 
itself results in several kinds of errors, with substitutions occurring more often than 
insertions or deletions. Using high-fidelity polymerases and choosing the right primer 
sequences to avoid homopolymer stretches, GC-rich regions and inverted repeats are 
therefore essential steps prior to analysis by sequencing. Targeted amplicon sequencing as 
used in this project makes these sequences most sensitive for sequencing biases, whilst it 
simultaneously limits the design of primers for the exclusion of such nucleotide profiles. PCR-
derived biases can hence not be accounted for through the bioinformatics pipeline and may 
result in false positives. It is therefore essential to include negative controls to identify 
possible biases inherent to analysis of the amplicon sequence and determine the minimal 
threshold to which to normalise SNV frequencies. Several steps that address these issues are 
included, with a focus on reducing the FDR of SNVs, which will be further addressed in the 





3.5.2 Pipeline is designed at analysing reads with less than 6 mismatches 
Alignment is an essential step in the correct calling of substitutions. BowTie2 parameters 
were optimised to map the maximum number of GFP reads to the reference sequence 
(section 0), with a focus on the mapping of mismatched bases and reads containing the HDR 
core. The final parameters allowed for the alignment of up to six nucleotide variants, which 
posed a problem in HDR-derived reads from the VarStop experiment; as these inherently 
contain a 6-nt core different from the wildtype sequence and additional mutations therefore 
often did not map to the reference. Therefore, sequences from respective experiments can 
additionally be mapped to the reference sequences containing the VarSil or VarStop HR core 
to account for these discrepancies. As the pipeline was aimed to analyse single nucleotide 
and single codon variants, the exclusion of reads with more than 6 mismatches to the 
reference sequence would not pose any issues in downstream analyses.  
 
The analysis of the SRSF1 data demonstrated that the BowTie2 parameters optimised for GFP 
also allow for the mapping of longer fragment including insertions and deletions (section 
3.4). On average 26.12% of the SRSF1 reads did not successfully map. A further analysis 
revealed that these reads were shorter sequences with little overlap to the reference, which 
were presumably PCR-derived contaminations. As the developed pipeline mapped other 
sequences from the dataset correctly to the reference, this demonstrates that the used 
parameters align experimental data with an equal efficiency to the artificial GFP data.  
 
3.5.3 Read pairs can be merged into a single contig at high quality 
PE sequencing greatly reduces the FDR by analysing each nucleotide twice. The read merger 
developed in this chapter allows for the creation of a single contig whilst taking the PBQS 
into account. It only merges and calls a base when called at high confidence by at least one 
of the two reads. For the calling of SNVs in amplicon sequences used in the following 
chapters, reads with single nucleotide variants called at high confidence were required. 
Therefore, the most stringent parameters in the merger script only pass reads with every 
base called at high confidence by both reads in a pair, excluding reads with deletions or 
insertions. These settings hence greatly reduce the FDR of an SNV and only pass contigs with 
a very low likelihood of reads with nucleotides wrongly called due to sequencing errors. PCR-
derived errors can however still be called at high confidence by both reads and can still pass 




consensus or with (a maximum of six) mismatches with respect to either the wildtype or HDR 
reference. As these reads are aligned and of equal length, they allow for convenient 
comparison and alignment. 
 
Using the artificial GFP dataset, it was shown that the stringent filters of the merger script 
did not pass reads with insertions, deletions or low-quality scores. In the SRSF1 data, 
unedited copies of allele 1 contained indels with respect to the reference sequence and 
would hence be excluded when using the highest stringency settings (section 3.4). By 
lowering these stringencies, these reads were shown to be processed and resulted in an 
average of 69.4% of the read pairs to be merged into contigs. This shows that the settings of 
the scripts developed in this chapter can be adjusted to select for different sequencing 
outcomes.  
 
3.5.4 Filtering of sequences for quantification of read outcomes 
Subsequent quantification and binning of predefined sequences (e.g. those containing the 
HDR tag) in the contig pool allow for the convenient quantification of editing outcomes and 
in case of SRSF1 showed to be sufficient to finish the sequencing analysis (section 3.4). As 
reads are sorted into separate folders, reads of interest are isolated for further analysis.  
 
It was demonstrated that in the quantification of HDR-derived mutations differing from the 
wildtype by a single C>G substitution, read errors can lead to the incorrect identification of 
HDR-derived reads, which could subsequently lead to the incorrect calling of a nucleotide 
variant as HDR-derived. However, as substitutions due to sequencing errors occur at a rate 
of 0.0107 and 0.0064 in respectively the forward and reverse read and thus at a rate of 6.8 x 
10-5 in a read pair, the chance of a read containing the C>G mutation or additional 
substitutions remains low and will be expected to be outnumbered by true HDR reads that 
will occur at a substantially higher rate. These false positives can be addressed by only 
considering SNVs occurring above this 6.8 x 10-5 noise level threshold in the HDR read 
population.  
 
The first five modules of the pipeline are sufficient for the processing and quantification of 
pre-determined sequence variants such as allelic variants and repair outcomes exemplified 




scripts are written and optimised for GFP. As stated in the user manual, most of these scripts 
are interactive and can easily be adapted to other amplicon sequences, which will be 
demonstrated in the following chapters.  
 
Together, the results from this chapter demonstrate that the developed scripts allow for the 
analysis of predefined sequencing outcomes from amplicon sequencing. With the majority 
of the scripts allowing for convenient adaptation of the scripts to other sequencing formats, 
amplicons from different experiments can be analysed by the use of this pipeline. It provides 
a clear guide and is convenient to use whilst requiring little computational power. In the 
following chapters this pipeline will be utilised for the analysis of sequences derived from 








4. Deep mutational scanning of 







4.1 Introduction  
In the previous chapter I developed a data analysis pipeline that can filter and assess the 
effects of nucleotide and amino acid variants introduced by CRISPR-Cas9 and multiplex HDR. 
The second aim of my thesis is to show that this pipeline can be applied to interrogate the 
effect of single nucleotide variants introduced into a chromosomally-encoded locus. In this 
chapter, GFP will be used as a proof-of-principle and show that a library of all possible single 
nucleotide substitutions can be created in a predefined window of a chromosomally encoded 
gene and assess their functional impact. 
 
Green fluorescent protein (GFP) is the first naturally fluorescent protein that has been 
identified after it was isolated from the jellyfish Aequorea Victoria (Shimomura, Johnson and 
Saiga, 1962; Prasher et al., 1992). Wildtype GFP is a 27kDa protein encoded by 240 codons 
and has an intrinsic fluorescence with excitation and emission maxima of respectively 395nm 
and 509nmm. This fluorescence is emitted from an a-helix chromophore that is surrounded 
by a b-barrel structure consisting of 11 b-strands (see Figure 4.1) (Tsien, 1998). Because the 
inward-facing side chains of amino acids in the b-barrel strongly interact with the 
chromophore, correct folding of these domains is essential for both spectroscopic and 
structural stability (Stepanenko et al., 2013).  
 
Since its discovery, GFP has been optimised through successive rounds of directed evolution 
both for use in eukaryotic systems and to enhance its fluorescence, resulting in a variant 
known as enhanced GFP (eGFP) (Cormack, Valdivia and Falkow, 1996; Yang, Cheng and Kain, 
1996). This variant of GFP fluoresces 35 times brighter than the wildtype form and with its 
codons optimised for its translation in mammalian cells (Cormack, Valdivia and Falkow, 
1996), eGFP rapidly turned into the mostly used variant for use in mammalian cells.  
 
As GFP allows for a convenient distinction between folded (functional) and misfolded 
(dysfunctional) variants by its fluorescence and the structure of the protein is resolved up to 
a high resolution, this protein was considered to be an ideal first target to assess the deep 
mutational scanning assay. In addition, the crystal structure of GFP is resolved up to a 
resolution of 1.9 Å (Yang, Cheng and Kain, 1996) allowing for the in silico modelling of the 





Figure 4.1 Structure of the GFP protein (A) Three-dimensional representation of the GFP 
protein. The protein consists of 11 b-sheets that together form a b-barrel in which the a-
helix chromophore resides. Interactions with inward-facing amino acids in the b-sheets are 
essential for fluorescence. Side chains are shown for amino acid residues 106NYKT--EVKF115, 
which are the residues targeted in this chapter. Amino acid T109 and V113 are inward facing 
and potentially interact with functioning of the fluorophore. (B) Top view of the GFP protein 
showing the fluorophore present in the b-barrel and the side chain of V113 in close proximity 
to the fluorophore.  
 
our experimental findings. The aim of this chapter is to interrogate the relationship between 
nucleotide variants and protein stability, so mutations were introduced into sequences 
coding for part of the b-barrel, which is the key structural scaffold, rather than the 
fluorophore itself (see Figure 4.1). Nucleotide variants will therefore be introduced into the 
codons for amino acids 106NYKT--EVKF115, which form the central part of one of the b-sheets. 
 
In this chapter, an experimental work-flow will be setup and tested to introduce single 
nucleotide variants (SNVs) into a chromosomally encoded gene and apply the bioinformatic 
analysis pipeline developed and tested in the previous chapter to assign a functional score to 
mutations introduced by HR. This functional score will be benchmarked to both in silico 
predictions of protein stability as well as previously published experimental data (Sarkisyan 






4.2.1 Experimental workflow for the introduction and functional assessment of single 
nucleotide variances in GFP 
The workflow used for the experiments in this chapter are schematically represented in 
Figure 4.2. The RCNβH-B(t)-GFP (RCN(t)-GFP) cell line was previously characterised as a single 
copy random integration of a pCAG-Gfp transgene with uniformly high GFP expression 
(Chambers et al., 2007) (see Figure 4.2A). RCN(t)-GFP are transfected for 24 hours with two 
plasmids encoding Cas9 nickase (pX335-U6-Chimeric_BB-CBh-hSpCas9n(D10A)) (Cong et al., 
2013) and different sgRNAs targeting the GFP locus, a plasmid coding for a puromycin 
resistance cassette (pSUPER.retro.puro) and an ssODN pool. A majority of ssODNs in this pool 
harbour one or more nucleotide changes within a central region, such that Cas9-mediated 
breaks in different cells can yield HDR edits with distinct sequences. In the VarStop 
experiment (left panel), which serves as a control, all cells that undergo HDR will incorporate 
a stop codon, resulting in a loss of GFP fluorescence irrespective of the genotype within the 
adjacent variable regions.  
 
In parallel, cells transfected with the VarSil ssODN pool will, in contrary to the VarStop 
experiment, incorporate a silent mutation instead of a stop codon. This should allow the 
effects of any single nucleotide changes within the variable regions to be unmasked, which 
is expected to result in a range of GFP expression. Cells will be subjected to puromycin 
selection for 24 hours, which will selectively kill cells that have not been transfected. 7 days 
post-transfection, the GFP populations will be sorted for genomic DNA isolation, after which 
PCR amplification across the target site and subsequent library preparation and indexing will 
allow for deep sequencing on the MiSeq platform. Each of the steps of the process will be 
further discussed in the following sections.  
 
4.2.2 Design of repair template oligonucleotides to assess incorporation efficiencies and 
effects of nucleotide variants 
As reports have shown that HDR efficiencies are increased with the use of ssODNs over 
double-stranded donors (Chen et al., 2011; F Ann Ran et al., 2013; Renaud et al., 2016) this 
system was chosen as an initial system for the delivery of our templates. For homology-




with homology to the GFP locus, while having two variable regions of each 12-nt centred 
around a 6-nt invariable core sequence (see 
Figure 4.3A).  
 
In the 24 variable nucleotide positions, non-consensus nucleotides (with consensus being the 
nucleotide found in the genomic sequence of Gfp) were introduced at controlled frequencies 
by ‘doping’ during the synthesis of the ssODNs (see 
Figure 4.3B). During synthesis of an exact ssODN sequence, a desired 2'-deoxynucleoside was 
added at each cycle of synthesis, resulting in the exact nucleotide being incorporated at that 
location in each ssODN molecule. However, different 2'-deoxynucleosides could be mixed at 
specific, pre-defined ratios in certain cycles, such that these positions contain different bases 
in different molecules synthesised in parallel. In contrast to degenerate oligonucleotides 
used in other studies (Findlay et al., 2014b; Ma et al., 2017; Mason et al., 2018), whereby a 
completely random nucleotide is incorporated at certain positions, we will utilise ‘doped’ 
oligonucleotides, whereby the sequence is biased towards the genomic consensus 
nucleotide with only a small level of randomization. Mixing of the four 2'-deoxynucleosides 
at equal ratios would for example result in each nucleotide being incorporated in 25% of the 
synthesised molecules. However, by manipulating the ratio of consensus versus non-
consensus nucleotides at each of the 24 variable positions in our ssODN, the level of diversity 
per position and per repair template could be controlled.  
 
For this study, the genomic consensus nucleotides for the variable positions were added at 
either 97% or 94% with respectively 1% or 2% for each of the remaining non-consensus bases 
(in different ssODN pools that are henceforth referred to as 97:1:1:1 and 94:2:2:2), such that 
the highest possible proportion of ssODN molecules with a single non-consensus base in any 
of the 24 variable positions (8 codons) could be achieved (see 
Figure 4.3C). As the ‘doping’ process was random, a substantial proportion of molecules was 
expected to contain either no or multiple mutations as is shown in the graph. However, this 
way of synthesis allowed for the introduction of any of the 72 nucleotide variants into the 






Figure 4.2 Experimental workflow for the introduction and functional assessment of single 
nucleotide variants in Gfp (A) For the introduction of amino acid substitutions, RCN(t)-GFP 
ES cells with a uniform high GFP fluorescence are transfected with plasmids encoding Cas9n 
and two sgRNAs (sgRNA8 and sgRNA17, see figure 4.6), a plasmid encoding a puromycin 
resistance gene and an 100nt ssODN repair template pool harbouring different single 
nucleotide substitutions per template (see figure 4.3). Two experiments (left and right hand 
of the figure) differ in the repair template used, which either contains an in-frame stop codon 
(VarStop) or a silent mutation (VarSil) at its centre. 24 hours after transfection, cells are 




Afterwards, cells are cultured until 7-days post-transfection, at which cells are analysed by 
flow cytometry. In the VarStop experiment, all cells that have undergone incorrect repair 
through NHEJ and have thus incorporated indels will lose GFP fluorescence, whereas the 
same will occur for cells that have incorporated the VarStop ssODN through NHEJ. 
Meanwhile, in the VarSil experiment, cells that have undergone NHEJ will lose GFP 
expression, whilst cells that have undergone HDR have incorporated a silent mutation (not 
affecting GFP expression) and an additional mutation that might (partially) destabilise GFP 
expression, thus leading to a wider range of GFP expression. The increase in GFP intermediate 
in VarSil over VarStop is used as a measure for HDR efficiencies. Cells are sorted into either a 
single negative bin (VarStop) or into three bins (VarSil) after which gDNA is extracted. (B) PCR 
amplification of the target site results in a 157-bp amplicon that spans the ssODN homology 
region, including the variable regions and HDR-core (further explained in figure 4.3). 
Amplicons are extended with universal Illumina adapters that include i5 and i7 index 
sequences that allow for the multiplexing of different libraries on the same sequencing lane.  
 
The 24 variable positions in the repair template covered 8 codons of the Gfp gene and could 
thus theoretically result in a total of (8 * 19) 152 amino acid substitutions. However, as the 
doping process makes the chance of two consecutive nucleotide substitutions very low, this 
approach would most likely be screening the effect of single nucleotide variants and thus 
limit the number of amino acid substitutions that can be interrogated. Whereas many of the 
introduced mutations were expected to result in the loss of a functional protein and hence 
lead to a complete loss in GFP fluorescence (termed null or amorphic mutations), some 
mutations might not affect GFP fluorescence compared to the wildtype fluorescence (silent 
mutations) (Muller, 1932). In addition, some nucleotide variants could result in a partial loss 
of gene function and would hence be expressing an intermediate level of fluorescence. By 
analysing the genomic variants present in the intermediate domain of GFP fluorescence, we 
hence expected to observe these so-termed hypomorphic mutations (Muller, 1932).  
 
Two different repair template classes were designed, with each containing its own invariable 
6 nucleotide core (‘HDR core’), which differs from the genome and serves as a genetic marker 
to identify HDR-derived reads in the sequencing pool. Two variable regions, each comprising 
12 nucleotides, are positioned either side of the HDR core (see Figure 4.2B). In the first repair 
template class, ‘VarStop’, this HDR core consist of an in-frame stop codon that result in 
premature translational termination (TAA), causing complete loss of the GFP protein – and 
hence fluorescence – in every cell that perfectly repaired Cas9-induced lesions through HDR. 
After editing, the pool of GFP negative cells would therefore contain both NHEJ and all HDR-





Figure 4.3 ssODN design and the doping by synthesis principle (A) Two classes of repair 
template ssODN molecules are designed, VarStop and VarSil, both with 100-nt in length and 
homology to the Gfp genomic locus with exception to the 6-nt HDR-core. This HDR-core 
sequence contains either an in-frame missense and stop codon (TTATAA, in VarStop) or a 
single, silent C>G substitution (CGCGCG, in VarSil). In addition, in the 12-nt flanking either 
side of the HDR-core (i.e. 24 nt in total), consensus nucleotides (with respect to the GFP locus) 
are randomly substituted with non-consensus nucleotides at either 1% or 2% for each non-
consensus nucleotide during synthesis. (B) During ssODN synthesis, each cycle a specific 2'-
deoxynucleoside (dN) is added and incorporated from 3’ to 5’ (exemplified by dA) in all 
molecules of the ssODN pool. However, the different 2'-deoxynucleosides can be mixed at 
pre-defined ratios in certain cycles, such that different nucleotides are incorporated at these 
ratios at the next residue. Mixing of the 2'-deoxynucleosides at 94% for the genomic 
consensus nucleotide and 2% for each of the other nucleotides, as exemplified in the figure, 
6% of the ssODN molecules harbour a non-consensus nucleotide at this position. For this 
study, 24 positions on the ssODN were ‘doped’ in this way. (C) Theoretical plot showing the 
percentage of oligonucleotides containing 0, 1 or >1 nucleotide substitution with 24 variable 




consensus versus non-consensus bases give the highest probability of a single nucleotide 
substitution occurring in a template. 
 
effects of the single nucleotide variants are masked, the VarStop sample thus allowed for 
assessment of HDR frequencies (by determining the number of reads with the TTATAA core) 
irrespective of phenotypic selection.   
 
The second class of repair templates (VarSil) contain a 6-nt HDR core which differs from 
wildtype GFP by a single silent C>G substitution (CGCGCG, ‘VarSil’), thereby still allowing for 
the identification of HDR-derived reads, whilst unmasking the phenotypic effects of 
nucleotide variants introduced at the variable positions. Whereas it would not be possible to 
use FACS to separate out cells harbouring a null mutation from cells with frameshift 
mutations and similarly silent mutations from cells without a mutation, hypomorphic 
mutations were expected to lead to a distinct level of intermediate GFP fluorescence not 
observed in the VarStop sample. By comparing the GFP profiles of cells transfected with 
VarSil to those transfected with VarStop, the HDR efficiency could hence be approximated 
by the increase in cells with intermediate GFP fluorescence. 
 
4.2.3  Assessing nucleotide diversity on repair template oligonucleotides 
As mentioned in the previous section, both 97:1:1:1 and 94:2:2:2 repair template ssODNs 
were ordered with either a VarStop or VarSil HDR core. The nucleotide diversity in these four 
repair template pools was empirically assessed by deep-sequencing of repair templates, 
which were PCR-amplified with adapters allowing for Illumina indexing (see Figure 4.4A,B). 
ssODN templates (containing either the VarStop or VarSil core sequence) were converted 
into double-stranded DNA and PCR-amplified with adapter-linked primers in a single step, 
such that the entire ssODN was amplified and primer sequences did not cover the variable 
positions (for a detailed description see Materials & Methods). The amplicon was 
subsequently indexed and sequenced on the Illumina platform as discussed in the previous 
chapter. 
 
Focussing solely on reads harbouring a single nucleotide substitution, each possible non-
consensus nucleotide was shown to be represented in each of the ssODN pools (see Figure 




94:2:2:2 were respectively 1.04 ± 0.055% and 2.24 ± 0.11 % as opposed to 0.22% outwith the 
variable positions (see Figure 4.4A and Figure 4.5), thus approximating overall substitution 
rates of approximately 3% and 6% per position at the variable sites (see Figure 4.5). Positional 
biases and consistent differences favouring the incorporation of thymidine over other bases 
were hereby observed. Correspondence with the manufacturer of these ssODN libraries (IDT) 
confirmed a slight skew towards the incorporation of guanine and thymidine during the 
synthesis process. As all single nucleotide substitutions were represented in the ssODN, this 
pool however demonstrated to be useful for the nucleotide diversification of our genomic 
locus of interest.  
 
Assessment of the number of non-consensus nucleotides per template additionally 
confirmed that both repair template classes harbour the same percentage (35%) of reads 
with a single nucleotide variant (see Figure 4.4B), indicating that both repair templates were 
equally suitable for introducing single nucleotide variants across 24 nucleotide residues. The 
94:2:2:2 repair template pools were used in subsequent experiments. 
 
4.2.4 Design of sgRNAs for the editing of GFP using CRISPR-Cas9  
As discussed in the introduction, individual nicks in the genome are frequently repaired with 
high fidelity to ensure genome integrity, whereas simultaneous nicking via appropriately 
offset guide RNAs is believed to yield lesions which are processed as double-stranded breaks 
whilst extend the number of specifically recognized bases for target cleavage by the created 
overhang (F. Ann Ran et al., 2013).  
 
Whilst these paired nickase-variants of Cas9 (Cas9D10A as discussed in section 1.5.3, hereafter 
referred to as Cas9n) were thought to increase HDR-efficiencies when using ssODNs to insert 
small fragments of up to 9 nt (F. Ann Ran et al., 2013; Christopher D. Richardson et al., 2016), 
we wanted to assess the effects of Cas9n and wildtype Cas9 (wtCas9) on introducing 
nucleotide diversity into a genomic locus. A side by side comparison of Cas9n and wtCas9 
was therefore performed.  
 
In order to test editing efficiencies of wtCas9, multiple sgRNAs were used that induced 





Figure 4.4 Assessment of nucleotide diversity of ssODN pools through deep-sequencing (A) 
For the sequencing of ssODNs (either with a VarStop (TTATAA) or VarSil (CGCGCG) HDR-core), 
the single-stranded molecules are PCR-amplified with a reverse primer that transforms it into 
double-stranded DNA, after which amplification with primers extended with Illumina 
adapters for sequencing is being performed. These amplicons can then be indexed (as 
mentioned in figure 4.2) and sequenced. (B) Analysis of ssODN shows that in both 97:1:1:1 
and 94:2:2:2 ssODNs 35% harbours a single mutation, whilst half of the oligo’s in the 97:1:1:1 
pool harbours no mutation in the variable region. (C) Dot plot of rate of non-consensus 




97% consensus, these rates average around 1% at the variable positions, whereas the 94% 
consensus pool averages around 2% as expected. T and G are consistently higher present 
across the variable positions as a result of synthesis bias.  
 
 
Figure 4.5 Stacked bar plots of nucleotide diversity across ssODN template pools Stacked 
bar plots showing distribution of non-consensus nucleotides and average substitution rate 
per position. Horizontal line indicates expected substitution rate in the variable positions (3% 
and 6% for bottom and top panes, respectively) and shows positional biases that are 
consistent between the different repair template pools. Non-consensus nucleotides in the 
non-variable regions are consistent between different experiments, suggesting PCR or 
sequencing biases.  
 
system for introducing nucleotide diversity into Gfp (see Figure 4.6A). Cleavage of Cas9 with 




allowed for the detection of nucleotide variants (i.e. NHEJ) at a specific locus (F Ann Ran et 
al., 2013) 
 
This demonstrated that sgRNA17, sgRNA100 and sgRNA8 promote cleavage of the target 
DNA by wtCas9, and that sgRNA17 and sgRNA8 together promote the cleavage of DNA by 
paired nickases. Having validated these reagents for basic editing procedures, their suitability 
for introducing nucleotide variants through HDR was tested next.  
 
4.2.5 Determining the optimal time between mutagenesis and selection by flow cytometry  
Analysis of the RCN(t)-GFP cell line by flow cytometry confirmed a consistent level of high 
GFP fluorescence in the untransfected cells (see Figure 4.7A). The experimental workflow 
was performed as described in section 4.2.1. Untransfected cells that were subjected to 
puromycin selection were killed, indicating that the drug selection scheme worked. 
Transfection of RCN(t)-GFP cells with plasmids (pX335-U6-Chimeric_BB-CBh-
hSpCas9n(D10A) (Cong et al., 2013)) and puromycin selection plasmid (pSuper.Puro) slightly 
affected GFP fluorescence in the absence of sgRNAs (see Figure 4.7B), which is most likely 
due to cellular stress associated with transfection and/or puromycin selection. However, a 
considerably larger loss in GFP fluorescence was observed in the presence of sgRNA8 and 
sgRNA17 (82.3% versus 1.3% GFP negative, see Figure 4.7B), demonstrating that the change 
in fluorescence was the result of cleavage in Gfp, and that a large majority of surviving cells 
had received editing reagents.  
 
Cells were then transfected with a puromycin selection plasmid, sgRNA8 and sgRNA17 (both 
at equimolar ratios from a Cas9n plasmid) and respectively the VarSil12 or VarStop12 ssODN. 
Fluorescence profiles were assessed at 7- and 14-days post-transfection (see Figure 4.7C). 
For gating, we defined the population corresponding to the GFP negative control as ‘GFP 
negative’, whilst the ‘GFP positive’ population was corresponding with the untransfected 
RCN(t)-GFP cells. The area between these two populations was called ‘GFP intermediate’. In 
cell populations transfected with the VarStop ssODN, separation into GFP positive and 
negative populations was clearly noticeable at 7 days post-transfection, with almost no GFP 
intermediate population (± 0.5 %). However, transfections using the VarSil ssODN donor 





Figure 4.6 Design and Cel1 assay assessing cleavage of sgRNA (A) sgRNA17 and sgRNA100 
are anti-sense oriented (indicated by R for reverse), thereby inducing a nick on the antisense 
strand (as the nickase encoded by the PX335 plasmid has the RuvC domain of Cas9 
inactivated), whereas sgRNA8 induces a nick on the sense strand. All three sgRNAs were used 
for experiments with wtCas9, whilst sgRNA17 and sgRNA8 were additionally used for double 
Cas9n. (B) Schematic overview of Cel-1 surveyor assay. After PCR amplification of gDNA from 
a targeted cell pool, the amplicon fragments are of approximately equal length regardless of 
sequence variants (due to NHEJ or HDR). These fragments get denatured and slowly 
reannealed, which occurs in a random fashion. The Cel-1 enzyme now recognizes DNA that 
contains mismatches and cleaves this DNA at the target site, hence creating smaller DNA 
fragments. This DNA pool can now be analysed by gel electrophoresis, in which the presence 
of smaller DNA fragments indicates the presence of sequence variation and, in the case of 
Cas9-edited cells, editing. (C) Cel-1 surveyor assay showing that wtCas9 cleaves the target 
site in combination with any of the sgRNAs, and Cas9n cleaves the target DNA in combination 





hypomorphic mutations in the variable positions are unmasked by the removal of the stop 
codon inherent to the VarStop ssODN. The fluorescence profile of VarStop-transfected cells 
Figure 4.7 Behaviour of GFP fluorescence as a result of 
targeting (A) Controls showing high GFP fluorescence in 
untargeted GFP+ cells (RCN(t)-GFP) as compared to a GFP- 
control cell line (E14 wildtype cells). (B) Cells transfected 
with Cas9n in the absence of sgRNAs indicates majority of 
cells, whereas the addition of sgRNA17 and sgRNA8 
results in a loss in GFP in 82.3% of the cells at 7d post-
transfection. “No sgRNA” indicates Cas9 in the absence of 
sgRNAs, indicating specificity of sgRNA. “No repair 
template” indicates Cas9 editing with sgRNA but without 
repair template ssODN, indicating Cas9 efficiency (82.3%). 
(C) Transfecting cells with Cas9n with sgRNAs and VarSil 
leads to an increase in GFP intermediate and GFP positive 
cells in comparison to the VarStop experiment, indicating 
that the effects of hypomorphic or silent mutations in the 
variable positions are unmasked by the silent mutation in 
the HR core. GFP fluorescence profiles have not changed 
14-days post-transfection, demonstrating that mutations 
in Gfp do not affect cell viability and separation is optimal 





did not change between 7 and 14 days, whereas a slight decrease in GFP positive cells was 
observed in the VarSil-transfected cells over the second week post-transfection. This was 
possibly due to second rounds of cleavage. As the intermediate population did however not 
change, 7 days was considered to be sufficient to observe the effects of mutations on GFP 
fluorescence and was therefore used as the time point for the isolation of cells for gDNA 
extraction.   
 
4.2.6 Targeting cells with CRISPR-Cas9 and multiplex library to introduce single nucleotide 
variants 
Transfections of RCN(t)-GFP cells with VarSil and VarStop ssODNs were performed 
simultaneously in biological duplicates and analysed by flow cytometry (see Figure 4.8). 
Whilst a complete loss of GFP is considered to be the result of either HDR-induced mutations 
or indels caused by NHEJ, cells with intermediate GFP expression are considered to be 
exclusively originating from nucleotide variants introduced from the VarSil template through 
HDR. As mentioned in section 4.2.1, the increase in intermediate population in the VarSil 
over VarStop condition was used as a proxy to assess the efficiency of HDR in a given 
experiment. In the nickase experiment, up to 2.43% of the VarSil cells harboured 
intermediate GFP fluorescence, a 7.3-fold increase over the VarStop experiment suggesting 
that some cells had undergone incorporation of the HDR repair template. Respectively 82.7% 
and 95.6% of the cells had lost GFP expression in the VarStop experiment which is thought 
to reflect overall editing efficiencies (i.e. all HDR plus NHEJ outcomes). As transfections were 
performed in parallel and editing and HDR efficiencies were thus assumed to be similar 
between VarSil and VarStop experiments, the HDR efficiency was approximated to be at least 
the difference in proportion in GFP negative populations, i.e. 3.6% and 5.4%.  
 
Whereas paired Cas9n creates DSBs with sticky (i.e. overhanging) ends, wtCas9 creates blunt 
DSB ends (as discussed in the main introduction). In parallel experiments, Cas9n was replaced 
with wtCas9 (pSpCas9(BB)-2A-Puro (PX459) V2.0 (F Ann Ran et al., 2013)) and three different 
sgRNAs (as depicted in Figure 4.6A) to determine whether these different DSB end-structures 
had an effect on introducing nucleotide diversity through HDR. Whilst there were 
considerable fluctuations between replicates, wtCas9 with sgRNA100 (cutting centrally with 
respect to the ssODN template) showed similar increases in intermediate cells, indicating 





Figure 4.8 Silent mutations unmask the effects of single nucleotide variability (A) 
Transfection controls as explained in 4.5.a. Percentages on right, centre and left are for the 
proportion of cells fallin in respectively the negative, intermediate and positive bin. (B) 
Fluorescence profiles of Cas9n experiments. Whilst there is variation between experiments, 
VarSil fluorescence profiles consistently show an increase in cells with intermediate GFP 
fluorescence ranging from 3.7X to 7.3X compared to VarStop. (C) Fluorescence profiles of 
wtCas9 experiments show similar patterns to the experiments using Cas9n. Intermediate 
populations are consistently higher in the VarSil experiment compared to the VarStop 
experiment.  
 
adjusted t-test p-value = 0.65, see Figure 4.9). wtCas9 with either of the distally-binding 





Figure 4.9 Fold increase in intermediate populations VarSil over VarStop in using Cas9 
nuclease and nickases Fold increase in intermediate population in VarSil over VarStop 
experiments of simultaneous transfections using either Cas9n (with sgRNA8 and sgRNA17) 
or wtCas9 with the sgRNA denoted under the graph, which is used as a measure for HDR 
efficiencies. The orientation of sgRNA is depicted in Figure 4.6a. The use of wtCas9 with 
sgRNA8 shows less of an increase in intermediate population compared to either the nickases 
or wtCas9 combined with sgRNA100.  
 
nickases (nickases vs. sgRNA8 and sgRNA17 p-values of 0.019 and 0.070, sgRNA100 vs. 
sgRNA8 and sgRNA17 p-values of 0.049 and 0.082), indicating lower efficiencies of 
integration of the repair template. Hence, HDR efficiencies in the use of wtCas9 are largely 
dependent on the sgRNA used.  
 
Cells were sorted into three bins based on GFP expression, with a minimum of 100,000 cells 
per bin. While the voltages between the experiments fluctuated slightly, gates for sorting 
were kept as constant as possible between experiments to ensure consistency. After isolation 
of genomic DNA for each of the samples, the target locus was PCR-amplified using primers 
binding outwith the region covered by the ssODN template (see Figure 4.2B), thereby 
preventing amplification of randomly-integrated oligonucleotide templates. HDR-core 
sequences were designed to introduce restriction sites that allow detection of HDR-derived 




4.10A,B). Digestion of PCR amplicons from different bins indicate that HDR cores are present 
in the respective samples, with the exception of the VarStop bins for the wtCas9 (GFP 
negative population of wtCas9 with g100 (i.e. centrally cleaving Cas9) and other) 
experiments. As this is consistent with the FACS profile of the wtCas9 not indicating high HDR 
efficiencies in these samples, these samples were excluded from further analyses. The 
remaining samples, including biological duplicates for the VarStop and VarSil Cas9n samples, 
were prepared in technical triplicates (i.e. separately PCR-amplified) for deep sequencing.  
 
For each sample, 100 nanograms of template DNA was used. As a single diploid murine 
genome contains approximately 2.86 picograms of DNA and a single copy of Gfp is found per 
genome, approximately 35,000 copies of Gfp would hence be sampled in each reaction. 
Assuming the maximum number of single nucleotide variants being 72 (3 non-consensus 
bases at 24 sites) and at an HDR efficiency of at least 5% (see first paragraph of this section), 
this would suggest an average representation of 24 clones per variant. However, as only 35% 
of the ssODN molecules in the pool contained a single nucleotide substitution in the variable 
positions, 100 nanograms of template DNA would on average give a minimal of 8 clones per 
single nucleotide variant per sample. This would be mostly applicable for VarStop negative, 
where a roughly equal representation of each variant is expected.  
 
4.2.7 Data analysis indicates contaminations across samples 
Sequencing data was analysed using the bioinformatics pipeline described in Chapter 3. 
Contrary to our expectations, analysis of an initial sequencing run revealed that all samples 
consistently harboured large proportions of reads (> 52%) with full consensus (whilst 
allowing mismatches) to the wildtype reference sequence in all bins (see Figure 4.10C). As 
wildtype reads were not expected to be present at high rates in any of the GFP negative bins, 
each step in the processing of the samples was interrogated to elucidate where these 
anomalies originated.  
 
PCR reactions with primers used for library preparation indicated a product in the absence 
of template DNA (see Figure 4.10B), revealing contamination of one or more reagents used 




plasmids in molecular biology labs could be the potential source of contaminants. Therefore, 
PCR amplification was cautiously prepared in a chemistry lab using new batches of reagents.  
 
4.2.8 Nucleotide variances can repeatedly be detected in replicates  
Sequencing of libraries prepared under these sterile conditions demonstrated that the 
frequency of wild-type reads in libraries generated from GFP negative cells were largely 
reduced, although still present at (see Table 4-1). This shows that contaminants present in 
the lab were the origin of these high rates of wildtype reads and that preparation of GFP 
amplicons requires care to avoid contamination. Each of the experiments was performed 
twice independently (i.e. two biological replicates per sample), whereas gDNA samples were 
PCR amplified in three independent technical replicates. 
 
Using the bioinformatics pipeline optimised and explained in the previous chapter, only reads 
with full consensus between both reads of a read pair (110,228 ± 42,399 contigs per sample) 
were considered for analysis. Typically, fewer reads from samples originating from the 
negative bin passed our pipeline, which is in line with the expected increased proportion of 
reads with indels in this population.  
 
Frequencies of non-consensus nucleotides at the 24 variable positions (i.e. 72 in total) 
correlated well between technical replicates with an average R2 of 0.94 (see Figure 4.11), 
indicating high technical reproducibility of our results. Sequencing data from technical 
replicates were therefore pooled prior to the assessment of correlation between biological 
replicates. Good correlations were observed (average R2 of 0.94), these correlations were 
substantially lower between the biological replicates of the different VarSil bins (average R2 
of 0.45), indicating that different bins harbour different non-consensus nucleotides. 
Reassuringly, the correlation of VarStop with any of the respective VarSil bins was higher (R2 
of 0.59 ± 0.038), which is in line with our expectation as the VarStop sample should contain 
all the nucleotide variants also present in the respective VarSil bin. The biological replicates 







Figure 4.10 Assessing HDR efficiencies using restriction enzymes and contamination of 
reads (A) Schematic representation of restriction sites. BsaXI specifically recognises and 
cleaves the HDR core sequence introduced by the VarSil ssODN repair template. PsiI similarly 
recognises and cleaves sequences introduced by the HDR core sequence on VarStop repair 
templates. (B) Digestion of PCR amplicons from gDNA derived from Cas9-exposed cells. 
VarSil-derived samples specifically show digestion products when exposed to BsaXI but not 
PsiI, indicating the presence of HDR sequences. Reciprocally VarStop samples are digested 
by PsiI samples providing an estimate for the level of HDR reads in these experiments. (C) 




reference sequence indicates very high levels of reads with full wildtype sequences, 
indicating contamination of the sequenced samples. (D) Analysis of PCR amplicons by gel 
electrophoresis shows the presence of a PCR product despite the absence of template DNA, 
indicating contamination of other reagents with GFP sequences.    
 
 
Figure 4.11 Correlations technical replicates Correlation of frequencies of non-consensus 
nucleotides show high correlations between technical replicates. Reproducibility was highest 
in the untransfected and VarSil positive samples. Correlation between cbiological replicates 






Table 4-1 Overview of samples and sequence read breakdown All samples were sequenced in two biological replicates (br) and three technical PCR 
replicates (tr), with the exception of RCNt_untransfected and the wtCas9 experiments respectively. Full consensus read pairs are reads with 
concordance between forward and reverse reads at each overlapping position. Hr frequencies are consistently higher in the VarStop negative 
samples. Abbreviations: RCN(t) = name of parent cell line; Neg = GFP negative bin, Int = GFP intermediate bin, Pos = GFP positive bin, Nicks = nickase 
variant of Cas9, wtCas9 = nuclease variant of Cas9;  












read pairs  
Reads 
with HR 
core   %  
Reads 
with WT 
core   %   Other   %  
RCN(t)_Untransfected_tr1 - - - unsorted  - 
                                 
97,116  
                       
134  0% 
                        
78,174  80%   18,808  19% 
RCN(t)_Untransfected_tr2 - - - unsorted  - 
                                 
78,634  
                       
471  1% 
                        
68,427  87%     9,736  12% 
RCN(t)_Untransfected_tr3 - - - unsorted  - 
                               
103,296  
                         
430  0% 
                        
86,885  84%   15,981  15% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.16 
                               
102,561  
                      
3,235  3% 
                        
23,606  23%   75,720  74% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.17 
                               
133,931  
                      
4,932  4% 
                        
31,364  23%   97,635  73% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.18 
                               
115,395  
                      
3,269  3% 
                        
27,477  24%   84,649  73% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.19 
                               
102,561  
                      
3,235  3% 
                        
23,606  23%   75,720  74% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.20 
                               
133,931  
                      
4,932  4% 
                        
31,364  23%   97,635  73% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.21 
                               
115,395  
                      
3,269  3% 
                        
27,477  24%   84,649  73% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.22 
                               
171,960  
                    
12,384  7% 
                      








fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.23 
                               
181,367  
                    
14,505  8% 
                      
112,272  62%   54,590  30% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.24 
                               
146,499  
                      
9,623  7% 
                        
93,503  64%   43,373  30% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.25 
                               
171,960  
                    
12,384  7% 
                      
105,473  61%   54,103  31% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.26 
                               
181,367  
                    
14,505  8% 
                      
112,272  62%   54,590  30% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.27 
                               
146,499  
                      
9,623  7% 
                        
93,503  64%   43,373  30% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.28 
                               
195,895  
                      
8,164  4% 
                      
164,091  84%   23,640  12% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.29 
                               
162,247  
                      
6,601  4% 
                      
141,901  87%   13,745  8% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.30 
                               
139,699  
                      
5,475  4% 
                      
121,895  87%   12,329  9% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.31 
                               
195,895  
                      
8,164  4% 
                      
164,091  84%   23,640  12% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.32 
                               
162,247  
                      
6,601  4% 
                      
141,901  87%   13,745  8% 




fig. 4.9; 4.10; 
4.11; 4.13; 
4.14; 4.33 
                               
139,699  
                      
5,475  4% 
                      
121,895  87%   12,329  9% 




fig. 4.9; 4.10; 
4.11; 4.12; 
4.14; 4.16 
                                 
41,052  
                    
5,332  13% 
                          
9,988  24%   25,732  63% 




fig. 4.9; 4.10; 
4.11; 4.12; 
4.14; 4.17 
                               
106,127  
                    
13,642  13% 
                        








fig. 4.9; 4.10; 
4.11; 4.12; 
4.14; 4.18 
                               
135,708  
                    
17,218  13% 
                        
42,825  32%   75,665  56% 




fig. 4.9; 4.10; 
4.11; 4.12; 
4.14; 4.19 
                                 
56,663  
                    
6,936  12% 
                        
47,308  83%     2,419  4% 




fig. 4.9; 4.10; 
4.11; 4.12; 
4.14; 4.20 
                               
128,408  
                    
13,024  10% 
                      
109,533  85%     5,851  5% 




fig. 4.9; 4.10; 
4.11; 4.12; 
4.14; 4.21 
                                 
79,653  
                  
10,772  14% 
                        
65,118  82%     3,763  5% 
wtCas9_g17_VarSil12_Neg_br1 VarSil12 sgRNA17 
PX459V2.0 
– WT Cas9 negative fig 4.15 
                                 
46,653  1662 4% 12542 27% 32449 70% 
wtCas9_g17_VarSil12_Neg_br2 VarSil12 sgRNA17 
PX459V2.0 
– WT Cas9 negative fig 4.15 
                                 
70,494  3948 6% 21781 31% 44765 64% 
wtCas9_g17_VarSil12_Int_br1 VarSil12 sgRNA17 
PX459V2.0
– WT Cas9 intermediate fig 4.15 
                               
106,310  522 0% 58812 55% 46976 44% 
wtCas9_g17_VarSil12_Int_br2 VarSil12 sgRNA17 
PX459V2.0
– WT Cas9 intermediate fig 4.15 
                                 
72,133  204 0% 42759 59% 29170 40% 
wtCas9_g100_VarSil12_Neg_br1 VarSil12 sgRNA100 
PX459V2.0
– WT Cas9 negative fig 4.15 
                                 
89,232  684 1% 28913 32% 59635 67% 
wtCas9_g100_VarSil12_Neg_br2 VarSil12 sgRNA100 
PX459V2.0
– WT Cas9 negative fig 4.15 
                                 
88,203  4080 5% 26828 30% 57295 65% 
wtCas9_g100_VarSil12_Int_br1 VarSil12 sgRNA100 
PX459V2.0
– WT Cas9 intermediate fig 4.15 
                                 
61,854  264 0% 36066 58% 25524 41% 
wtCas9_g100_VarSil12_Int_br2 VarSil12 sgRNA100 
PX459V2.0
– WT Cas9 intermediate fig 4.15 
                                 
55,672  240 0% 34488 62% 20944 38% 
wtCas9_g100_VarSil12_Pos_br1 VarSil12 sgRNA100 
PX459V2.0 
– WT Cas9 positive fig 4.15 
                               
102,440  1284 1% 66916 65% 34240 33% 
wtCas9_g100_VarSil12_Pos_br2 VarSil12 sgRNA100 
PX459V2.0
– WT Cas9 positive fig 4.15 
                               
127,153  1350 1% 77330 61% 48473 38% 
wtCas9_g8_VarSil12_Neg_br1 VarSil12 sgRNA8  
PX459V2.0
– WT Cas9 negative fig 4.15 
                                 
46,141  3339 7% 16923 37% 25879 56% 
wtCas9_g8_VarSil12_Neg_br2 VarSil12 sgRNA8  
PX459V2.0
– WT Cas9 negative fig 4.15 
                                 
74,999  5241 7% 38651 52% 31107 41% 
wtCas9_g8_VarSil12_Int_br1 VarSil12 sgRNA8  
PX459V2.0
– WT Cas9 intermediate fig 4.15 
                                 
42,544  504 1% 23310 55% 18730 44% 
wtCas9_g8_VarSil12_Int_br2 VarSil12 sgRNA8  
PX459V2.0
– WT Cas9 intermediate fig 4.15 
                                 




wtCas9_g8_VarSil12_Pos_br1 VarSil12 sgRNA8  
PX459V2.0
– WT Cas9 positive fig 4.15 
                                 
71,571  2868 4% 60153 84% 8550 12% 
wtCas9_g8_VarSil12_Pos_br2 VarSil12 sgRNA8  
PX459V2.0
– WT Cas9 positive fig 4.15 
                                 





Table 4-2 Coefficients of determination of biological replicates After pooling of the technical 
replicates, correlation coefficients for all biological replicates for all samples were calculated 
and transformed into coefficients of determination (i.e. R2). Biological replicates of the four 
samples (VarStop, VarSil negative, VarSil intermediate, VarSil positive) highly correlate, 
indicating sufficient sampling and sequencing depth across the samples. The correlation of 
VarStop with any of the respective VarSil bins was higher than between the VarSil bins, which 
is in line with our expectation as the VarStop sample should contain all the nucleotide 











































































































Nicks_VarStop12_Neg_br1   0.94 0.58 0.56 0.65 0.62 0.52 0.53 
Nicks_VarStop12_Neg_br2 0.94   0.62 0.59 0.63 0.60 0.57 0.55 
Nicks_VarSil12_Neg_br1 0.58 0.62   0.89 0.52 0.53 0.45 0.44 
Nicks_VarSil12_Neg_br2 0.56 0.59 0.89   0.43 0.47 0.43 0.44 
Nicks_VarSil12_Int_br1 0.65 0.63 0.52 0.43   0.97 0.43 0.43 
Nicks_VarSil12_Int_br2 0.62 0.60 0.53 0.47 0.97   0.40 0.41 
Nicks_VarSil12_Pos_br1 0.52 0.57 0.45 0.43 0.43 0.40   0.97 
Nicks_VarSil12_Pos_br2 0.53 0.55 0.44 0.44 0.43 0.41 0.97   
 
4.2.9 Nucleotide variants on variable regions are present at lower but equal proportions in 
genome compared to ssODN  
As discussed in section 4.2.2, the VarStop sample allowed for calculating both the HDR 
efficiencies and nucleotide substitution frequencies irrespective of phenotypic selection. 
Across the samples, an average HDR frequency of 12.3 ± 0.010% was seen in the VarStop 
Negative sample (see Table 4-1), as determined by the proportion of reads containing the 6-
nt HDR core sequence that was specifically introduced from the ssODN donor.  
 
In the HDR-derived reads, the average rates of substitution (i.e. presence of non-consensus 
bases) across the 24 variable positions and 70 constant positions were respectively 4.4% and 




and 0.22% in the ssODN donor pool. The rate of substitutions in the constant positions was 
likely due to either PCR or sequencing error as has been previously described (Austinat et al., 
2008) and discussed in the previous chapter. The decrease in non-consensus nucleotides in 
the variable positions in the experimental samples compared to the ssODN could indicate 
short incorporation tracts that include the HDR core but not the variable positions.  
 
Reassuringly however, all 72 possible single nucleotide substitutions were detected above 
background noise level (0.065, see previous paragraph) in the VarStop Negative sample, 
demonstrating that our pipeline can be used to introduce all possible single nucleotide 
substitutions into a specified genomic region (see Figure 4.12A). In addition, comparisons 
between the edited VarStop Negative sample and the VarStop ssODN repair template 
demonstrated that the proportions of non-consensus nucleotides did not differ at the 
variable positions (see Figure 4.12B,D and Table 4-3; p-values for z-scores for the variable 
positions were > 0.05 after false discovery rate correction). While the previous paragraph 
showed that the overall frequency of non-consensus nucleotides is lower, these results 
demonstrate that the ratio of non-consensus nucleotide variants per position did not differ 
between VarStop Negative and ssODN. 
 
4.2.10 Unmasking the effects of genomic variants using VarSil allows for phenotypic 
selection of destabilising mutations  
Whereas the VarStop experiment allowed for the assessment of HDR integration efficiencies, 
the VarSil experiment was intended to assess the functional consequences of the single 
nucleotide variants introduced by HDR. HDR frequencies in the VarSil bins reached 2.3% - 
6.7% (see Table 4-1), indicating that HDR efficiencies were slightly lower in comparison to 
the VarStop experiment. The majority of reads in the GFP negative population of VarSil were 
reads that had a length different to that of the reference sequence, which presumably 
harboured indels, and non-consensus nucleotides (see ‘Other’, Table 4-1), whilst the majority 
of the reads in the positive population had full consensus with the wild type sequence. This 
demonstrates that the phenotypic selection scheme used in this chapter correctly identifies 






Figure 4.12 Distribution of mutations in HR reads from VarStop Negative (A) Dot plot of the 
rate of non-consensus nucleotides at each position of the targeted region in HR reads. This 
shows an enrichment of non-consensus nucleotides in the variable regions but not in the 
constant flanking region. These findings are consistent across both biological replicates. (B) 
Fold enrichment of non-consensus nucleotides in VarStop sample over the VarStop oligo was 
calculated by dividing the frequency of each non-consensus nucleotide in the VarStop ssODN 
repair template from the VarStop genomic sample. Dots below the horizontal grey line are 
non-consensus nucleotides underrepresented in the genomic sample, whereas dots above 
the line are found more frequently in the genomic sample compared to the ssODN. These 
results show that the majority of the nucleotide frequencies are within 1% difference. (C) 
Correlation plot of amino acid substitutions rates at the variable positions in VarStop ssODN 
donor and genomic sample. Nucleotide variants in the respective samples were translated 
into amino acid substitutions, after which their frequency in the total HDR pool was 




with those in the ssODN pool. (D) Proportions of non-consensus bases per variable position 
show variances between the VarStop oligo and genomic sample. All non-consensus 
nucleotides are however represented in both the oligo and genomic sample. 
 
Similar to the VarStop experiment, the VarSil samples showed an increase in non-consensus 
nucleotides in the variable regions (see Figure 4.13A). Assessment of the number of 
nucleotide variances per HDR template revealed that in VarStop Negative, 28% of the reads 
containing the HR core did not harbour any additional mutations, which is higher than the 
21% that was observed in the ssODN template pool (see Table 4-4). In the VarSil samples, 
the number of HDR reads without additional mutations ranged from 3% in the Negative bin 
to 33% in the Positive bin. The VarSil Negative bin harboured the highest percentage of reads 
with multiple mutations (see Table 4-4), which is to be expected as multiple mutations are 
assumed to have a destabilising effect on the stability of the GFP protein. Assessment of the 
classes of individual nucleotide substitutions reveals that nonsense mutations are 
predominantly found in the VarSil Negative class while silent mutations most frequently 
occur in the VarSil positive population, although also still present in the Negative and 
Intermediate populations (see Figure 4.13B). Together, these results demonstrate that 
replacing the VarStop with VarSil HR core unmasks the effects of adjacent mutations on GFP 
fluorescence.  
 
4.2.11 Cas9 nuclease is less effective than Cas9 nickase in introducing nucleotide diversity 
We next wanted to assess the effect of wtCas9 compared to the Cas9 paired nickases, for 
which both the HDR frequency and nucleotide diversity were assessed (see Table 4-1 and 
Figure 4.14). sgRNAs were designed to be in different orientations and proximities to the 
HDR core sequence. Based on read analysis, HDR frequencies were consistently lower using 
wtCas9 regardless of the position of the sgRNA with respect to the ssODN (see Table 4-1). 
This is in contrast to the increase in intermediate population in VarSil over VarStop found in 
WT Cas9 with sgRNA100 (see Figure 4.9), which was also used as a measure for HDR 
efficiencies (see  section 4.2.6).  
 
Nucleotide diversity, as measured by the proportions of non-consensus nucleotides in the 
variable region (Figure 4.14), was lower compared to the double nickases when using WT 




Table 4-3 P-values for z-scores for non-consensus nucleotides in HR reads In order the ascertain the differences in proportions of each non-consensus 
nucleotide at each position between the VarStop negative sample and VarStop ssODN, Z-scores were calculated for each non-consensus nucleotide. 
Afterwards, significance of Z-scores was assessed corrected for false-discovery. Whilst nucleotides in the constant regions (nucleotide positions 208-
315 and 345-378) were significantly different (highlighted in red) between the genomic VarStop ssODN and genomic VarStop sample, the non-
consensus nucleotide frequencies in the variable region (316-327 and 334-345) did not differ. As HR reads were selected based the 6-nt core 
sequence, these positions could not be calculated. NA indicates consensus nucleotides. 
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Table 4-4 Number of non-consensus nucleotides in variable positions in HR reads The number of non-consensus nucleotides per HR read varies per 
bin. In VarStop Negative, nearly half of the reads have a single mutation. Reads with no mutation predominantly reside in the VarSil Positive bin, 
whereas reads with multiple mutations predominantly fall in the VarSil Negative bin. There is a skew in incorporation of reads with one mutation 
over reads with multiple mutations when comparing rates in the VarStop Negative sample with the VarStop oligo. 
Sample 
Total no. HR 
reads 
Reads with no 
mutation 
Reads with single 
mutation 
Reads with multiple 
mutations 
Nicks_VarSil12_Neg 22873 893 4% 14856 65% 7124 31% 
Nicks_VarSil12_Int 73024 3602 5% 53167 73% 731 22% 
Nicks_VarSil12_Pos 40480 13591 34% 14491 38% 12398 28% 
Nicks_VarStop12_Neg 66924 19451 29% 31623 47% 15850 24% 







Figure 4.13  Distribution of mutations in HR reads from the VarSil samples (A) Dot plots 
indicate an enrichment of non-consensus nucleotides in the variable positions over the 
constant positions and a slight increase in the right variable region over the left variable 
region (see table 4.3) (B) Bar plots of amino acid substitution classes. Non-sense mutations 
are predominantly observed in the negative bin of VarSil, whereas missense mutations form 
the predominant class in the intermediate bin and the positive bin shows the highest number 
of reads without a mutation. These differences become more apparent when observing 
reads harbouring only a single mutation. (C) Non-consensus amino acids at the variable 
positions that are observed in at least a single read across the VarSil samples. All 160 amino 
acids were observed in the repair template oligo, but only 60 were observed in the VarSil 
genomic samples. The majority of the amino acid substitutions were observed in multiple 




acids found in the different classes. Most left, distribution of all DDG values theoretically 
possible for amino acid substitutions at the variable positions. Oligo represents the amino 
acid substitutions found on the ssODN repair templates, whereas VarStop Negative shows a 
similar distribution, indicating there is no selection for destabilising mutations. Amino acid 
substitutions found in the VarSil samples show different distributions, suggesting a selective 
distribution of amino acid substitutions based on their effect on protein stability. P-values 
were calculated using Wilcox signed-rank sum test.   
 
that the HDR efficiencies were consistently higher in the nickase experiments, these results 
suggest that double nickases are favoured over nucleases for introducing single nucleotide 
variants from ssODNs. Analyses hereafter are hence performed solely on samples from the 
nickase dataset. 
 
4.2.12 Amino acid substitutions are limited by the required number of nucleotide 
substitutions 
After having confirmed that single nucleotide variants could be introduced into our region of 
interest, the next step was to assess whether the functional consequences of mutations 
could be assessed across the VarSil bins by predicting their effect on protein stability. 
Therefore, nucleotide variants were translated into amino acid substitutions. Theoretically, 
19 possible amino acid substitutions could be found at any of the 8 codons that were targeted 
by the variable positions, hence totalling 152 possible amino acid substitutions. Out of these, 
67 substitutions (44.1%) were found in the VarStop negative bin and 94 (61.8%) across the 
VarSil bins (see Table 4-5). Although the HDR efficiencies were higher in the VarStop Negative 
sample than for any of the VarSil samples, the number of reads was considerably higher for 
the latter, thereby explaining the substantial higher number of amino acid substitutions 
found in the VarSil bins.  
 
As some amino acids are encoded by more codons than others and amino acid substitutions 
at each of the target residues can require up to three separate nucleotide substitutions, the 
‘distance’ from one codon to another in terms of nucleotide changes was assessed for each 
site (see Table 4-6). All 51 amino acid substitutions that can be achieved by a single 
nucleotide change and half (43/87) of all the amino acids requiring two nucleotide changes 
were found in the VarSil samples, whilst none of the amino acids that required 3 nucleotide 
changes were observed. These findings show that the range of amino acid substitutions that 





Figure 4.14 Dot plots of non-consensus nucleotides in wtCas9 samples (A) Dot plots of the 
wtCas9 samples with sgRNA17 shows an enrichment of nucleotide substitutions in the right 
variable region over the left variable region as was observed in the Cas9n experiment, albeit 
at a higher frequency. In the intermediate population, a much lower nucleotide diversity was 
observed. The positive sample was not sequenced. (B) sgRNA100 shows similar distributions 
to sgRNA17. (C) sgRNA8 results in low sequence diversity, likely due to lower HR frequencies. 
  




Table 4-5  Amino acid substitutions found in variable regions in HR reads List of all amino acid substitutions and consensus amino acids found in 
repair template ssODN, VarStop Negative and VarSil Negative, Intermediate and Positive samples, respectively. For each sample, numbers indicate 
absolute read counts (left column) and proportion (right column) for each sample. DDG values were extracted from table 4.9. While all 160 possible 
amino acids were detected in the ssODN, 67 unique amino acid substitutions were found in the VarStop negative bin and 94 substitutions across the 
VarSil bins. Table was sorted based on read count in priority VarSil_Neg, VarSil_Int, VarSil_Pos and amino acid.        



















N 106 * nonsense -0.93 79 8.5E-04 - - - - - - - - 
N 106 A missense -0.93 35 3.7E-04 - - - - - - - - 
N 106 C missense -1.06 40 4.3E-04 - - - - - - - - 
N 106 E missense -0.83 97 1.0E-03 - - - - - - - - 
N 106 F missense -1.53 40 4.3E-04 - - - - - - - - 
N 106 G missense 0.09 44 4.7E-04 - - - - - - - - 
N 106 L missense -2.83 25 2.7E-04 - - - - - - - - 
N 106 M missense -2.86 37 4.0E-04 - - - - - - - - 
N 106 P missense 0.95 10 1.1E-04 - - - - - - - - 
N 106 Q missense -1.43 62 6.6E-04 - - - - - - - - 
N 106 R missense -1.53 106 1.1E-03 - - - - - - - - 
N 106 V missense -1.43 40 4.3E-04 - - - - - - - - 
Y 107 S missense 6.46 979 1.0E-02 114 1.5E-02 - - - - - - 
Y 107 A missense 5.28 24 2.6E-04 - - - - - - - - 
Y 107 E missense -0.84 54 5.8E-04 - - - - - - - - 
Y 107 I missense 2.71 27 2.9E-04 - - - - - - - - 
Y 107 K missense 4.60 32 3.4E-04 - - - - - - - - 




Y 107 P missense 4.59 20 2.1E-04 - - - - - - - - 
Y 107 Q missense 4.25 53 5.7E-04 - - - - - - - - 
Y 107 R missense 3.62 31 3.3E-04 - - - - - - - - 
Y 107 T missense 5.37 19 2.0E-04 - - - - - - - - 
Y 107 V missense 3.54 27 2.9E-04 - - - - - - - - 
Y 107 W missense 7.66 37 4.0E-04 - - - - - - - - 
K 108 A missense 1.18 26 2.8E-04 - - - - - - - - 
K 108 D missense 1.11 39 4.2E-04 - - - - - - - - 
K 108 F missense -0.09 2 2.1E-05 - - - - - - - - 
K 108 G missense 1.83 43 4.6E-04 - - - - - - - - 
K 108 H missense 0.44 38 4.1E-04 - - - - - - - - 
K 108 I missense -0.47 68 7.3E-04 - - - - - - - - 
K 108 L missense -0.28 65 7.0E-04 - - - - - - - - 
K 108 P missense 3.62 11 1.2E-04 - - - - - - - - 
K 108 S missense 1.23 84 9.0E-04 - - - - - - - - 
K 108 V missense 0.06 31 3.3E-04 - - - - - - - - 
K 108 W missense -0.16 33 3.5E-04 - - - - - - - - 
K 108 Y missense 0.12 58 6.2E-04 - - - - - - - - 
T 109 * nonsense 0.93 2 2.1E-05 - - - - - - - - 
T 109 C missense -0.24 30 3.2E-04 - - - - - - - - 
T 109 D missense 3.25 37 4.0E-04 - - - - - - - - 
T 109 E missense -0.04 1 1.1E-05 - - - - - - - - 
T 109 F missense 10.19 46 4.9E-04 - - - - - - - - 
T 109 G missense 1.96 42 4.5E-04 - - - - - - - - 




T 109 K missense 2.00 58 6.2E-04 - - - - - - - - 
T 109 L missense -1.49 35 3.7E-04 - - - - - - - - 
T 109 M missense -2.42 41 4.4E-04 - - - - - - - - 
T 109 Q missense -0.38 2 2.1E-05 - - - - - - - - 
T 109 R missense 3.76 111 1.2E-03 - - - - - - - - 
T 109 V missense -2.03 44 4.7E-04 - - - - - - - - 
T 109 Y missense 16.90 34 3.6E-04 - - - - - - - - 
E 112 M missense -1.18 31 3.3E-04 11 1.5E-03 - - - - - - 
E 112 * nonsense 0.61 1335 1.4E-02 - - - - - - - - 
E 112 F missense -1.67 1 1.1E-05 - - - - - - - - 
E 112 I missense -1.11 1 1.1E-05 - - - - - - - - 
E 112 K missense -0.91 1076 1.2E-02 - - - - - - - - 
E 112 L missense -1.27 64 6.9E-04 - - - - - - - - 
E 112 P missense 0.49 18 1.9E-04 - - - - - - - - 
V 113 * nonsense 2.96 17 1.8E-04 - - - - - - - - 
V 113 D missense 4.40 25 2.7E-04 - - - - - - - - 
V 113 F missense 6.60 57 6.1E-04 - - - - - - - - 
V 113 H missense 3.32 1 1.1E-05 - - - - - - - - 
V 113 I missense -0.63 62 6.6E-04 - - - - - - - - 
V 113 K missense 3.41 15 1.6E-04 - - - - - - - - 
V 113 N missense 3.36 1 1.1E-05 - - - - - - - - 
V 113 P missense 4.70 11 1.2E-04 - - - - - - - - 
V 113 Q missense 3.92 20 2.1E-04 - - - - - - - - 
V 113 R missense 5.77 42 4.5E-04 - - - - - - - - 




V 113 T missense 2.29 15 1.6E-04 - - - - - - - - 
V 113 W missense 11.86 24 2.6E-04 - - - - - - - - 
K 114 A missense 4.77 30 3.2E-04 - - - - - - - - 
K 114 C missense 0.38 2 2.1E-05 - - - - - - - - 
K 114 D missense 2.25 68 7.3E-04 - - - - - - - - 
K 114 F missense -1.55 1 1.1E-05 - - - - - - - - 
K 114 G missense 0.88 26 2.8E-04 - - - - - - - - 
K 114 H missense 0.14 53 5.7E-04 - - - - - - - - 
K 114 I missense 2.59 99 1.1E-03 - - - - - - - - 
K 114 L missense -0.35 88 9.4E-04 - - - - - - - - 
K 114 P missense 2.89 20 2.1E-04 - - - - - - - - 
K 114 S missense 0.42 88 9.4E-04 - - - - - - - - 
K 114 V missense 2.75 52 5.6E-04 - - - - - - - - 
K 114 W missense 0.81 45 4.8E-04 - - - - - - - - 
K 114 Y missense -1.39 59 6.3E-04 - - - - - - - - 
F 115 * nonsense 3.54 84 9.0E-04 - - - - - - - - 
F 115 A missense 3.54 12 1.3E-04 - - - - - - - - 
F 115 D missense 5.70 21 2.2E-04 - - - - - - - - 
F 115 G missense 4.46 7 7.5E-05 - - - - - - - - 
F 115 H missense 3.02 10 1.1E-04 - - - - - - - - 
F 115 K missense 2.95 1 1.1E-05 - - - - - - - - 
F 115 M missense 1.02 30 3.2E-04 - - - - - - - - 
F 115 N missense 3.80 17 1.8E-04 - - - - - - - - 
F 115 P missense 2.23 12 1.3E-04 - - - - - - - - 




F 115 R missense 2.75 16 1.7E-04 - - - - - - - - 
F 115 T missense 3.84 21 2.2E-04 - - - - - - - - 
F 115 W missense 0.60 21 2.2E-04 - - - - - - - - 
E 112 R missense -0.60 59 6.3E-04 - - - - - - 4 7.7E-04 
E 112 Q missense -0.10 1001 1.1E-02 - - - - - - 7 1.3E-03 
E 112 T missense 0.19 19 2.0E-04 - - - - - - 18 3.5E-03 
E 112 S missense 0.97 18 1.9E-04 - - - - 1 5.8E-05 - - 
E 112 Y missense -1.57 55 5.9E-04 8 1.1E-03 - - 1 5.8E-05 1 1.9E-04 
E 112 N missense 0.36 40 4.3E-04 - - - - 1 5.8E-05 12 2.3E-03 
N 106 H missense 0.33 994 1.1E-02 105 1.4E-02 - - 1 5.8E-05 25 4.8E-03 
K 108 K silent 0.00 934 1.0E-02 98 1.3E-02 - - 2 1.2E-04 15 2.9E-03 
K 114 R missense -1.42 1303 1.4E-02 172 2.3E-02 - - 2 1.2E-04 91 1.7E-02 
K 108 N missense 0.92 1878 2.0E-02 202 2.7E-02 - - 3 1.7E-04 8 1.5E-03 
E 112 H missense -0.72 31 3.3E-04 - - - - 4 2.3E-04 12 2.3E-03 
Y 107 Y silent -0.01 1573 1.7E-02 133 1.8E-02 - - 4 2.3E-04 19 3.6E-03 
N 106 T missense -1.39 992 1.1E-02 93 1.2E-02 - - 4 2.3E-04 23 4.4E-03 
K 108 T missense 0.49 962 1.0E-02 231 3.1E-02 - - 6 3.5E-04 31 5.9E-03 
K 108 E missense 0.89 1091 1.2E-02 168 2.2E-02 - - 8 4.6E-04 31 5.9E-03 
K 108 R missense 0.26 1420 1.5E-02 118 1.6E-02 - - 13 7.5E-04 8 1.5E-03 
N 106 K missense -2.07 3276 3.5E-02 234 3.1E-02 - - 13 7.5E-04 43 8.2E-03 
Y 107 G missense 6.83 31 3.3E-04 - - - - 15 8.6E-04 - - 
E 112 V missense -0.46 1443 1.5E-02 274 3.6E-02 - - 20 1.2E-03 177 3.4E-02 
Y 107 F missense 0.62 1431 1.5E-02 160 2.1E-02 - - 61 3.5E-03 68 1.3E-02 
T 109 A missense 0.93 1328 1.4E-02 98 1.3E-02 - - 129 7.4E-03 - - 




Y 107 C missense 4.77 1373 1.5E-02 160 2.1E-02 - - 269 1.5E-02 11 2.1E-03 
F 115 Y missense -0.42 1019 1.1E-02 86 1.1E-02 - - 380 2.2E-02 17 3.3E-03 
T 109 N missense 1.63 1479 1.6E-02 161 2.1E-02 1 1.6E-04 - - - - 
E 112 W missense -1.47 20 2.1E-04 - - 1 1.6E-04 - - - - 
N 106 S missense -0.31 1557 1.7E-02 23 3.1E-03 1 1.6E-04 5 2.9E-04 18 3.5E-03 
K 108 M missense -0.23 1294 1.4E-02 133 1.8E-02 1 1.6E-04 10 5.8E-04 48 9.2E-03 
F 115 F silent -0.03 2177 2.3E-02 52 6.9E-03 1 1.6E-04 25 1.4E-03 224 4.3E-02 
N 106 N silent -0.02 1758 1.9E-02 57 7.6E-03 2 3.3E-04 1 5.8E-05 27 5.2E-03 
K 114 T missense 0.24 1175 1.3E-02 110 1.5E-02 2 3.3E-04 216 1.2E-02 66 1.3E-02 
T 109 S missense 0.82 2998 3.2E-02 495 6.6E-02 3 4.9E-04 85 4.9E-03 30 5.8E-03 
Y 107 N missense 5.61 978 1.0E-02 70 9.3E-03 4 6.5E-04 - - - - 
K 108 Q missense 0.57 995 1.1E-02 69 9.2E-03 4 6.5E-04 3 1.7E-04 46 8.8E-03 
K 108 * nonsense 1.18 1457 1.6E-02 45 6.0E-03 5 8.1E-04 7 4.0E-04 - - 
K 114 Q missense 0.13 842 9.0E-03 246 3.3E-02 5 8.1E-04 692 4.0E-02 40 7.7E-03 
N 106 I missense -1.73 1613 1.7E-02 78 1.0E-02 6 9.8E-04 1 5.8E-05 18 3.5E-03 
F 115 C missense 3.47 820 8.8E-03 150 2.0E-02 6 9.8E-04 346 2.0E-02 2 3.8E-04 
E 112 E silent -0.01 1037 1.1E-02 36 4.8E-03 9 1.5E-03 4 2.3E-04 67 1.3E-02 
V 113 A missense 2.96 1042 1.1E-02 149 2.0E-02 10 1.6E-03 129 7.4E-03 1 1.9E-04 
E 112 A missense 0.61 1027 1.1E-02 66 8.8E-03 12 2.0E-03 198 1.1E-02 115 2.2E-02 
K 114 E missense 1.33 1270 1.4E-02 262 3.5E-02 13 2.1E-03 1888 1.1E-01 14 2.7E-03 
Y 107 H missense 4.48 965 1.0E-02 98 1.3E-02 15 2.4E-03 4 2.3E-04 - - 
N 106 Y missense -0.93 1539 1.6E-02 59 7.8E-03 15 2.4E-03 6 3.5E-04 26 5.0E-03 
K 114 M missense -1.03 1735 1.9E-02 10 1.3E-03 16 2.6E-03 307 1.8E-02 156 3.0E-02 
K 114 N missense 0.92 2630 2.8E-02 169 2.2E-02 17 2.8E-03 1963 1.1E-01 18 3.5E-03 




Y 107 * nonsense 5.28 2609 2.8E-02 74 9.8E-03 24 3.9E-03 4 2.3E-04 1 1.9E-04 
V 113 M missense 0.54 998 1.1E-02 32 4.2E-03 24 3.9E-03 17 9.8E-04 5 9.6E-04 
Y 107 D missense 6.72 942 1.0E-02 97 1.3E-02 26 4.2E-03 - - 2 3.8E-04 
K 114 K silent 0.00 1231 1.3E-02 126 1.7E-02 29 4.7E-03 30 1.7E-03 134 2.6E-02 
V 113 E missense 4.20 1006 1.1E-02 102 1.4E-02 46 7.5E-03 135 7.8E-03 76 1.5E-02 
E 112 D missense 1.18 2190 2.3E-02 133 1.8E-02 51 8.3E-03 679 3.9E-02 125 2.4E-02 
F 115 L missense 1.26 4099 4.4E-02 276 3.7E-02 53 8.6E-03 1345 7.7E-02 34 6.5E-03 
E 112 G missense 1.82 1268 1.4E-02 25 3.3E-03 69 1.1E-02 914 5.3E-02 - - 
V 113 G missense 4.62 1073 1.1E-02 11 1.5E-03 72 1.2E-02 11 6.3E-04 1 1.9E-04 
T 109 I missense -2.74 1738 1.9E-02 153 2.0E-02 79 1.3E-02 7 4.0E-04 - - 
F 115 S missense 4.16 1061 1.1E-02 106 1.4E-02 163 2.7E-02 6 3.5E-04 - - 
K 114 * nonsense 4.77 1343 1.4E-02 183 2.4E-02 212 3.5E-02 - - 3 5.8E-04 
T 109 P missense 2.75 1020 1.1E-02 126 1.7E-02 246 4.0E-02 29 1.7E-03 - - 
V 113 L missense -0.21 2099 2.2E-02 139 1.8E-02 296 4.8E-02 2130 1.2E-01 41 7.9E-03 
F 115 V missense 3.45 831 8.9E-03 139 1.8E-02 733 1.2E-01 1214 7.0E-02 408 7.8E-02 
N 106 D missense 1.32 1509 1.6E-02 20 2.7E-03 1592 2.6E-01 1518 8.7E-02 895 1.7E-01 







Table 4-6 Nucleotide per codon overlap table For each alternative triplet at each target codon, the number of overlapping nucleotides 
with the reference codon were calculated and depicted in this graph. These values can be used to calculate the likelihood of an amino 
acid substitution to arise from nucleotide substitutions at each triplet. Corresponding codons (i.e. 3 nucleotides overlap) are highlighted 
in dark grey.  
    A A A A C C D D E E F F G G G G H H I I I K K L L L L L L Met N N 
Pos Ref AA Ref codon GCA GCC GCG GCT TGC TGT GAC GAT GAA GAG TTC TTT GGA GGC GGG GGT CAC CAT ATA ATC ATT AAA AAG TTA TTG CTA CTC CTG CTT ATG AAC AAT 
106 N AAC 0 1 0 0 1 0 2 1 1 1 1 0 0 1 0 0 2 1 1 2 1 2 2 0 0 0 1 0 0 1 3 2 
107 Y TAC 0 1 0 0 2 1 2 1 1 1 2 1 0 1 0 0 2 1 0 1 0 1 1 1 1 0 1 0 0 0 2 1 
108 K AAG 0 0 1 0 0 0 1 1 1 2 0 0 0 0 1 0 1 1 1 1 1 2 3 0 1 0 0 1 0 2 2 2 
109 T ACC 1 2 1 1 1 0 1 0 0 0 1 0 0 1 0 0 1 0 1 2 1 1 1 0 0 0 1 0 0 1 2 1 
112 E GAG 1 1 2 1 0 0 2 2 2 3 0 0 1 1 2 1 1 1 0 0 0 1 2 0 1 0 0 1 0 1 1 1 
113 V GTG 1 1 2 1 0 0 1 1 1 2 1 1 1 1 2 1 0 0 1 1 1 0 1 1 2 1 1 2 1 2 0 0 
114 K AAG 0 0 1 0 0 0 1 1 1 2 0 0 0 0 1 0 1 1 1 1 1 2 3 0 1 0 0 1 0 2 2 2 
115 F TTC 0 1 0 0 2 1 1 0 0 0 3 2 0 1 0 0 1 0 1 2 1 0 0 2 2 1 2 1 1 1 1 0 
                                   
   P P P P Q Q R R R R R R S S S S S S T T T T V V V V W Y Y Stop Stop x 
Pos Ref AA Ref codon CCA CCC CCG CCT CAA CAG CGA CGC CGG CGT AGA AGG TCA TCC TCG TCT AGC AGT ACA ACC ACG ACT GTA GTC GTG GTT TGG TAC TAT TAA TAG TGA 
106 N AAC 0 1 0 0 1 1 0 1 0 0 1 1 0 1 0 0 2 1 1 2 1 1 0 1 0 0 0 2 1 1 1 0 
107 Y TAC 0 1 0 0 1 1 0 1 0 0 0 0 1 2 1 1 1 0 0 1 0 0 0 1 0 0 1 3 2 2 2 1 
108 K AAG 0 0 1 0 1 2 0 0 1 0 1 2 0 0 1 0 1 1 1 1 2 1 0 0 1 0 1 1 1 1 2 0 
109 T ACC 1 2 1 1 0 0 0 1 0 0 1 1 1 2 1 1 2 1 2 3 2 2 0 1 0 0 0 1 0 0 0 0 
112 E GAG 0 0 1 0 1 2 0 0 1 0 0 1 0 0 1 0 0 0 0 0 1 0 1 1 2 1 1 1 1 1 2 0 
113 V GTG 0 0 1 0 0 1 0 0 1 0 0 1 0 0 1 0 0 0 0 0 1 0 2 2 3 2 1 0 0 0 1 0 
114 K AAG 0 0 1 0 1 2 0 0 1 0 1 2 0 0 1 0 1 1 1 1 2 1 0 0 1 0 1 1 1 1 2 0 
115 F TTC 0 1 0 0 0 0 0 1 0 0 0 0 1 2 1 1 1 0 0 1 0 0 1 2 1 1 1 2 1 1 1 1 





4.2.13 Synonymous mutations can affect GFP fluorescence differently 
The Venn diagram in Figure 4.13C shows that the majority of amino acid substitutions occur 
in multiple bins of VarSil, albeit the frequencies are different (see Table 4-5). It was therefore 
tested whether synonymous codons could have different effects on GFP fluorescence, which 
would be obscured by translating nucleotide variants into amino acids (see Table 4-7). All 
possible nucleotide variances apart from T343G and A325T were present in the VarStop 
Negative bin and in at least one of the VarSil bins. The ratios between nucleotide variances 
resulting in the same amino acid change were compared between bins (see Table 4-7).  
 
The ratios between other codons encoding the same amino acid did not differ between 
different bins, demonstrating that the occurrences of amino acids across the different bins 
are not the result of different mutations on the nucleotide level and are therefore likely not 
due to biological differences.  
 
4.2.14 Validation of mutations using in silico modelling 
Because the b-barrel region constitutes the structural scaffold of GFP, I hypothesised that 
loss of fluorescence arising from missense mutations in this region should occur through loss 
of structural stability. In order to test this hypothesis, I performed in silico modelling to 
predict the effect of each variant on protein stability. For this, amino acid substitutions were 
modelled onto the resolved crystal structure as was described in the Material & Methods 
chapter. For each possible single amino acid substitution, the DDG was calculated, providing 
a measure for the change in free energy relative to the wildtype sequence (see Table 4-8). 
Of the 152 possible amino acid substitutions, 67 have a neutral or positive effect on the 
thermodynamic stability of the protein (arbitrarily defined as DDG < 0.8 kcal/mol), whilst 65 
have a severely destabilising effect (DDG > 1.6 kcal/mol). The remaining 20 amino acid 
substitutions were intermediate in their effect on protein stability, leading to a partially 





Table 4-7 Nucleotide substitution read counts in HR-derived reads with a single mutation. 
Nucleotide substitutions that encode the same amino acid are highlighted in blue (two 
synonymous codons) or yellow (three synonymous codons). All possible nucleotide 
substitutions were found in both the VarStop Negative and either of the VarSil samples. 
T109T mutations are found at significantly different proportions between the three bins, 
indicating that A and G residues affect fluorescence. Other amino acid substitutions occurring 
in all three samples do not show differences in read frequencies for the different nucleotide 
substitutions, suggesting that the simultaneous occurrences of amino acids across different 
bins are likely due to overlapping bins or sequencing errors. Substitutions were ordered 
alphabetically.  
NT mutation # synonymous codons Substitution Mutation class StopNeg SilNeg SilInt SilPos 
A316G single N106D missense 93 0 4 46 
A316C single N106H missense 106 1 0 4 
A316T single N106Y missense 77 32 6 35 
A317T single N106I missense 73 2 1 34 
A317G single N106S missense 155 0 13 57 
A317C single N106T missense 36 31 6 36 
C318A two N106K missense 181 79 8 0 
C318G two N106K missense 161 1 1 0 
C318T single N106N silent 113 2 129 1 
T319G single Y107D missense 180 6 346 2 
T319C single Y107H missense 10 16 308 268 
T319A single Y107N missense 41 2 787 8 
A320G single Y107C missense 52 116 25 305 
A320T single Y107F missense 107 72 531 15 
A320C single Y107S missense 110 90 216 150 
C321A two Y107* nonsense 125 66 30 212 
C321G two Y107* nonsense 194 29 2 127 
C321T single Y107Y silent 156 21 1179 10 
A322T single K108* nonsense 288 38 1889 15 
A322G single K108E missense 105 88 30 300 
A322C single K108Q missense 183 212 98 4 
A323T single K108M missense 59 7295 2070 1587 
A323G single K108R missense 64 2 2 84 
A323C single K108T missense 246 6 692 72 
G324A single K108K silent 124 4 108 2 
G324C two K108N missense 133 0 7 31 
G324T two K108N missense 58 2 0 1 
A325G single T109A missense 89 1 4 0 
A325C single T109P missense 16 24 4 0 




C326T single T109I missense 94 15 2 2 
C326A single T109N missense 160 48 61 90 
C326G two T109S missense 160 0 269 11 
C327A three T109T silent 38 202 240 60 
C327G three T109T silent 72 103 198 195 
C327T three T109T silent 274 92 20 288 
A335C single E112A missense 77 237 686 40 
A335G single E112G missense 62 92 1520 16 
A335T single E112V missense 33 24 17 5 
G336C two E112D missense 36 132 4 116 
G336T two E112D missense 95 0 440 194 
G336A single E112E silent 25 69 918 0 
G337C two E112L missense 86 2006 380 17 
G337T two E112L missense 106 163 7 0 
G337A single E112M missense 108 114 559 24 
T338C single V113A missense 12 63 721 25 
T338A single V113E missense 156 22 66 5 
T338G single V113G missense 139 1 1304 491 
G339A three V113V silent 20 6065 1793 1029 
G339C three V113V silent 119 32 1 65 
G339T three V113V silent 100 51 1 18 
A340T single V114* nonsense 406 1 19 21 
A340G single V114E missense 138 246 29 0 
A340C single V114Q missense 104 64 66 48 
A341T single K114M missense 233 35 64 388 
A341G single K114R missense 188 34 95 273 
A341C single K114T missense 127 5 43 255 
G342A single K114K silent 11 11 18 2 
G342C two K114N missense 120 26 138 108 
G342T two K114N missense 148 62 129 1 
T343A single F115I missense 69 8 3 103 
T343C three F115L missense 118 0 14 35 
T343G single F115V missense 87 0 0 0 
T344G single F115C missense 188 43 8 42 
T344C single F115S missense 122 1 3 8 
T344A single F115Y missense 96 1 2 20 
C345T single F115F missense 230 42 6 45 
C345A three F115L missense 45 5 7 0 




4.2.15 Multiple amino acid substitutions per read obscure the effect on GFP fluorescence  
As mentioned in section 4.2.10, the VarSil negative bin harboured the highest proportion of 
reads with multiple mutations. To assess whether reads with multiple mutations could be 
used to assess the effects of individual amino acid substitutions on GFP stability, the 
distribution of change in thermodynamic free energy (DDG) for amino acid substitutions per 
bin was plotted using the independent values that were predicted in the previous section 
(see Figure 4.15), as in silico predictions did not allow for multiple mutations. Larger numbers 
of amino acid substitutions occurring on the same read resulted in smaller differences in DDG 
values between the different VarSil bins. This signifies that reads with a single amino acid 
substitution are most informative on interrogating the effects of these mutations on GFP 
stability.  
 
Nonsense mutations were excluded from this analysis as their free energy changes could not 
be assessed in silico. Mutations found in the VarStop Negative class show a wide range of 
DDG values comparable to the distribution found in the ssODN repair template, indicating 
that both the genomic integration and depth of our screening are sufficient to detect all 
introduced amino acid substitutions.  
 
The VarSil samples in the violin plot reveal that the GFP negative bin harbours mutations with 
high DDG, indicating a negative effect on GFP stability (see Figure 4.13D). Mutations found 
in the GFP intermediate bin show a wide distribution of predicted effects on stability, with a 
mean DDG value that is nonetheless intermediate between GFP negative and positive. We 
reasoned that the arbitrary boundaries of the gates for sorting (defined in section 4.2.5) 
could allow for the collection of cells harbouring null, hypomorphic and neutral mutations in 
the intermediate bin explaining the wide range of DDG values found in this bin. Whilst 
overlapping, the distribution of free energy predictions per bin follow the expected pattern 
of distribution and therewith validate our ability to classify mutations by functional effect. 
 
4.2.16 Mutational effect score provides a single value per amino acid substitution  
Despite the different distributions of DDG values between bins, the majority of the amino 




Table 4-8 Predicted effect of amino acid substitutions on thermal stability of GFP protein FoldX was used to calculate the change in thermal 
protein stability (DDG) due to each of the 152 possible amino acid substitutions at the target residues in GFP. A higher DDG indicates a more 
severely reduced effect on protein stability. Three classes of amino acid substitutions were classified with thresholds at 0.8 and 1.6 kcal/mol, 
resulting in 67 mutations having no effect on protein stability, 20 mutations causing a reduced protein stability and 65 mutations causing a 
severely reduced protein stability. 












































































































N106 -0.93 -1.06 1.32 -0.83 -1.53 0.09 0.33 -1.73 -2.07 -2.83 -2.86   0.95 -1.43 -1.53 -0.31 -1.39 -1.43 1.46 -0.93 
Y107 5.28 4.77 6.72 -0.84 0.62 6.83 4.48 2.71 4.60 1.86 1.48 5.61 4.59 4.25 3.62 6.46 5.37 3.54 7.66   
K108 1.18 0.93 1.11 0.89 -0.09 1.83 0.44 -0.47   -0.28 -0.23 0.92 3.62 0.57 0.26 1.23 0.49 0.06 -0.16 0.12 
T109 0.93 -0.24 3.25 -0.04 10.19 1.96 7.71 -2.74 2.00 -1.49 -2.42 1.63 2.75 -0.38 3.76 0.82   -2.03 13.73 16.90 
E112 0.61 0.24 1.18   -1.67 1.82 -0.72 -1.11 -0.91 -1.27 -1.18 0.36 0.49 -0.10 -0.60 0.97 0.19 -0.46 -1.47 -1.57 
V113 2.96 2.12 4.40 4.20 6.60 4.62 3.32 -0.63 3.41 -0.21 0.54 3.36 4.70 3.92 5.77 4.09 2.29   11.86 5.41 
K114 4.77 0.38 2.25 1.33 -1.55 0.88 0.14 2.59   -0.35 -1.03 0.92 2.89 0.13 -1.42 0.42 0.24 2.75 0.81 -1.39 




       Count 
No effect on structural stability          ΔΔG < 0.8 kcal/mol (cyan) 67 
Reduced structural stability  ΔΔG > 0.8 & < 1.6 kcal/mol (magenta)  20 
Severely reduced structural stability  ΔΔG > 1.6 kcal/mol (red) 65 





Figure 4.15 Average DDG dependent on the number of mutations per read HDR reads from 
each bin were sorted based on the number of amino acid substitutions in the variable region 
of the read, after which the average DDG per bin was calculated. Reads with a single 
substitution show the largest difference in DDG between VarSil negative, intermediate and 
positive, indicating that the presence of multiple amino acid substitutions in a single read 
obscures the effects of hypomorphic and null mutations.  
 
several scores on both the mutational effect and confidence to each amino acid substitution, 
such that the substitutions with a highly-confident effect remain.  
 
Three amino acid substitutions and one silent mutation (N106D, DDG = 1.32; F115V, DDG = 
3.45; V113L, DDG = -0.21; V113V, DDG = -0.01) were amongst the most abundantly found  
mutations, ubiquitously present in all 3 bins (see Table 4-5). These mutations did not occur 
at a higher frequency in VarStop, raising the possibility that this could be a VarSil-specific 
issue down to the synthesis of these ssODN. However, as these mutations were also not 
enriched in the ssODN pool, these artefacts were most likely introduced during library 
synthesis and were thus excluded from further analysis.  
 
A single functional score was assigned to each amino acid substitution based on the relative 
enrichment of these mutations across each bin relative to the other bins. A previously 
published equation (Kosuri et al., 2013) was found to calculate a single score per mutation 
allowing for this, while also accounting for the differences in abundance between the 
different codons in the overall pool. 
  
To estimate mutational effect scores, we first calculated, for each codon i and each bin j, the 
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, where fi is the fraction of cells harboured in each bin based on the VarSil FACS plot and cij is 
the number of amino acid i in each bin j. For a given substitution, ∑jaij = 1 (i.e. each codon has 
one aij per bin, and these six values together add up to 1).  
 
The final mutational effect score, Ei, was calculated as: 
 




, where mj is the median fluorescence measurement of bin j (45.9, 1,338 and 23,800 for 
negative, intermediate and positive, respectively). 
 
After calculating the effect scores for the amino acid substitutions, we next sought to 
eliminate mutations that were expressed at low levels or that were not differentially 
expressed in different bins. To minimise the noise arising from this effect, a threshold was 
set by subtracting the read error (0.0064%, as published in Schirmer et al., 2015, and 
discussed in the previous chapter) from the proportions each amino acid i made out of the 
whole HR pool in each bin, which left a total of 26 amino acid substitutions and an additional 
four synonymous mutations that were detected above the level of background noise and 
could be functionally classified (see Table 4-9).  
 
To remove amino acid substitutions with a low confidence mutational effect score, we sought 
to ensure mutations were not evenly distributed across all the bins and hence assessed the 
enrichment of amino acids across the respective bins. Enrichment of amino acids in any of 
the bins was represented by an F value following from an F distribution, with corresponding 
p value and demonstrated that 15 amino acid substitutions were significantly enriched in one 






significantly enriched in one of the bins. The synonymous mutations are all highly significant 
with a low mutational effect score, serving as internal controls for our assay. 
 
For the significantly enriched amino acid substitutions, the calculated mutational effect 
scores correlated with the predicted DDG values (R2=0.60, see Table 4.9). As DDG values only 
gages the effect of an amino acid substitution on protein stability, the scores were 
additionally benchmarked to another experimental dataset, the most comprehensive study 
that previously quantified the effect of individual amino acid substitutions on GFP 
fluorescence (Sarkisyan et al., 2016). This ‘Kondrashov score’ for single mutations correlated 
similarly with the DDG values (R2=0.58, see Table 4.9) but relatively poorly with our 
mutational effect score (R2=0.43, see Table 4.9). The lower correlation between the data 
from this study and the Kondrashov score is likely due to the different nature of the proteins 
used, as we use the optimised eGFP variant in comparison to the native form from Aequorea 
victoria (avGFP). However, as this was the most comprehensive study systematically studying 
the effects of amino acid substitutions on GFP, this demonstrates that our deep mutational 
effect score is equally sophisticated at predicting mutational effects of amino acid 
substitutions as Sarkisyan et al., whilst acknowledging that their study assessed a much wider 
set of both single and double mutations. 
 
4.2.17 Use of long double-stranded DNA donor templates result in high HDR frequencies 
but impairs phenotypic selection  
As ssODNs and double-stranded donors are both suggested to be suitable as a repair 
template for the introduction of specific variants through DSB repair (Radecke et al., 2006, 
2010; Chen et al., 2011; Soldner et al., 2011), we sought to assess whether double-stranded 
repair template (dsRT) donors would either improve HDR efficiencies or reduce the positional 
bias during the introduction of nucleotide variants through HDR as was demonstrated in 
section 4.2.11. Therefore, ssODNs donor libraries with variable positions were PCR-amplified 
into 820-bp products using four ssODNs, each 200-bp in length with homology to the Gfp 
gene, as primers (see Figure 4.16). As starting templates, VarStop and VarSil repair templates 
with either 24 variable positions at 94:2:2:2 consensus versus non-consensus ratios 
(VarStop12 and VarSil12), or 94 variable positions (i.e. all positions except for the HDR core) 




between each primer and the template, there is expected to be some loss of diversity at the 
distal ends of the repair templates with full diversity. 
 
In section 4.2.6 it was demonstrated that HDR repair from the VarSil12 ssODN template leads 
to a spectrum of GFP intensities, including intermediate GFP fluorescence, that was not 
observed in the experiment using VarStop12. In the samples using any of the dsRTs, analysis  
by flow cytometry at 7-days post-transfection showed that the majority of the targeted cells 
had completely lost GFP fluorescence, with a complete absence of a GFP intermediate 
population (see Figure 4.17). This indicates that whilst editing efficiencies are high, 
phenotypic selection for specific variants is completely lost when compared to the use of 
ssODNs in section 4.2.6. With the lack of an intermediate and positive population in the 
fluorescence profile, these results show that under the conditions tested, long double 
stranded repair templates are not suitable for the integration and functional assessment of 





Table 4-9 Mutational effect scores for amino acid substitutions occurring above 
background level Mutational effect scores were calculated for the 30 mutations that 
occurred above background noise frequency (0.0064). 15 of these are significantly enriched 
in at least one of the three populations as depicted by the F score and p value. Highly 
stabilising mutations (N106K, K114R, E112V), partially destabilising (K108M, K114T) and 
highly destabilising (F115L, K114N, F115I) mutations typically correspond with low, 
intermediate and high DDG values, but do not correlate well with previously published work 
(Kondrashov score, whereby a lower score indicates a more destabilising mutation). 
 
 
Substitution Mutational Effect DDG Kondrashov F value p value  
E112A 1383.88 0.61 3.63 8.22 0.019 * 
E112D 261.65 1.18 - 1.60 0.278  
E112G 83.71 1.82 3.54 4.21 0.072  
E112V 22823.83 -0.46 3.75 24.31 0.001 ** 
F115C 260.10 3.47 3.62 2.45 0.167  
F115F 18496.97 -0.03 - 37.84 0.000 *** 
F115I 168.51 2.62 3.57 13.62 0.006 ** 
F115L 163.84 1.26 3.67 14.60 0.005 ** 
F115S 45.99 4.16 3.14 6.07 0.036 * 
F115Y 2788.10 -0.42 3.66 3.66 0.091  
K108K 22655.34 0.00   682.93 0.00 *** 
K108M 9328.18 -0.23 3.65 7.48 0.023 * 
K108Q 1834.74 0.57 3.73 9.96 0.012 * 
K114* 46.41 - - 9.17 0.015 * 
K114E 572.08 1.33 3.49 3.11 0.118  
K114M 1415.86 -1.03 3.63 1.04 0.408  
K114N 497.48 0.92 3.69 14.53 0.005 ** 
K114Q 1193.52 0.13 3.63 6.46 0.032 * 
K114R 23604.63 -1.42 3.72 30.54 0.001 ** 
K114T 4602.96 0.24 3.71 0.78 0.502  
N106K 21333.91 -2.07 3.70 106.39 0.000 *** 
T109A 1338.00 0.93 3.61 26.05 0.001 ** 
T109I 46.12 -2.74 3.42 2.52 0.161  
T109P 46.20 2.75 - 2.03 0.212  
V113A 87.57 2.96 3.56 2.47 0.165  
V113E 146.42 4.20 1.34 0.45 0.660  
V113G 46.79 4.62 - 1.14 0.381  
Y107C 2657.28 4.77 3.40 2.82 0.137  
Y107F 17596.27 0.62 3.79 12.96 0.007 ** 





Figure 4.16 PCR schematic of synthesis and library preparation of double-stranded RT pool 
(A) Both VarStop and VarSil ssODN molecules are used as templates for the construction for 
the double-stranded (ds) RT pool. In addition to the repair templates with variable 
nucleotides at 2 x 12-nt (VarSil12), other pools or ssODNs have variable positions across the 
entire 100-nt ssODN except for the 6-nt HDR-core. All ssODN pools are prepared in 4 different 
reactions, hence leading to 4 different pools of ds RTs. (B) In an initial reaction, ssODNs are 
PCR-amplified with 200-nt Ultramer primers, which each have a 20-nt overlap with the 
ssODN, hence resulting in an 460-bp ds product. (C) In an second reaction, 460-bp amplicons 
are again amplified with 200-nt Ultramer primers, this time resulting in a (D) final 820-bp ds 
product with complete homology (with the exception for the 6-nt HDR-core and substitutions 
in the variable positions) to the GFP locus. This product was gel-purified and used as an HDR-
template. (E) For sequencing library preparation of both the ds RT pool and gDNA from 
transfected cells, the same primers were used as described in figure 4.2, resulting in a 157-





Figure 4.17 Effect of double-stranded repair templates on GFP fluorescence 7-days post-transfection with double-stranded long DNA repair 
templates, cells were analysed for GFP fluorescence by flow cytometry. Regardless of the use of wtCas9 or Cas9n or the concentration of repair 






In this chapter, I have shown that a genomic library containing all possible single nucleotide 
variants in a predefined genomic region can be created using CRISPR-Cas9 and multiplex 
HDR. Multiple conditions for introducing these genomic variants were tested and it was 
demonstrated that the use of paired Cas9n and ssODN templates as a donor is the most 
suitable system for this application. The effect of these nucleotide changes on GFP 
fluorescence can be determined by translating them into amino acid substitutions and 
subsequently calculating a single weighted score from the proportion of HDR reads encoding 
that substitution in each bin. Ultimately, these scores are benchmarked by calculating the 
predicted effect on protein stability using the resolved protein structure of GFP in silico. In 
the presence of an appropriate functional classification system, this pipeline can be used for 
the interrogation of single nucleotide and amino acid variants in endogenous genes.  
 
4.3.1 Deep-mutational scanning on the nucleotide level can be used to interrogate gene 
function 
As an example, the direct fusion of a fluorescent gene to an endogenous open reading frame 
which would be diversified could be used to infer something about transcription or stability 
of the encoded protein. Whilst supporting data is not shown in this thesis, we made a fusion 
of an mCherry fluorophore to endogenous Nanog and yielded consistent high (± 30 %) HDR 
rates. However, due to both the complexity of the transcriptional regulation of Nanog and 
issues with the screening assay, it was decided to not continue with this project. Yet, this 
provides one example for the application of the pipeline developed in this chapter.   
 
4.3.2 Effects of nucleotide variants can be explained by their translation into amino acid 
substitutions 
Whilst on the outset the aim was to test the effect of nucleotide variants, the findings in this 
chapter demonstrate that the effects of these variants can all be explained by their effect on 
the codon sequence and do not underlie codon-specific differences (with the exception of 
T109T, see section 4.2.13). All 51 amino acid substitutions that can be achieved with a single 
nucleotide change and 43/87 amino acid that can be achieved by two nucleotide 
substitutions were detected above noise levels in the VarSil samples (section 0). This shows 




number of nucleotide changes required for that amino acid change. To study the effect of all 
possible amino acid substitutions using CRISPR-Cas9 and multiplex HDR, it would therefore 
be more suitable to design repair templates with codons for all amino acid substitutions, 
although this was not feasible using the oligonucleotide doping strategy deployed in this 
chapter. 
 
4.3.3 Depth of analysis of HDR-derived variants is limited by a variety of factors 
Another limiting factor in studying the effects of amino acid substitutions using this pipeline 
is the depth of detecting single changes in HR reads, which is due to several reasons. Firstly, 
whilst NGS allows for thousands to millions of reads per sample (depending on the number 
of samples multiplexed on a single lane), the overall rates of HDR in the experiments in this 
chapter do not exceed 14% (section 4.2.8), meaning that the large majority of the reads are 
rejected from downstream analysis. Therefore, low HDR frequencies, and the amplification 
of wildtype and indel containing alleles are the main limiting factor on the extent to which 
single nucleotide variations can be detected.   
 
HDR efficiencies were increased by limiting the level of contamination with wildtype GFP 
sequences, which arose from plasmid sequences present in the laboratory environment 
(section 4.2.7). It is however expected that these levels of contamination are characteristic 
of GFP, as it is a widely used selective marker and abundantly present on plasmid sequences. 
We therefore expect that this will not be a major issue in the study of other genes. 
 
Secondly, the design of sgRNAs and repair templates allowed for the re-cleavage of alleles 
that have already undergone HDR as the donor template does not destroy either of the PAM 
sequences. The elevated HDR rates in VarStop (14 %) compared to VarSil (4 – 8 %) could also 
be explained by the respective HDR core sequence destroying the sgRNA binding site. To 
increase HDR efficiencies without causing a bias in nucleotide frequencies, future HDR donor 
sequences should therefore ideally destroy the PAM sequence with a constant mutation in 
the HDR core or the constant region outwith the variable regions.  
 
A third factor limiting the sequencing depth is the low number of sequencing reads 




genomic samples, nearly a third of the HDR reads did not harbour any mutations whilst nearly 
half (47%) contained a single nucleotide variant (section 4.2.10). Whilst in some cases 
multiple nucleotide substitutions occurred in a single codon and thus in a single amino acid 
change, the majority of these reads also contained multiple amino acid changes. As I 
demonstrated that the DDG values correlating with the amino acid substitutions are best 
interrogated without the presence of additional amino acid substitutions (section 4.2.15), 
this means that the majority of the HDR sequences could not be used in downstream analysis. 
Non-random parallel synthesis of donor templates using technology available through 
companies such as Twist and Agilent, could perhaps further increase the number of reads 
with a single nucleotide or amino acid variant and thus the depth of analysis.  
 
4.3.4 Mutational effect score provides a weighted measure for the phenotypic effect  
Sequence reads encoding 94 out of 152 possible amino acid substitutions were discovered in 
the pool of amplicons with a VarSil HR core (section 0). Many amino acid substitutions were 
detected in more than a single bin and a large overlap was detected in the distribution of 
DDG values, which are likely due to inherent variability in fluorescence levels from mutant 
proteins, thus leading to a decreased separability between the bins. This overlap was 
resolved by using a weighted score encapturing the frequencies of amino acids and median 
fluorescence in each bin (section 4.2.16). The mutational score was eventually calculated for 
the 30 amino acid substitutions that occurred above noise level and were enriched in one of 
the bins, which demonstrated that these scores highly correlate with the predicted effect on 
protein stability.  
 
Whilst the use of three bins allows for the detection of mutational effects on a large scale, it 
does limit the sensitivity of our screen in determining the effect of amino acid substitutions. 
For example, both neutral mutations (e.g. Y107Y and K108K) and stability-enhancing 
mutations, i.e. with a predicted negative DDG (e.g. N106K and K114R), have similar 
mutational effect scores of approximately 22 as they are most abundantly present in the GFP 
positive bin (section 4.2.16). Similarly, amino acid substitutions with different grades of 
predicted destabilising effects (e.g. F115L (DDG = 1.26) and F115I (DDG=2.62)) have a similar 




detection of these minor differences and would hence allow for a better assessment of 
mutational effects.  
 
The change in thermodynamic stability (DDG) is of course an in silico modelling and not 
benchmarked and thus might itself not be as sensitive and accurate for all values. In 
application of this assay in studying endogenous genes, benchmarking such a score to 
monoclonal cell lines harbouring specific mutations would hence be an appropriate control. 
 
4.3.5 Mutational effect scores indicate a positional bias 
Most of the mutational effect scores can be explained by the effect of the amino acid 
substitution on protein stability as is shown by the correspondence of mutational effect 
scores with the predicted DDG values (section 4.2.16). Y107C and T109I are the largest 
outliers and were predicted to not have an effect on protein stability. As inward-facing 
residues in the b-sheet are known to interact with the fluorophore (Stepanenko et al., 2013), 
mutations on residues 107, 109 and 113 would be expected to have a negative effect on 
fluorescence whilst they would not directly destabilise the GFP protein. Mutational effect 
scores were proportional to the predicted DDG of the 6 amino acid substitutions at these 
residues found in our screen, whilst the effect on Y107C and T109I could be explained by the 
difference in chemical properties destroying the interactions of these residues with the 
fluorophore.  
 
4.3.6 Efficiency of HDR is dependent on sgRNA position  
The difference in HDR-efficiencies using paired Cas9 nickases (Cas9n) and wildtype Cas9 
showed that the increase in HDR efficiency with the use of Cas9n over wtCas9 largely 
depends on the sgRNA that is used (section 4.2.11). By assessing the fluorescence profiles 
and difference in intermediate populations between the VarSil and VarStop experiments, it 
was shown that wtCas9 used with sgRNA100 had similar levels of HDR to the use of paired 
nickases, whilst sgRNA8 and sgRNA17 showed slightly lower increases in intermediate 
populations. Lower nucleotide diversity in the variable region was observed between the 
experiments with different sgRNAs, which can also be attributed to these variations in HDR 
frequencies, as samples with lower diversity were those with lower levels of HDR. Previous 




to the PAM (i.e. the strand complementary to the sgRNA) largely improve HDR efficiencies 
(Christopher D. Richardson et al., 2016), which in our design is the case for sgRNA17 and 
sgRNA100 but not for sgRNA8. The same study showed that asymmetric donor DNA with a 
longer PAM-proximal than PAM-distal homology arm (optimally 91-nt against 36-nt) even 
further enhances HDR efficiencies, which is closer resembled with sgRNA100 (52-nt and 48-
nt) than with sgRNA17 (18-nt and 82-nt). This provides an explanation as to why the highest 
HDR efficiencies are achieved with sgRNA100 and demonstrates that careful design of Cas9 
editing experiments can largely enhance targeting efficiencies. These results hence 
demonstrate that complementary strandedness of sgRNA and ssODN donor provides the 
best targeting efficiencies with wtCas9 but that this does not exceed the efficiencies yielded 
with the double nickases. 
 
4.3.7 Use of long double-stranded DNA donor templates impairs phenotypic selection  
The addition of a dsRT consistently lead to a nearly complete loss of both GFP fluorescence 
compared to the no-template controls (section 4.2.17). This suggests that CRISPR editing 
efficiencies are highly increased due to the presence of a double-stranded molecule, but that 
these variances are not incorporated in frame of the initial GFP locus. One possibility is that 
the dsRTs were incorporated in tandem, thereby impeding correct expression or folding of 
GFP. Therefore, future experiments with the use of double-stranded donors should ensure a 
suitable selection scheme to avoid amplification from random integrands, ideally through a 
PCR selection outwith the region covered by the homology arms of the donor whilst also 
selectively amplifying loci with HDR-specific mutations.  
  
An alternative explanation for the loss in GFP is that the addition of linear DNA (either single- 
or double-stranded) skews the repair of CRISPR-Cas9-induced breaks to NHEJ, as is suggested 
in previously published work (C. D. Richardson et al., 2016). As short ssODNs are suggested 
to be efficiently incorporated through the FA pathway (Richardson et al., 2018), double-
stranded donors would thus be more efficient when introduced from a plasmid.  
 
4.3.8 Concluding remarks 
The experimental pipeline optimised in this chapter combined with the bioinformatics 




interrogation of large numbers of nucleotide variants in a genomic copy of GFP. Fluorescence 
is a convenient measure to detect different gradients of activity as a result of genetic variants. 
To apply this pipeline to an endogenous gene, a selectable marker would have to be coupled 
to that gene to assess the phenotypic consequences of the introduced genetic variant. Design 
of a suitable marker depends on the hypothesis that needs testing; whereas stability would 
require a direct fusion of a fluorophore to the target gene, signalling activity would require 
the coupling of a fluorophore to a downstream promoter and fitness could be assessed by 
the relative survival rate of individual clones. In the following chapter I will test the 
applicability of this system by performing deep mutational scanning on the signalling activity 








5    Deep mutational scanning of 






5.1. Introduction  
The canonical Wnt/β-catenin signalling pathway is one of the primary regulatory mechanisms 
balancing self-renewal, differentiation and apoptosis in several adult stem cell niches, 
thereby maintaining tissue homeostasis in the adult organism (Reya and Clevers, 2005).  
 
Wnt proteins are highly conserved throughout evolution and can be found in many phyla 
across the animal kingdom, ranging from sea anemones (Kusserow et al., 2005) to insects 
(Nusslein-Volhard and Wieschaus, 1980) and mammals including human and mouse. The 
Wnt1 proto-oncogene encodes a 40kDa secreted protein containing many conserved 
residues (Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondoh H, Takao T, 2006). Whilst 
signalling of the Wnt-homolog Wg in Drosophila is best known for the tissue-wide 
concentration gradient it forms (Zecca, Basler and Struhl, 1996), Wnt in other organisms 
predominantly signals between cells that are in each other’s vicinity (Sato et al., 2011). 
 
The signal transduced by the canonical Wnt cascade is largely regulated through the 
destruction complex that regulates proteolytic turnover of cytoplasmic β-catenin (see Figure 
5.1A). β-catenin (encoded by the CTNNB1 gene) is a dual function protein, being involved in 
both cell-cell adhesion, linking intercellular cadherin proteins in simple epithelia, and as a 
signal-transducer in the Wnt signalling pathway (Peifer et al., 1991; Noordermeer et al., 
1994; Peifer, Berg and Reynolds, 1994). It is expressed across almost all tissues in vertebrates, 
with elevated expression found in highly proliferating cells including a wide variety of stem 
cells.  
 
When Wnt receptors are not engaged, Axin, WTX and adenomatous polyposis coli (APC) form 
a scaffolding complex which can dock cytoplasmic β-catenin (Reya and Clevers, 2005; Major 
et al., 2007). This complex now allows for casein kinase 1 (CKI) and glycogen synthase kinase 
3β (GSK-3β) to phosphorylate β-catenin on a set of highly conserved serine and threonine 
residues in the amino terminus of the protein (Cohen, 1986; Tuazon, 1991; Fish et al., 1995; 
Aberle et al., 1997; Orford et al., 1997; Winston et al., 1999). CKI phosphorylates serines on 
several components of the Wnt signalling pathway including β-catenin at Ser45 (Davidson et 





Subsequently, GSK-3β binds this phosphorylated residue with a positively charged pocket 
neighbouring its active site in order to sequentially phosphorylate Thr41, Ser37 and Ser33. 
The active site of GSK-3β binds the terminal phosphate of ATP and transfers it to each of the 
target locations on the substrate (Patel and Woodgett, 2017). A fully phosphorylated 
‘degron’ motif will then be recognised by β-transducin repeat containing E3 ubiquitin protein 
ligase (β-TrCP), an E3 ubiquitin ligase, which subsequently targets β-catenin for proteosomal 
degradation in the 26S proteasome (Aberle et al., 1997). In the absence of Wnt signalling, 
this process is constitutively active resulting in a high turnover rate of β-catenin protein, 
thereby preventing accumulation and nuclear translocation of cytoplasmic β-catenin. 
 
Wnt proteins bind to a heterodimeric receptor complex consisting of Frizzled and LRP5/6 
proteins that contain a large extracellular cysteine-rich domain to which Wnt can bind 
(Bhanot et al., 1996; Clevers and Nusse, 2012) (see Figure 5.1A). This binding allows the 
receptor complex to interact with cytoplasmic proteins including Dishevelled (Chen, 2003). 
This protein in turn passes on the signal through a downstream intracellular signalling 
cascade, inhibiting the kinase activity of CKI and GSK-3β and hence preventing the proteolytic 
turnover of β-catenin (Hatsell et al., 2003). Cytoplasmic levels of β-catenin now accumulate, 
eventually resulting in the protein being transported to the nucleus with the help of Rac1 
(Wu et al., 2008). 
 
Once in the nucleus, β-catenin binds to DNA-binding proteins of the T-cell factor (TCF) and 
lymphoid enhancer-binding factors (LEF) families (Behrens et al., 1996; Molenaar et al., 
1996). In the absence of Wnt signalling, TCF/LEF proteins are bound by Groucho 
transcriptional repressors (Cavallo et al., 1998; Roose et al., 1998), but interaction with β-
catenin converts TCF/LEF into transcriptional activators, targeting specific downstream genes 
and affecting subsequent cellular decisions. Over a hundred genes are activated by β-catenin, 
some of which are oncogenes such as c-MYC (MYC), Cyclin D1 (CCND1), Survivin (BIRC5), 
Axin2 (AXIN2), matrix metalloproteinases (MMPs) and other factors involved in proliferation 
and stem cell maintenance (Arend et al., 2013). While different stem cell types require 
distinctive extrinsic signals to maintain their ‘stemness’, Wnt signalling stands out as it is 





Figure 5.1 The canonical Wnt/β-catenin signalling cascade, simplified (A) In the absence of 
Wnt, cytoplasmic β-catenin protein is bound by APC and Axin, which allows CKI and GSK-3β 
to phosphorylate β-catenin. The phosphorylated protein is now recognised by β-TrCP and 
ubiquitinated subsequently degraded by the proteasome. When Wnt is present, it binds 
transmembrane proteins LRP5/6 and Frizzled, which now form an intracellular complex 
which inhibits the activity of kinases CKI and GSK-3β, thereby inhibiting the turnover of β-
catenin protein, allowing for it to accumulate in the cytoplasm and translocate to the nucleus. 
Once in the nucleus, it binds TCF/LEF factors that activate transcription of Wnt-responsive 
genes. (B) The β-catenin protein consists of an N-terminal region, a central Armadillo repeat 




can be phosphorylated by CKI (orange) or GSK-3β (red). β-TrCP subsequently recognises a 6-
nucleotide binding motif including pS33 and pS37 (highlighted in green, φ indicating a 
hydrophobic and X any amino acid) and result in the ubiquitination of β-catenin necessary 
for proteolytic degradation. The C-terminal region acts as a trans-activator that may interact 
with the armadillo domain to regulate interactions with other proteins. (C) Distribution of 
amino acid substitutions affecting β-catenin found in cancer. Left: gene-wide overview of 
substitution frequencies affecting β-catenin shows a clustering of substitutions in the N-
terminal region of the protein. Right: enlargement of the N-terminal mutational cluster 
shows mutations happen most frequently in residues T41, S45 and residues D32-S37. These 
residues additionally harbour different frequencies of amino acid substitutions. Figure 
adapted from the Catalogue of Somatic Mutations in Cancer (COSMIC).  
 
5.1.1. β-catenin structure and function  
The β-catenin protein consists of 782 amino acids, of which the bulk is structured in twelve 
characteristic armadillo repeats that together form the rigid armadillo repeat domain (ARM) 
(Huber, Nelson and Weis, 1997; Loh et al., 2006) (see Figure 5.1B). The highly structured ARM 
region forms a wedge-shaped curvature, of which the inner surface serves as a ligand-binding 
site for the various interaction partners of β-catenin. These proteins bind to adjacent but not 
identical residues in the ARM region, allowing partners from the same complex to bind β-
catenin simultaneously. This domain has affinity with several binding partners and binding 
sites for these proteins thus overlap, causing competition and requiring regulation at several 
levels to maintain delicate equilibria between the different roles of β-catenin. 
 
The N-terminal and far C-terminal domains that flank the ARM domain do not adopt any 
structure by themselves but do play crucial roles in the regulation of β-catenin function. The 
C-terminus functions as a transcriptional activator that allows interaction with TCF/LEF (Van 
de Wetering et al., 1997). The N-terminal domain contains a region that is highly conserved 
in evolution with four residues that can be phosphorylated. Interaction with APC and Axin in 
the degradation complex initiate phosphorylation of Ser45 by CKI (Aberle et al., 1997; Orford 
et al., 1997; Winston et al., 1999). The resulting pSer45 priming site now allows GSK-3β to 
phosphorylate three residues adjacent to this, each one separated by three other residues in 
its primary structure (Hagen and Vidal-Puig, 2002). This phosphorylation cascade results in a 
six amino acid sequence in the N-terminal region that forms a 32DpSGφXpS37 binding motif 
(φ indicating a hydrophobic and X any amino acid) for β-TrCP (see Figure 5.1B) necessary for 
proteolytic degradation (Wu et al., 2003). In addition to degradation, nuclear phosphorylated 




centromeres (Huang, Senga and Hamaguchi, 2007). Although unstructured, the β-TrCP 
binding motif was determined to require a tight bend of residues 30 to 40 in order for β-TrCP 
to bind (Megy et al., 2006). The phosphate groups of pSer37 and especially pSer33 make the 
largest number of contacts with β-TrCP, whilst Asp32 is an invariant residue making the most 
rigid contacts (Wu et al., 2003). Ile35, of which the hydrophobic nature is conserved in the 
binding motif, makes Van der Waals contacts with β-TrCP. His36 is the only variable position 
of the motif as its side chain points outward and therefore has no interactions with β-TrCP. 
The backbone amide and carbonyl groups of His36 however make a pair of hydrogen bonds 
with β-TrCP in the absence of Wnt signalling. The essential role of this region in turnover of 
β-catenin makes it hence unsurprising that residues in this part have been highly conserved 
throughout evolution.  
 
With β-catenin having these different roles, it raises questions with regards to its regulation: 
How does β-catenin choose among its different binding partners and can it switch from one 
complex to another once it is bound? Whereas the role of β-catenin in Wnt signalling has 
been most extensively described in the literature, at low cytoplasmic concentrations β-
catenin interacts with adherens junction proteins such as E-cadherin (Nelson and Nusse, 
2004), indicating that affinity for these partners is highest. In adherens junctions, β-catenin 
connects cadherin adherens receptors in the cell membrane with a-catenins that are bound 
to the cytoskeleton. Whilst the half-life of cytoplasmic β-catenin is in the order of minutes, 
the protein in these complexes is very stable, presumably as it is protected from regulation 
through β-TrCP (Peifer, M., McCrea, P.D., Green, K.J., Wieschaus, E., and Gumbiner, 1992).  
When protein levels increase, adherens junction partners are saturated and β-catenin 
becomes available in the cytoplasm for binding by the destruction complex components 
APC/axin (Nelson and Nusse, 2004) and destroyed in the absence of Wnt signalling (Harris 
and Peifer, 2005). As described earlier, β-catenin only becomes available for transcriptional 
regulation when turnover by the destruction complex is inhibited through Wnt signalling. 
Together these different affinities provide a principal model for regulating the different 
functions of β-catenin.  
 
Whilst the described regulatory mechanisms would in principle be sufficient to explain the 




affinity to its transcriptional partner TCF/LEF as to cadherins (Gottardi and Gumbiner, 2004). 
The authors found that the C-terminus of the protein can fold back to interact with the 
armadillo repeats to yield a closed conformation, thereby selectively preventing cadherins to 
interact with β-catenin and favour interactions with TCF/LEF (Gottardi and Gumbiner, 2004). 
This is due to the difference in interaction, requiring all twelve armadillo repeats for cadherin 
binding as opposed to TCF/LEF which only requires the central eight repeats (Gottardi and 
Gumbiner, 2004). It is suggested that this conformational change of β-catenin might also be 
regulated by the Wnt pathway, although this has not been confirmed. In addition, a similar 
mechanism could be in place to block APC and axin interactions, but this has again not been 
confirmed.  
 
Another mechanism skewing the function of β-catenin towards interaction with its 
transcription factor partners is through the actions of BCL9 (Kramps, 2002). Through 
phosphorylation of Y142 in the ARM domain of β-catenin, BCL9 weakens the interactions of 
the protein with cadherins, thereby dissociating it from adherens junctions and shifting the 
balance to transcription complexes (Brembeck et al., 2004).  
 
Hence, whilst differences in binding affinity play a role in regulating the binding of partner 
proteins to β-catenin and its subsequent function, there are several additional factors that 
regulate the protein’s function post-transcriptionally. Wnt signalling can hence manipulate 
β-catenin functioning in several different ways to modulate its downstream role in 
transcriptional activation.  
 
5.1.2. Mutations in Wnt/β-catenin signalling pathway 
Underscoring the relevance of the Wnt/β-catenin pathway, this pathway is frequently 
hijacked in cancers. This most notably occurs in cell types that are normally Wnt-dependent 
(Polakis, 2000; Giles, Van Es and Clevers, 2003). Besides initiating tumours, mutations in the 
Wnt/β-catenin pathway are also found to positively influence tumour progression through 
processes such as invasion, tubular branching, tumour growth and epithelial to mesenchymal 
transitions in colorectal tumours (Hao et al., 1997; Kirchner and Brabletz, 2000). Upregulation 
of β-catenin signalling is therefore correlated with aggressive and metastatic colorectal 




many components involved in the signalling cascade have mutated in tumours as is 
summarised in Clevers & Nusse, 2012. 
 
The majority of colorectal tumours, for example, have inactivating mutations on both copies 
of the APC gene, the main negative regulator of the Wnt/β-catenin pathway (Polakis, 2000; 
Kramps, 2002). Loss of function mutations are frequently found in APC, thereby perturbing 
differentiation and triggering tumour formation (Fodde, Smits and Clevers, 2001; Kielman et 
al., 2002; Gaspar and Fodde, 2004). Loss of APC by itself leads to cytoplasmic accumulation 
of β-catenin but is not sufficient to promote its nuclear translocation (Phelps et al., 2009), 
whereby only 1-2% of the tumours harbouring APC additionally upregulate signalling through 
mutations in CTNNB1 (the gene encoding for β-catenin) itself (Polakis, 2000; Kramps, 2002), 
thus suggesting there is no strong selection for mutations in both components of the 
pathway. Additional mutations resulting in oncogenic K-ras are thought to enhance Rac1-
dependend nuclear relocalisation of β-catenin and these two targets are hence frequently 
mutated together (Phelps et al., 2009).  
 
5.1.3. Oncogenic mutations found in CTNNB1 cluster in the N-terminus 
While in some developmental disorders loss-of-function mutations are found in CTNNB1 
(Kuechler et al., 2014), most mutations found in tumours stabilise β-catenin protein levels. 
The non-uniform distribution of predominantly missense mutations in CTNNB1 reveals a 
mutation hotspot frequently seen in oncogenes such as TP53. This clustering is consistent 
with oncogenic mutations in CTNNB1 acting through a gain-of-function mechanism (Walker 
et al., 1999; Glazko et al., 2006).  
 
Mutations in CTNNB1 are found in a wide range of tumours, including soft tissue (42.5% of 
all tumours), pituitary (37.0%), liver (21%) and endometrial tumours (18.2%) (Forbes et al., 
2018). Several common themes are apparent across cancer types. For instance, 88.8% of all 
mutations found in CTNNB1 are missense, of which 92.4% occur within residues 32-45 in 
exon 3 (see Figure 5.1C) (Forbes et al., 2018). In-frame deletions of the entire exon 
(Rebouissou et al., 2016), or residues 32-37 (Cairo et al., 2008) have also been described in 
some tumours, although at much lower frequency. As explained, this N-terminal region 




region hence desensitise the protein to proteolytic degradation (see Figure 5.1B) (Polakis, 
2000; Fodde, Smits and Clevers, 2001; Giles, Van Es and Clevers, 2003; Luo et al., 2007). 
  
Measurements of signalling activity in colorectal cell lines show that some mutations in APC 
and CTNNB1 only cause a subtle increase in β-catenin and that particular sites cause specific 
levels of signalling (Rosin-Arbesfeld et al., 2005). It has also been shown that certain 
nucleotide substitutions encoding for the same amino acid in CTNNB1 can result in different 
levels of β-catenin signalling in hepatocellular carcinoma (Austinat et al., 2008). Asp32, Ser33, 
Gly34 and Ser37 are often found to be mutated in cancers, consistent with the most 
conserved residues in the 32DpSGφXpS37 binding motif for β-TrCP as mentioned in section 
5.1.2. In contrast, Ile35 is rarely mutated in cancer (Polakis, 2000; Rebouissou et al., 2016). 
Despite the previously mentioned phosphorylation cascade, mutations in the Ser45 residue 
of β-catenin have been shown to not prevent phosphorylation at the other residues (Wang, 
Vogelstein and Kinzler, 2003), suggesting that, at least in colorectal cancer, this site is not 
always essential for phosphorylation. It is suggested that mutations affecting the β-TrCP 
binding motif have a higher transcriptional activity compared to mutations in Thr41, which 
are in turn more disruptive than mutations in Ser45 (Rebouissou et al., 2016). As S45 is the 
most frequently altered in tumours after T41, these results suggest that partially increased 
signalling is preferred over a complete loss of β-catenin turnover (Forbes et al., 2018).  
 
5.1.4. Just right signalling model suggests selection for an optimal level of β-catenin 
signalling 
Whilst the previous section discussed that oncogenesis can involve selection for mutations 
enhancing β-catenin expression, overexpression of CTNNB1 with missense mutations 
frequently found in hepatocellular carcinoma suggests that these variants result in different 
levels of downstream signalling and that optimal levels of β-catenin signalling are not 
consistent between tumour types (Austinat et al., 2008). This in turn suggests that, whilst 
upregulation of β-catenin signalling promotes tumour progression, β-catenin levels need to 
be optimal in each cell type. Albuquerque et al. hypothesised this and stated that cells with 
mutations blocking β-catenin degradation over a certain threshold (either through β-catenin 
directly or through another partner such as APC) may trigger apoptosis and are hence not 




in CTNNB1 rarely being found biallelically (Björklund et al., 2008; Le Guellec et al., 2012), 
although this could also partially be explained by individual missense mutations being rare 
(compared to the likelihood of loss-of-function mutations) and are hence less likely to 
happen on both alleles in a cell. By now, this ‘just right’ model has been well described for 
colorectal cancers (Lamlum et al., 1999; Albuquerque et al., 2002, 2011), whereby it is shown 
that classes in mutations in APC differ along the colorectal tract. In addition, hypomorphic 
Apc mutations in mice remarkably result in liver tumours but not intestinal tumours (Gaspar 
and Fodde, 2004), giving additional support to the idea that tumorigenesis happens in a 
tissue-specific way depending on Wnt/β-catenin signalling levels.  
 
5.1.5. Mutational signatures arise from different mutational processes 
Tumours arise from somatic cells undergoing stepwise mutagenesis. This creates genetic 
diversity amongst cells on which natural subclonal selection can subsequently act, which is a 
characteristic of Darwinian evolution (Curtis, 1965; Nowell, 1976). All cells in an organism are 
exposed to a continuous mutational burden proportional to their proliferation rate and age 
due to intrinsic infidelities in the DNA replication and repair machinery (Stratton, Campbell 
and Futreal, 2009). For instance, over-activity of members of the APOBEC family of cytosine 
deaminases can cause C>U conversions that typically get repaired by base excision repair, 
which when mutagenic most often results in C>T conversions (Chen et al., 1987; Powell et 
al., 1987; Seeberg, Eide and Bjørås, 1995).  
 
In addition to intrinsic factors, exposures to exogenous carcinogenic factors can result in 
accumulation of distinct mutations in specific tissues (Pfeifer, 2010). For example, ultraviolet 
radiation in sunlight is a common source of DNA damage but does not typically penetrate 
further than our skin. The elevated abundance of C>T substitutions in melanomas are hence 
thought to be the result of excessive exposure to ultraviolet light (Ravanat, Douki and Cadet, 
2001; Pleasance et al., 2010). In contrast, substitutions due to tobacco carcinogens are 
typically associated with C>A and CC>AA in lung cancer (Pfeifer et al., 2002). Hence, each 
carcinogenic process operating on a tissue generates a characteristic imprint, or mutational 
signature, on the cancer genome. With multiple processes acting on a given tissue and 




elucidate the mutational contribution of up to 21 different processes (Alexandrov et al., 
2013; Alexandrov and Stratton, 2014).  
 
To identify a mutational signature, single nucleotide substitutions in cancer genomes cancer 
type are enumerated in their trinucleotide context, i.e. accompanied by their 5’ and 3’ 
neighbouring bases. For example, T[C>A]G would denote a C to A substitution in its 
trinucleotide context of TCG. As each base can be mutated into the 3 other possible bases, 4 
possible neighbouring bases can be present on either side of the target base and mutations 
on the Watson and Crick strands cannot be distinguished (i.e. C[G>T]A on the Watson strand 
has the same result as T[C>A]G on the Crick strand), there are (3 x 4 x 4 x 2) 96 possible 
substitution mutations. This thus allows one to distinguish cases where the same mutation 
occurs in different contexts. This is crucial as it has been shown that mutation frequencies 
are heavily influenced by nucleotide context (Ellegren, Smith and Webster, 2003). 
 
With the knowledge of the underlying mutational processes (e.g. infidelities in DNA 
maintenance and replication, the carcinogens to which specific tissues are exposed and 
additional information on the age of collection of tumours), the contribution of each 
mutational process to a specific tissue, the mutational signature, can be computed through 
mathematical analyses (Alexandrov et al., 2013). These mutational signatures together make 
up the eventual palette of genetic changes found in a tumour, which is referred to as the 
mutational portrait (Helleday, Eshtad and Nik-Zainal, 2014). Hence, mutational signatures 
provide insights on (1) the mechanistic bases of endogenous and exogenous carcinogenic 
burdens and (2) the likelihood of a nucleotide substitution to arise in a particular cell lineage.  
 
Mutational signatures explain how certain tissues may acquire specific mutations more 
frequently than others, affecting the raw material available for natural selection to work 
upon. In CTNNB1, specific tissues show strong biases for residues between tumour types. For 
example, whilst the serine phosphorylation residues Ser45, Ser37 and Ser33 are all encoded 
by TCT, colorectal cancers mainly present mutations affecting Ser45 and Thr41, while 
tumours in the endometrium and ovaries predominantly harbour mutations at Ser37 and 
Ser33 (Polakis, 2000; Albuquerque et al., 2011). A study investigating CTNNB1 mutational 




T41A (59%), S45F (33%), and S45P (8%) were the most frequently occurring in desmoids, with 
a significantly poorer five-year survival rate in S45F-mutated desmoids (23%, p < 0.0001) 
versus either T41A (57%) or tumours without a mutation (65%) (Lazar et al., 2008). These 
results thus show that the observed frequency of mutations is different between tissues that 
the tumours originate from, but the extent to which either the background mutation rate or 
selective pressure contributes to the eventual mutational pattern remains a major open 
question in the field and is crucial in order to understand the biology of tumours. 
 
5.1.6. Motivation for study 
Oncogenic mutations in CTNNB1 cluster in the N-terminal region of the protein, typically 
impeding phosphorylation by CKI or GSK-3β or by destroying the β-TrCP binding motif. Many 
questions in the field remain, as to why different tumours preferentially harbour mutations 
at certain residues and to what the functional consequences of specific point mutations are. 
Most studies thus have not systematically assessed the effects of specific amino acid 
substitutions in CTNNB1 on downstream signalling or cell fitness.  
 
Since the mechanism of Wnt/β-catenin signalling is not known to differ between tumour 
types or between tissues, other cellular mechanisms such as the level of signalling required 
to trigger apoptosis might underlie the different responses to specific levels of β-catenin 
signalling. As yet, there no evidence to suggest that the same CTNNB1 variant can elicit 
different phenotypic consequences in different cell types, although this has not been 
rigorously tested. While previous efforts have assessed the effects of mutations in CTNNB1 
on downstream TCF/LEF signalling have been tested, only a small number of mutations has 
been assessed (Austinat et al., 2008). As the hotspot region is confined to a few residues of 
CTNNB1 (Figure 5.1C) and tumour-associated mutations are primarily missense, this region 
was therefore considered as a suitable subject for our deep mutational scanning pipeline. In 
this chapter, I have adapted the pipeline described in chapters 1 & 2 to assess the effects of 
single amino acid substitutions in this region on β-catenin signalling.  
 
The experimental design for this study was done by Derya Özdemir and Peter Hohenstein 
with help from Andrew Wood, and all the experimental work was performed by Anagha 




one exception: the background mutation rates in tumours with CTNNB1 mutation were 
calculated by Dr Ailith Ewing with help from Colin Semple.  
 
5.2. Results 
5.2.1. Using double-stranded repair templates containing codon replacements  
In contrast to our study on GFP, we here wanted to assess the consequences of all possible 
amino acid substitutions within the CTNNB1 hotspot region. Therefore, the proposed 
pipeline was reassessed for its applicability to perform deep mutational scanning on the 
amino acid level. Because the oligo doping approach to template synthesis is biased against 
amino acid substitutions requiring more than one nucleotide substitution, it was instead 
opted to synthesise double stranded templates using the ssDNA-synthesis platform provided 
by Twist Bioscience that allows for the specific incorporation of alternative codons instead of 
alternative nucleotides, as discussed in the main introduction to this thesis. This should 
theoretically result in predefined codon substitutions without biasing against those requiring 
multiple simultaneous nucleotide changes. As described more extensively in section 2.2.2, 
HDR template plasmids contained ±2-kb homology arms to CTNNB1, with residues L31 to 
G50 of the gene encoding β-catenin replaced with codons encoding for all 19 possible amino 
acid substitutions (see Figure 5.2). As sgRNA binding sites are within the puDtk selection 
cassette, the wildtype allele (Allele 1 in figure 5.2a) will remain uncleaved, limiting 
subsequent edits to the puDtk allele. In addition, the sgRNA binding sites are removed upon 
repair by HDR, such that Cas9 is prevented from cleaving either the episomal HDR templates, 
or genomic DNA from cells that have already undergone HDR. This served to maximise the 
frequency of HDR-derived alleles in the cells undergoing selection, which was a large 
bottleneck in the screen on GFP described in the previous chapter. In addition, repair 
templates contained silent mutations situated just outside the variable amino acid positions, 
which create novel binding sites for PCR primers, making it possible to selectively amplify 
from HDR-derived template strands while ignoring unedited alleles or template strands 
containing indels. Together, these modifications would maximise the percentage of HDR 





5.2.2. Monoallelic replacement of CTNNB1 with a puDtk cassette allows for targeting of a 
single allele and for the selection of targeted cells.  
The presence of biallelic copies of CTNNB1 could obscure both targeting and the downstream 
analysis of allelic variants. Whilst an approach utilising a single copy proved useful in our 
analysis of GFP, oncogenic mutations in tumours typically occur in the presence of a wildtype 
copy in trans. To mimic the activity of mutations found in cancer, it was reasoned that the 
allelic series would have to be introduced onto one of the allelic copies whilst leaving the 
other copy intact.  
 
For this reason, Anagha Krishna monoallelically replaced exon 1-6 of CTNNB1 with a cassette 
containing a fusion protein between puromycin N-acetyltransferase and a truncated form of 
herpes simplex virus thymidine kinase (puΔtk) driven by its own promoter (Chen and Bradley, 
2000). This positive/negative selection cassette facilitates positive selection of cells 
harbouring this cassette in-frame using puromycin, whilst making these cells sensitive to 1-(-
2-deoxy-2-fluoro-1-β-D-arabino-furanosyl)-5-iodouracil (FIAU). A schematic overview of our 
pipeline is displayed in Figure 5.2B. 
 
Subsequent targeting of these cells with sgRNAs that direct Cas9 cleavage at either end of 
the puΔtk cassette lead to its excision and replacement with sequence from the HDR donor 
template library and reconstitution of the CTNNB1 open reading frame (see Figure 5.2B). 
These cells, but not cells that are unedited or have undergone NHEJ, lose sensitivity to FIAU, 
thereby allowing for the selection of cells that have undergone desired editing outcomes. In 
addition, silent mutations introduced onto the targeted allele by this final HDR step allow for 
the selective amplification of this allele by PCR. With this, an approach was set up to 
introduce putative gain of function mutations specifically into one allele of CTNNB1 while 








Figure 5.2 Schematic representation of experimental design to perform deep mutational 
scanning of CTNNB1 (A) Schematic overview of cell line harbouring a single wildtype copy of 
CTNNB1, whilst the other allelic copy has exon 3-6 replaced by an insert containing a 
puromycin N-acetyltransferase and a truncated form of herpes simplex virus thymidine 
kinase (puΔtk) cassette, a promoter (PGK-1) and bGH polyadenylation signal (polyA), ±2.4kb 
in size. sgRNAs guide wtCas9 to induce double-stranded DNA breaks at the termini of the 
cassette that are hence specific for allele 2. HDR repair template plasmids contain 
endogenous exon 3-6 with a single codon substitution in any of the 20 targeted triplets 
(amino acid residues 31-50 in exon 3), together making up a total of 380 possible variants, 
and flanking homology arms of ±2kb. Amplification of the samples by PCR is performed by a 
primary amplification from outwith the homology arms (F1 & R1) to exclude off-target 
integrations, whereas a second round of PCR amplification selectively amplifies from HDR-




parallel, the pool (‘HRM’) was PCR-amplified with an alternative reverse primer (R3) binding 
20bp downstream from R2 that was not specific for HDR-derived reads and hence also 
amplified from non-HDR reads, thereby allowing for the assessment of the frequency of HDR 
reads in the pool. (B) Schematic of CTNNB1 targeting strategy. TCF/LEF::H2B-GFP ES cells are 
targeted with CRISPR-Cas9 and repair template targeted with puΔtk selection cassette and 
screened for heterozygous replacements to achieve the cell line described in (A). Targeting 
of these cells with CRISPR-Cas9 and an HDR vector library followed by selection for successful 
integration by FIAU results in a pool of cells harbouring biallelic codon variants of CTNNB1. 
After fluoresce-based sorting of cells, genomic DNA was isolated and selectively amplified as 
described in (A). These amplicons were finally subjected to deep sequencing. 
 
5.2.3. The TCF/LEF::H2B-GFP reporter system allows for the efficient measuring of 
fluctuations in Wnt/β-catenin signalling activity 
In the previous chapter I described how a direct readout of the effects of mutations on the 
targeted protein was used by either measuring its fluorescence directly (GFP). While I have 
shown that this is a suitable way to assess loss-of-function or hypomorphic mutations, in the 
case of β-catenin we wished to assess the effect of gain of function mutations on signalling 
pathway activation. For this reason, our phenotypic assay utilised a well-established 
transcriptional reporter of Wnt/β-catenin signalling (Ferrer-Vaquer et al., 2010).  
 
This reporter comprises a transgene containing six copies of a TCF/LEF-responsive element 
and an hsp68 minimal promoter driving expression of a cDNA encoding human histone H2B 
fused to GFP (Ferrer-Vaquer et al., 2010). This TCF/LEF::H2B-GFP system has been widely 
used as a sensitive reporter of the Wnt/β-catenin signalling pathway at single cell resolution 
both in vitro and in vivo (Faunes et al., 2013; Kuwajima et al., 2013). It was hypothesised that 
cells harbouring mutations stabilising β-catenin would lead to an increase in GFP 
fluorescence and could subsequently be separated out by FACS, similar to the experiments 
done in the previous chapter. Therefore, mouse embryonic stem cells harbouring this 
reporter were used as the model system for this study, which were derived specifically for 
this project by the lab of Anna-Katerina Hadjantonakis at the Memorial Sloan-Kettering 
Cancer Center.  
 
5.2.4. Culturing embryonic stem cells under 2i conditions allows for an unbiased 
integration of amino acid substitutions into CTNNB1 
A key aim of culturing embryonic stem (ES) cells in vitro is to maintain pluripotency and avoid 




were cultured on irradiated mouse embryonic fibroblasts (MEFs) in media containing fetal 
bovine serum (FBS) (Martin, 1981), until it was discovered that leukaemia inhibiting factor 
(LIF) could replace MEFs (Smith et al., 1988; Williams et al., 1988).  
 
Three decades later, media containing both serum and LIF, either on feeder cells or 
gelatinized surfaces, are still routinely used for the culturing of ES cells in many labs. Since 
sera such as FBS are animal derived, a shortcoming of these culture conditions is that the 
media is not completely defined, may show batch variability and contain differentiation 
factors.  
 
In 2008 an alternative, defined culturing method was developed containing inhibitors of two 
key signalling pathways; the mitogen-activated protein kinase/extracellular-signal-regulated 
kinase (MEK) inhibitor PD0325901 and GSK-3β inhibitor CHIR-99021 (Ying et al., 2008). These 
two inhibitors (‘2i’) enable the maintenance of self-renewal and pluripotency marker 
expression in mouse ES cells, without the use of animal-derived factors. 2i is increasingly used 
in the field and is thought to better represent ‘ground state pluripotency’ than culturing 
under serum and LIF (Ying et al., 2008).  
 
As any oncogenic mutation affecting β-catenin would immediately give these cells a 
proliferative advantage in the presence of Wnt signalling, culturing cells using serum and LIF 
would adversely bias our screen towards these faster replicating cells. Therefore, cells were 
cultured under 2i conditions to avoid the confounding effect on cell fitness. As stated in the 
Materials & Methods chapter, two days before selecting cells based on their activity by FACS, 
the GSK-3β inhibitor CHIR-99021 was removed from the culture media, thereby unmasking 
the effects of amino acid substitutions in β-catenin on signalling without giving these cells 
enough time to selectively proliferate.  
 
5.2.5. Targeting cells with CRISPR-Cas9 and HDR library causes an increase in TCF/LEF 
signalling 
Analysis by FACS revealed that the targeted cell population showed a wider range in 
increased GFP fluorescence compared to the unedited population (compare Figure 5.3A with  





As it was aimed to detect subtilties in effects of mutations on β-catenin signalling, cells were 
sorted into six equally log-spaced bins (referred to as bin P2-P7) based on their fluorescence 
(with  Figure 5.3C,D and Table 5-1) and genomic DNA was isolated from each bin. In addition, 
unsorted cells (referred to as pool) were also processed for genomic DNA isolation. This 
experiment was performed in duplicate to account for experimental noise. In the sections 
hereafter, I will refer to the directly sequenced dsDNA repair template pool as “plasmid”, the 
entire unsorted population of targeted cells as “pool” and each of the six fluorescence-
restricted populations as “bins”. 
 
After selectively amplifying HDR-derived alleles from the genomic DNA (from samples P2-P7 
and the pool, amount of gDNA denoted in Table 5-1) by two sequential PCR steps (see Figure 
5.2A), samples were indexed for multiplexing. In parallel, the KO allele was amplified and 
indexed with a different reverse primer (P3) that did not selectively amplify HDR reads 
(referred to as HRM, see Figure 5.2A) in order to ascertain the proportion of HDR reads as 
part of the whole pool. For some samples the amount of gDNA suggested a higher number 
of biallelic copies (e.g. 133 ng represents ± 2.2 x 104 biallelic copies in P7.1) than the number 
of cells sorted (e.g. 4,075 cells in P7.1) and the gDNA concentrations are thus likely to be 
overestimated. Therefore, the experimental design hereby does not allow for the accurate 
estimation of the number of HDR alleles that were amplified. Samples were sequenced on 
the Illumina MiSeq platform using 150bp paired-end sequencing.  
 
5.2.6. Data analysis shows high HDR efficiencies and a high sequencing depth per sample 
After trimming reads for both adapter sequences and bases with a low-quality score (as 
described in Chapter 3), pairs of sufficient read length were aligned to the reference 
sequence. For the biological replicates of HRM (i.e. the sample that had not undergone a 
selective PCR-step for HDR-derived alleles and hence includes all HDR and non-HDR reads), 
perfect FIAU selection resulting in 100% cells having undergone HDR would yield 50% 
wildtype reads. Respectively 497,470 and 430,202 reads (64.8% and 67.9%) aligned to the 
wildtype reference sequence (of 162 nt), whereas 205,698 and 162,663 reads (26.8% and 




Table 5-1 Number of cells sorted per bin Cells were sorted into a total of six bins which were 
equally log-scaled, with the exception of p2 which spanned a relatively larger range. Amounts 
of genomic DNA (gDNA) used per PCR reaction, whereby the lower values (i.e. p7) were at 
very low concentrations and correspond with higher numbers of cells and are therefore likely 
to be overrepresented. Values were provided by Anagha Krishna. 
Bin Fluorescence range Replicate 1 Replicate 2 
Cells 
sorted 
gDNA used in 
PCR (ng) 
Cells sorted gDNA used in 
PCR (ng) 
p2  5.0 x 102 - 5.0 x 103 100,000 2,156 100,000 2,254 
p3 5.0 x 103 - 1.0 x 104 100,000 2,646 100,000 3,469 
p4  1.0 x 104 - 5.0 x 104 100,000 2,744 100,000 3,577 
p5  5.0 x 104 - 1.0 x 105 30,000 475 50,000 10,098 
p6  1.0 x 105 - 5.0 x 105 234,000 5,929 211,000 13,573 
p7  5.0 x 105 - 1.0 x 106 4,075 133 4,234 87 
Pool All cells 200,000 2,500 200,000 5,941 
 
the HDR repair template, which is 142 nt in length, while not mapping to the non-HDR 
reference sequence. This was expected, as the HRM samples (i.e. the sample that had not 
undergone a selective PCR-step for HDR-derived alleles and hence includes all HDR and non-
HDR reads) were amplified with F2 and R3 rather than F2 and R2 primers (see  Figure 5.2A) 
and therefore contained both HDR and non-HDR reads.  A small proportion (64,301 and 
41,064 (8,4% and 6,6%)) of the reads did not map to either of the reference sequences, and 
a closer examination demonstrated that these were reads with more than 6 mismatches. 
Sequences mapping to the wildtype reference did not contain the silent mutations specific 
for HDR-derived alleles whereas the reads mapping to the HDR reference did (see Figure 
5.2A), indicating that the overall frequency of HDR-derived reads approximates 26.2% in both 
biological replicates. Considering that only HDR-derived alleles and non-targeted allele from 
both edited (‘HDR cells’) and unedited cells are amplified, an equal proportion of the reads 
(26.2%) should result from the unedited allele from ‘HDR cells’ and (100 - 26.2 - 26.2 =) 47.6% 
of the reads come from the unedited allele of non-HDR cells. Thus, about a third (26.2 * 
(100/(47.6+26.2)) =) 35.5% of the cells after FIAU selection harboured an HDR allele. While 
the overall HDR efficiencies (i.e. before FIAU selection) cannot be assessed, these results 






Figure 5.3 FACS analysis of TCF/LEF::H2B-GFP post-targeting (A) Fluorescence profile of 
wildtype TCF/LEF::H2B-GFP cells harbouring biallelic wildtype copies of CTNNB1 shows that 
fluorescence does not exceed ± 5 x 104 fluorescence units. (B) Fluorescence profile of 
TCF/LEF::H2B-GFP cells harbouring heterozygous replacement of CTNNB1 with puΔtk 




Fluorescence profiles of cells (C: replicate 1; D: replicate 2) targeted harbouring allelic 
variants shows increased range of GFP fluorescence. Fluorescence increased beyond the 
baseline levels shown in (A). Cells were sorted into bins 2-7, which represent equally log-
spaced bins as described in table 5.1.  
 
For the other samples (i.e. P2-P7 and Pool, all amplified with F2 and R2 primers, see  Figure 
5.2A), consistent mapping efficiencies of >98% to the HDR reference sequence were 
observed, with an average of 679,845 ± 76,509 mapped reads per sample. As this mapping 
only occurs for reads containing silent mutations introduced by HDR, this indicates that the  
selective PCR efficiently discriminates HDR-derived reads from wildtype. Read pairs without 
insertions or deletions and with no more than 6 conflicting nucleotides with respect to the 
reference sequence were considered for further analysis. On average 463,583 ± 72,680 reads 
(68.2%) passed this threshold. Because 381 possible variants were assessed (19 codon 
substitutions at 20 positions and the wildtype allele), this suggests an average 10X coverage 
for variants occurring at a frequency as low as 2.16 x 10-6. However, as for p7 only ± 4,000 
cells were sorted, this reflects ± 100X coverage, whereas in P2 not all cells will have 
undergone HDR (as P2 reflects wildtype expression levels) and with 100,000 there will thus 
be < 10-fold coverage. The overall coverage was however deemed sufficient to correctly 
assess variances in proportions between the bins. 
 
5.2.7. Amino acid substitutions are efficiently integrated through homology-directed repair  
Whilst multiple codons can encode the same amino acid, only a single codon was used per 
amino acid change in our repair templates. Amino acid replacement frequencies are 
displayed in Figure 5.4. The average percentage of non-consensus codons in the non-variable 
region (residues 19 – 30) across all samples is 0.02%, which is consistent with the error rate 
of the Illumina MiSeq platform (0.0064% * 3 nucleotides = 0.0192%) (Schirmer et al., 2015). 
The observed frequency of non-consensus codons per site is 5.92 ± 1.34% in the variable 
region (residues L31 – G48) of the pool (i.e. the total population of targeted unsorted cells) 
and closely resembles the frequency found on the plasmid (5.59 ± 1.14%), whilst the 
frequencies of non-consensus codons correlate between plasmid and the sequenced pool (R2 
= 0.737, see Figure 5.5). Whilst there is some degree of variability, this demonstrates that 
genomic integration of the plasmid sequences through HDR is largely unbiased and all codons 






Figure 5.4 Stacked bar plot of amino acid substitution rates per codon Colours represent 
specific amino acid substitutions as explained in the legend at the bottom. Dashed line 
separates saturated residues (right) from constant residues (left), whereas asterisks indicate 




substitutions show elevated levels in targeted residues L31-48G as compared to non-
targeted residues 19K-30Y. This heterogeneity was not observed in residues 49K and 50G. 
Amino acid substitution profiles are consistent between the plasmid and unselected pool, 
suggesting an unbiased genomic integration of the nucleotide diversity found in the plasmid 
library. Amino acid substitutions at residues 32D, 33S, 34G, 37S, 41T, 45S are depleted in bins 
P2, P3, P4 but show an enrichment for amino acid substitutions in bins P5, P6, P7.  
 
 
Figure 5.5 Correlation of codon frequencies in repair template plasmid and cell pool Codon 
frequencies as proportion of the total number of HDR reads were analysed in both the repair 
template plasmids and in the unsorted cell pool to assess the level of integration. Codons 
occurring at low proportions were typically those at residues 49 and 50, as is also visible in 
figure 5.4. L46M was observed as the most frequent codon in both the plasmid and pool. 
Analysis showed a strong correlation (R2=0.737), indicating efficient genomic integration of 
the plasmid pool through HDR. 
 
Codon frequency analysis of the template plasmid confirms that, whilst there are differences 
between the residues, all intended codon substitutions are represented across targeted 
residues L31 – G48 (see Figure 5.4), while an underrepresentation of codon substitutions was 
observed at residues K49 and G50. Frequencies of these codons are consistently lower in the  
repair template plasmid similarly to the targeted pool of cells (see Figure 5.5), thus excluding 
the possibility of a skew in editing. This underrepresentation was found to be consistent 
throughout all sequenced samples (see Figure 5.4 and Figure 5.5). This raised the possibility 




diversity at these distal residues, resulting in the loss of these codons in the eventual pool. 
To distinguish between these possibilities, an unbiased search using the UNIX command grep 
in the unprocessed data files for sequences containing codon substitutions at these positions, 
confirmed that these sequences are scarcely present in all sequenced samples. Finally, 
frequencies are also consistently low in the HRM sample, which uses a sequencing primer 
different from the other samples. From this it was deduced that these sequences are truly 
underrepresented in the sequencing pool and that the low diversity stems from an issue 
during construction of the original plasmid donor library used for this screen. For this reason, 
only amino acid substitutions at residues L31 – G48 were considered for further analyses. 
 
5.2.8. Technical replicates show reproducibility of the data 
Frequencies of non-consensus codons show a very high correlation between technical 
replicates of the plasmids (R2 = 0.92; see Figure 5.6), indicating that the sequencing depth of 
the samples is sufficient. The biological replicates of the pool and P2-P7 consistently show a 
high correlation (see Figure 5.6) (R2 = 0.83 ± 0.11). The highest correlation found (P6, R2 = 
0.99) can be explained by the fact that many amino acid substitutions were not represented 
in this bin and their values hence approximate 0, thereby increasing the correlation between 
the replicates. Following this reasoning, P7 would be expected to have a similar correlation 
between replicates, but counterintuitively here the lowest correlation between replicates 
was observed (R2 = 0.653). As the sequencing depth for these samples was not different from 
the other bins, this outlier was considered to likely be due to the low number of cells that 
was sorted for this bin (see Table 5-1).  
 
To further ascertain whether a high enough coverage was obtained in each bin, the extent 
to which the combined bins resemble the pool was assessed. The frequency of each codon 
in the pool cir was therefore artificially reconstructed by multiplying the frequency of a given 
codon i in each bin j (cij) by the fraction of cells sorted into that bin fj, such that: 
 




The codon frequencies in the reconstructed pool highly correlate with the frequencies from 






Figure 5.6 Correlation of codon frequencies in sequenced replicates Technical (plasmid 
sample) and biological (pool and P2-P7) replicates show high correlation, indicating a low 
variation between biological replicates. P7 shows the highest variation which is likely due to 






Figure 5.7  Correlation of codon frequencies in sequenced pool and reconstructed pool 
Codon frequencies from individual bins P2-P7 were combined proportionally to the number 
of cells sorted in that bin in order to assess the extent to which they together represent the 
unsorted pool. Codon frequencies show a high correlation between the sequenced pool and 
the reconstructed pool, indicating that there is no loss in diversity through separation of cells 
into individual bins.  
 
coverage within each bin is sufficient to accurately represent the true allelic frequencies. 
With correlation for all replicates being high, the biological replicates were merged for 
further analyses. 
 
5.2.9. Reads predominantly harbour a single alternative codon 
As mentioned, the aim is to assess the effects of all single amino acid substitutions across the 
targeted residues. To ensure only assessing alleles with a unique amino acid change were 
assessed, the number of non-consensus codons per read in each bin were analysed (see 
Table 5-2). The highest frequencies of wildtype reads (i.e. with no codon substitutions) were 
found in bins P2 and P3, which correspond with the baseline fluorescence levels of 
TCF/LEF::H2B-GFP in unedited cells. Reads with no mutations were rare across all populations 
(i.e. < 10%) and as expected, were even lower in bins with b-catenin signalling levels 
exceeding wildtype (i.e. < 3% in bins 6 and 7). With a sequencing error rate of 0.02%, (54 * 




Table 5-2 Number of non-consensus codons per read. In each sample, the number of non-
consensus codons per read were counted. Whilst in all samples the vast majority of the reads 
contained a single codon change, approximately 5% of the reads in the plasmid and 7% in the 
pool contained no mutation and less than 3% contained more than a single mutation. Across 
the bins, reads with no mutation are more frequently found in the bins of low GFP 
fluorescence. The proportion of reads with more than a single mutation did not show large 
fluctuations between the bins. 
 Number of non-consensus codons (read count)   
Sample 0 1 2 3 4 > 4 Total 
Plasmid_1 22,935 412,429 9,671 116 2   445,153 
  5.2% 92.6% 2.2% 0.0% 0.0%     
Plasmid_2 22,224 344,630 7,225 91     374,170 
  5.9% 92.1% 1.9% 0.0% 0.0%     
pool_1 36,941 459,119 14,370 226 2   510,658 
  7.2% 89.9% 2.8% 0.0% 0.0%     
pool_2 32,280 406,863 13,132 214 4   452,493 
  7.1% 89.9% 2.9% 0.0% 0.0%     
p2_1 42,540 395,869 11,938 172 2   450,521 
  9.4% 87.9% 2.6% 0.0% 0.0%     
p2_2 42,804 459,333 17,434 547 11 1 520,130 
  8.2% 88.3% 3.4% 0.1% 0.0% 0.0%   
p3_1 37,304 414,470 13,759 185 3 1 465,722 
  8.0% 89.0% 3.0% 0.0% 0.0% 0.0%   
p3_2 27,965 397,381 13,579 244 4   439,173 
  6.4% 90.5% 3.1% 0.1% 0.0%     
p4_1 31,880 444,303 14,339 219 1   490,742 
  6.5% 90.5% 2.9% 0.0% 0.0%     
p4_2 30,644 428,893 14,307 261 1   474,106 
  6.5% 90.5% 3.0% 0.1% 0.0%     
p5_1 16,050 413,139 13,296 213 3   442,701 
  3.6% 93.3% 3.0% 0.0% 0.0%     
p5_2 16,891 474,162 14,777 230 3   506,063 
  3.3% 93.7% 2.9% 0.0% 0.0%     
p6_1 12,328 461,180 15,618 261 3   489,390 
  2.5% 94.2% 3.2% 0.1% 0.0%     
p6_2 12,692 423,905 14,886 236 5   451,724 
  2.8% 93.8% 3.3% 0.1% 0.0%     
p7_1 5,638 425,364 16,734 243 3   447,982 
  1.3% 95.0% 3.7% 0.1% 0.0%     
p7_2 8,852 434,828 12,713 199     456,592 





more than a single mutation were not enriched in any of the populations, which could be 
explained by combinations of codons either disrupting b-catenin phosphorylation (expected 
to result in higher GFP) or disrupting stability of the protein all together (which would result 
in low GFP). As the aim was to assess the effects of single amino acid changes, only reads 
containing only a single alternative codon in the targeted residues were passed. 
 
5.2.10. Amino acid substitutions are found at different proportions in the bins 
With the knowledge that our assay had efficiently integrated the desired genomic variants at 
positions 31-48 in an unbiased manner, it was assessed whether the frequencies of particular 
substitutions differed among the cell populations sorted into ‘bins’ based on transcriptional 
activation of TCF/LEF::H2B-GFP (see Figure 5.3C,D). Plotting the codon substitution 
frequency per residue (Figure 5.4), it is clear that bins P2, P3 and P4 show a spread of 
substitutions across all residues while slightly depleted at residues D32, S33, G34, S37, T41 
and S45 (with respect to the pool), whereas the bins with higher transcriptional activity (P5, 
P6, P7) show an enrichment over these latter mentioned residues. This boundary in 
mutational patterns between bins P4 and P5 is consistent with the GFP fluorescence of the 
unedited samples, which does not extend beyond 1.0 x 103 fluorescence units (see Figure 
5.3C,D), corresponding to the upper limit of P4. This suggests that cells with fluorescence 
higher than P4 (i.e. P5, P6, P7) harbour mutations which enhance reporter expression. This 
threshold identifies positions that are permissive for mutations (those mutated in P2, P3, P4) 
and positions at which disturbances tend to lead to an increase in transcriptional activity, i.e. 
the CKI and GSK3b phosphorylation sites and residues in the 32DpSGφXpS37 binding motif for 
β-TrCP. As previous studies have shown that these residues are involved in the proteolytic 
turnover of β-catenin (see section 5.1.3), this confirms that our pipeline is able to detect 
amino acid substitutions that enhance the effect of β-catenin on TCF/LEF expression.  
 
5.2.11. Hydrophobic residues do not affect β-catenin activity at I35 
Amino acids have distinct physicochemical properties that, in combination, determine the 
structure and function of a protein. For example, hydrophobic residues are typically buried 
inside a protein whereas hydrophilic amino acids are typically found at the surface of a 
protein. Similarly, amino acids are crucial in the formation of binding pockets for interactions 





Figure 5.8 Codon enrichment scores of amino acid substitutions at different sites (A) 
Overview of the 20 different amino acids and their properties. Each amino acid has specific 
characteristics defining its role in protein structure. The thiol side chain of cysteine is 
susceptible to oxidation resulting in the disulphide derivative cysteine (“S-S Cysteine”), which 
serves an important role in many proteins. Therefore, both forms of cysteine are depicted. 
These characteristics aid in understanding why some amino acid substitutions have a larger 
effect on protein stability and function than others. Figure adapted from (Livingstone and 
Barton, 1993). (B) Enrichment of non-consensus amino acids at residue 35 across bins. Amino 
acids with hydrophobic properties (highlighted in yellow) and asparagine (N) are mostly 
enriched in populations P2-P4 indicating that they do not affect b-catenin activity. Amino 
acid substitutions with hydrophilic properties proline (P) are underrepresented in 
populations P2-P4 but enriched in P5-P7, indicating that these substitutions may interfere 
with the turnover of b-catenin. Alanine (A) and glycine (G) are hydrophobic but show a 




figure A). (C) Enrichment of non-consensus amino acid substitutions at residue 36 across the 
bins. Most amino acid substitutions show an enrichment in the lower fluorescence bins, 
indicating a neutral effect o b-catenin signalling, which supports earlier studies describing 
that this residue does not interact with b-TrCP upon binding. Lysine (K) and proline (P) show 
some enrichment in higher populations indicating that these amino acids (partially) increase 
b-catenin signalling.  
 
Figure 5.8), certain substitutions are more likely than others to conserve protein stability and 
function. β-TrCP binds a motif with a hydrophobic residue at its core, in the case of b-catenin 
at residue I35 (Wu et al., 2003). In order to test the hypothesis that hydrophobic substitutions 
are better tolerated than hydrophilic substitutions, the relative frequency of each 
substitution in each bin compared to the frequency in the pool was calculated. 
 
Analysis of all substitutions at position I35 across all bins revealed that hydrophobic amino 
acid substitutions are consistently depleted at position I35 in bins P5-P7, whereas proline and 
polar amino acids are enriched in these bins with higher b-catenin activity (see Figure 5.8B). 
Alanine (A) and glycine (G) are hydrophobic but show a positive effect on b-catenin signalling 
at residue 35, which could be explained by their small side chain not being able to make Van 
der Waals interactions. Amino acid replacements at the variable position H36 (see Figure 
5.8C), with the exception of proline, do not affect β-catenin signalling. The behaviour of 
substitutions at these sites in our dataset therefore confirms and extends previously 
published work on β-TrCP (Wu et al., 2003) and suggests that our dataset provides sufficient 
power to assess the effect of individual amino acid substitutions.  
 
5.2.12. Serine and threonine are interchangeable at the phosphorylation sites of b-
catenin  
As CKI and GSK-3β can phosphorylate proteins at both serine and threonine residues (in the 
case of GSK-3β only adjacent to a phosphorylated serine or threonine four residues towards 
the C-terminus) (Cohen, 1986; Tuazon, 1991; Fish et al., 1995), it was hypothesised that these 
two amino acids should be interchangeable without affecting the activity of the TCF-LEF:H2B-
GFP reporter (see Figure 5.9A). The frequency of serine/threonine substitutions at the 
phosphorylation sites are generally depleted in the bins with higher activity, indicating that 
these mutations do not enhance β-catenin signalling. S33T and S37T show highest activity in 




addition, these mutations show an elevated occurrence in P7 whilst depleted in P6. We do 
not have an immediate explanation for this unexpected occurrence and hypothesise that the 
hike in P7 could be due to fluctuations as a result of the low number of cells that was sampled 
from this bin (table 5.1). Despite this caveat, the data nonetheless suggests that 
serine/threonine substitutions at the phosphorylation sites do not disrupt CTNNB1-mediated 
signalling, presumably because the ability of CKI or GSK-3b to add a phosphate group to these 
sites is preserved.  
 
5.2.13. The behaviour of phosphomimetics is context dependent  
Some amino acids show chemical resemblance to a phosphorylated serine or threonine and 
replacement of a phosphorylation site with such a phosphomimetic is thought to mimic a 
constitutively phosphorylated residue. Aspartic acid (D) and glutamic acid (E) are the best 
known phosphomimetics for both serine and threonine residues (Hiscott et al., 1999; Konson 
et al., 2010) and would, in the case of b-catenin, theoretically lead to a continuous turnover 
of the protein and subsequent low steady-state GFP levels. Our dataset provides an 
opportunity to determine how effectively these phosphomimetic substitutions operate and 
to test their relative efficacy at different positions in a single phosphodegron motif. 
 
Our data show that aspartic acid (D) leads to an elevated (or in the case of S45D a partially 
elevated) transcriptional activity at all four phosphorylation sites (see Figure 5.9B,C). This is 
inconsistent with phosphomimetic function. Glutamic acid at site S33 is most abundant in 
the bins of lower activity (P2-P4) suggesting that it mimics a phosphorylated serine at this 
site. As this trend is not seen at the other three phosphorylation sites, it shows that the 
behaviour of phosphomimetic substitutions is context dependent.  
 
5.2.14. Mutational effect scores: Single metrics for effects of substitutions on b-catenin 
activity 
Whilst the relative abundances of codon sequences across each of the six bins allow for an 
initial assessment of effect size for a small number of mutations on b-catenin activity, six 
separate values per substitution hampered any systematic comparisons of phenotypic 
effects between different codon sequences. It was therefore examined whether a single 





Figure 5.9 Behaviour of serine, threonine and phosphomimetics across phosphorylation 
sites (A) Reciprocal replacement of serine and threonine at phosphorylation sites shows a 
steady decline towards bins with higher GFP fluorescence, indicating that these changes do 
not affect the phosphorylation of b-catenin. P7 shows an interruption of this trend for S33T 
and S37T. (B) Behaviour of phosphomimetic aspartic acid (D) at phosphorylation sites. The 
enrichment of these frequencies in the higher populations indicates that aspartic acid does 




at phosphorylation sites. Glutamic acid enhances b-catenin activity at sites S37, T41 and S45 
but not at S33E, suggesting that the behaviour of this amino acid as a phosphomimetic is 
context dependent.  
 
or depletion across all six sorted bins relative to the unsorted pool. To achieve this, a 
previously published equation that calculates mutational effect scores from codon 
frequencies in each FACS-purified bin based on GFP fluorescence levels was adapted (Kosuri 
et al., 2013). 
 
To estimate mutational effect scores, we first calculated, for each codon i and each bin j, the 
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,                                                              (5.2) 
 
where fi is the fraction of cells harboured in each bin and cij is the number of amino acids i in 
each bin j. For a given substitution, ∑jaij = 1 (i.e. each codon has one aij per bin, and these six 
values together add up to 1).  
 
 
The final mutational effect score, Ei, was calculated as: 
 




A heatmap based on mutational effect scores provides a straightforward way to visualise 
which residues are most sensitive to perturbations (see Figure 5.10A). Reassuringly, this 
highlights the phosphorylation sites (S33, S37, T41 and S45) and residues comprising the b-
TrCP binding motif (D32, G34, I35 and, to a lesser extent, H36). The mutational effect score 
hence provides a reliable metric with which to compare the relative effect of each amino acid 






A histogram was plotted to show the distribution of all calculated effect scores, which 
revealed a bimodal spread across the sampled codon substitutions (see Figure 5.10B). In 
order to classify the different amino acid substitutions based on their effect score, the scores 
were divided into two categories based on where the slope of the curve approximated 1 (see 
Figure 5.10B, by eye), binning the majority of the mutations to not have an effect on b-
catenin activity (212; 62%), whereas approximately a third enhanced signalling activity (130; 
38%) (see Figure 5.10C). 
 
5.2.15. Different mutations in CTNNB1 are found in specific cancer types 
Previous studies have suggested that cancers arising from distinct tissues have mutations at 
specific residues in the CTNNB1 N-terminus (Polakis, 2000; Albuquerque et al., 2011), while 
even different subtypes of liver cancer were previously shown to harbour distinct amino acid 
substitutions (Austinat et al., 2008; Rebouissou et al., 2016). To ascertain the extent of 
differences between tumour types, all tumours with mutations in codons 31-48 of CTNNB1 
were identified across 9 different cancer types from the Catalogue of Somatic Mutation in 
Cancer (COSMIC) (Forbes et al., 2018) (see Figure 5.11A). COSMIC was the largest database 
for missense mutations in cancer at the time of writing.  
 
Plotting the fraction of tumours with a mutation at each position, broken down by tissue-of-
origin, supports the hypothesis that different tumour types preferentially harbour CTNNB1 
mutations at different N-terminal residues. For instance, whereas cancers from adrenal gland 
(in adrenal gland vs. other, Pearson’s Chi-squared p = 1.41 x 10-12), kidney (p = 2.2 x 10-14) and 
skin (p = 0.0201) predominantly harbour mutations in S45, mutations in soft tissue cancers 
are predominantly found in T41 (p = 2.2 x 10-16).  
 
Endometrial and liver cancer contrastingly show a much wider distribution of mutated 
residues. When focussing on the most frequently mutated residue across all cancers, S45, 
variance between cancer types is less apparent with the majority of cancer types 
predominantly harbouring a phenylalanine (see Figure 5.11B). However, it is notable that 
although many cancers harbour a tyrosine at residue 45, this is completely absent in soft 






Figure 5.10  Mutational effect score per amino acid substitution (A) Heat map of mutational 
effect score per amino acid substitution. Amino acid substitutions at residues 32D, 33S, G34, 
S37, T41 and S45 show the highest effect on enhancing b-catenin activity. Scale runs from 
blue indicating the lowest (445), to white indicating median (2500) to red indicating the 
highest (9647) score. (B) Histogram of frequencies of mutational effect scores in bins with a 
size of 100. Most amino acid substitutions have a mutational effect score < 1000, indicating 
no positive effect on b-catenin signalling. (C) Bar plot of mutational effects scores sorted from 
high to low. Mutations are categorised based on their scores into no effect (N=212) and 







Figure 5.11  Frequency of residues and mutations in CTNNB1 found across cancers (A) 
Distributions of mutated residues across 9 cancer types show that different cancer types 
harbour mutations in specific residues. Cancers from adrenal gland, kidney and skin tissues 
predominantly harbour mutations in S45 (light blue), while mutations in soft tissue cancers 
are predominantly found in S37 (green). Endometrial and liver cancers show a much wider 
distribution of mutations, with S45 mutations completely absent in the former. Sample sizes 
are denoted at the top of each distribution, whereas the legend on the right indicates the 
colour indexes. (B) Distributions of amino acids found at residue 45 across the same cancer 
types as in A show that variance between cancer types is less apparent and most cancer types 
most often harbour a phenylalanine (F, orange) followed by proline (P, green). However, 




type, this amino acid is completely absent in soft tissues despite the relatively high number 
of samples (N=135). 
 
confirm that different tumour types preferentially harbour different amino acid substitutions 
within the CTNNB1 N-terminal region. 
 
The observed difference in mutated residues between cancer types could theoretically result 
from either tissue-specific dissimilarities in selection, i.e. selection for effects on Wnt 
signalling that are optimal for tumorigenesis in that tissue, or tissue-specific differences in 
mutational signatures that cause particular amino acid substitutions to arise more frequently 
in certain tissue contexts. The extent to which these two influences contribute to the overall 
pattern of mutation is not clear. Given that the mutational effect scores provide a metric of 
Wnt signalling strength, it was assessed whether predominant mutations in each tumour 
type were characterised by different mutational effects.  
 
To assess whether different tumours preferentially harboured mutations of particular effect 
size, I next plotted the distribution of mutational effect scores extended to all 31 tissues in 
which at least one mutation in residues 31 – 48 was found (see Figure 5.12). Whereas the 
distribution of all possible amino acid substitutions (left column) shows that most mutations 
do not affect b-catenin activity (average mutational effect score of 2730; see Figure 5.12, 
most left column), tumour samples show a clear enrichment for high mutational effect 
scores. This suggests that cancers preferably contain mutations that enhance Wnt/b-catenin 
signalling.  
 
Next, inter-tumour differences in b-catenin activity were ascertained. Whereas tumours in 
the central nervous system (CNS) and endometrium predominantly carry mutations with 
very high effect score (averages of respectively 7407 and 7436), other tissues such as large 
intestine (5359), liver (6679) and soft tissue (6921) harbour mutations with high effects on 
b-catenin activity, whereas stomach (1212) and kidney (4857) tumours show no high 
activity mutations, although these could be explained by their small sample sizes and that 
these tumours are not driven by these mutations. Statistical analyses furthermore show 
that some tumours with larger sample sizes such as pituitary gland and soft tissue are 
significantly different (average mutational effects of 7387 and 6921, unpaired t-test with 




Table 5-3), suggesting that different tumour types harbour mutations with different levels of 
activity.  
 
5.2.16. Coupling mutational effect scores and mutational probability of amino acid 
substitutions  
The mutational effect scores provide a quantitative measure for the effect an amino acid 
substitution in CTNNB1 has on TCF-LEF signalling in ESCs. While acknowledging that the same 
mutation could conceivably influence the reporter in a distinct way in a different cell type, 
these experiments are done under the assumption that it can be used as a proxy to infer the 
functional effect (i.e. what is being “selected” for) in tumours. In the context of 
tumorigenesis, the availability of amino acid changes for selection depends upon the 
probability of such amino acid changes arising through nucleotide changes. With this in mind, 
we wanted to determine the extent to which the different patterns of amino acid 
substitutions observed in different tumour types, could be attributed to different mutational 
processes influencing the likelihood these mutations to arise. Therefore, the probability of 
each amino acid substitution to arise in tumours that specifically harboured a mutation in 
CTNNB1 was calculated. 
 
To assign a value to the probability for a given amino acid substitution to occur at each 
residue, I first assessed the nucleotide changes necessary to achieve an amino acid at a given 
position. Whilst the amino acid sequence for the targeted region is fully conserved between 
human and mouse, synonymous substitutions mean that their codon sequences differ at 6 
out of 54 nucleotides. As the clinical data is available for human, the human coding sequence 
was used as the reference sequence. 
 
As discussed in the introduction (section 5.1.5) it is well established that mutational 
signatures differ between tissues (Alexandrov and Stratton, 2014), meaning that different 
nucleotide changes are likely to occur at different rates between tumour types. In order to 
account for this mutational bias, publicly available data from primary tumours harbouring 
mutations in CTNNB1 was used to derive these values using the trinucleotide context 






Figure 5.12 Distribution of mutational effects as a result of amino acid substitutions across 
different cancers Plots were depicted for all cancers types from which primary tumour data 
was available in COSMIC. A distribution of mutational effect scores of all possible amino acid 
substitutions (‘All’, left-most plot) shows that most mutations do not have a positive effect 
on b-catenin signalling. Distributions of mutational effect scores across tumour types show 
that tumours most frequently harbour mutations with a high mutational effect score, but 
that different tumours harbour different missense mutations resulting in specific levels of 
signalling. Mutations found in central nervous system (CNS) and endometrium are associated 
with high mutational effect scores, whereas soft tissue cancers harbour mutations with 





Table 5-3 Differences between average mutational effect scores in cancer types 
Significance levels are shown for those samples between which the mutational effect scores 
were significant and sorted by the p-value (unpaired t-test), which was Bonferroni-corrected. 
Levels of significance are indicated by * (0.05), ** (0.01) and *** (0.001). Mean and sample 
size (N) are indicated for sample 1 (1) and sample 2 (2). 
 
A given amino acid may be encoded by up to six different triplets, which each differ at up to 
three nucleotides from the reference codon, maximising the number of combinations of 
nucleotide changes per amino acid substitution to 36 (i.e. (3 * 2 * 1 = ) 6 paths for 6 codons, 
Sample 1 Sample 2 P-value (Bonferroni) 
Mean 
(1) N (1) 
Mean 
(2) N (2) 
Stomach Endometrium 1.88E-12 *** 1213 159 7437 384 
Stomach CNS 4.38E-12 *** 1213 159 7407 252 
Pituitary Kidney 5.74E-12 *** 7387 99 4857 140 
Liver Stomach 3.41E-11 *** 6679 1026 1213 159 
Stomach Pituitary 5.49E-10 *** 1213 159 7387 99 
CNS Kidney 5.89E-10 *** 7407 252 4857 140 
Stomach Ovary 6.39E-10 *** 1213 159 7524 138 
Stomach Soft tissue 2.94E-09 *** 1213 159 6921 1408 
Pituitary Adrenal gland 3.76E-09 *** 7387 99 5467 178 
Stomach Adrenal gland 6.15E-09 *** 1213 159 5467 178 
Soft tissue Kidney 7.26E-09 *** 6921 1408 4857 140 
Stomach Skin 2.01E-08 *** 1213 159 6055 133 
Stomach Lung 6.76E-08 *** 1213 159 6813 47 
Stomach Kidney 1.94E-07 *** 1213 159 4857 140 
Large intestine Stomach 2.89E-07 *** 5359 165 1213 159 
CNS Adrenal gland 8.25E-07 *** 7407 252 5467 178 
Stomach Pancreas 1.53E-06 *** 1213 159 6458 133 
Liver Kidney 2.06E-05 *** 6679 1026 4857 140 
Pituitary Soft tissue 3.26E-05 *** 7387 99 6921 1408 
Endometrium Kidney 3.58E-05 *** 7437 384 4857 140 
Ovary Kidney 1.19E-04 ** 7524 138 4857 140 
Adrenal gland Endometrium 3.24E-03 ** 5467 178 7437 384 
Adrenal gland Ovary 3.65E-03 ** 5467 178 7524 130 
Large intestine Pituitary 6.94E-03 ** 5359 165 7387 99 
Large intestine CNS 1.19E-02 * 5359 165 7407 252 
Liver Adrenal gland 1.97E-02 * 6679 1026 5467 178 
CNS Soft tissue 0.019744 * 7407 252 6921 1408 




see Figure 5.13A-C). In some cases, multiple nucleotide changes are required to yield a single 
codon change paths or multiple codon changes can lead to the same amino acid change. 
Double and triple nucleotide polymorphisms can theoretically arise from independent 
sequential lesions or from a single event resulting in the change of multiple nucleotides and 
may hence be more complex than the sum of individual mutations (Rosenfeld, Malhotra and 
Lencz, 2010). However, as we had no insight into the extent to which nucleotide substitutions 
co-occur, it is assumed that all codon changes are the result of independent successive single 
nucleotide changes. This resulted in an overview (see Table s5.1, available via https://uoe-
my.sharepoint.com/:x:/g/personal/s1478317_ed_ac_uk/EWFH4G4WPDlDnhqppDlPh0IBQE
BGtFKnXVwm4Rebs70W6Q?e=Sg570S) of all the possible codon replacement ‘paths’ and 
their respective single nucleotide substitution ‘steps’ in their trinucleotide context for each 
analysed codon in CTNNB1.  
 
Ailith Ewing extracted whole exome-based somatic mutation data from The Cancer Genome 
Atlas (TCGA) Research Network (https://cancergenome.nih.gov/, 01-02-2018) from the two 
largest databases that harboured mutations in CTNNB1, i.e. liver hepatocellular carcinoma 
(TCGA-LIHC, N = 74 tumour exomes) and uterine corpus endometrioid carcinoma (TCGA-
UCEC, N = 103 tumour exomes). From this data, Ailith calculated the observed frequency for 
all 64 possible nucleotide changes (relative to the human reference genome sequence) in 
their trinucleotide context as described in detail in Material & Methods.  
 
As mentioned, I denoted each single nucleotide change (step) in its trinucleotide context, i.e. 
in the context of the nucleotides present at its 3’ and 5’ end (see Figure 5.13A-C). Knowing 
the possible paths to each codon change, the calculated background probabilities for each 
step within a path were then multiplied together to ascertain the probability of a certain 
codon substitution. After calculating probability values (P) for each individual path, the 
probabilities of all individual paths were combined to calculate the overall probability of an 
amino acid substitution to occur, which would require at least one of the n paths to that 
amino acid to occur (see Figure 5.13D). The probability of at least one of the paths to occur 
and the probability of none of the paths to occur should sum up to 1,  
 







Figure 5.13 Calculating mutational signatures and amino acid substitution rates in tumours 
harbouring a CTNNB1 mutation All possible paths of single nucleotide substitutions to 
achieve each possible alternative codon were determined as exemplified in this panel. In the 
figures, G[A>C]A indicates an A substituted by a C in a GAA trinucleotide context. (A) In some 
cases, an alternative codon (in this case GCA) differs only by a single nucleotide from the 
reference (GAA) and can hence by achieved by only a single path of a single nucleotide 
change (step; in this case G[A>C]A). (B) Other codons may differ from the reference by two 
nucleotide changes (CCA), which can be achieved by two paths, which each consists of two 
steps. (C) Finally, a codon may differ at all three nucleotides from the reference requiring 
three individual amino acid substitutions and can be achieved by six possible routes. (D) The 
probability of a path to occur is calculated by multiplying the probabilities of each mutation 
in that path. To combine all possible paths to arrive at a single likelihood score per codon 




substitution to arise) as depicted in figure 5D. Here, three possible paths with exemplary 
probabilities of 0.01, 0.02 and 0.03 would together lead to an eventual probability of 0.059. 
As several amino acids are encoded by different codons, probabilities of the individual 
codons were combined by a similar rationale as in this figure.   
 
, which means that the probability of any one of the paths to occur equals to: 
 
:;<	=>;?<	@A>	B;<C	@DDE##"AF = 1 −	:A@A>	@H	<C>	B;<C?	@DDE##"AF  
 
The probability of none of the paths occurring equals to the product of the probabilities of n 
paths to not occur, i.e.: 
 
													:;<	=>;?<	@A>	@H	<C>	B;<C?	@DDE##"AF = 1 − (K1 − :B;<CLM × …K1 −	:B;<C	AM) 
 
Using this equation, the probability of each codon change was determined (as exemplified in 
Figure 5.13D) occurring in respectively liver and endometrial tumours using clinical data. As 
multiple codon changes could lead to the same amino acid change, the probabilities of 
different codon changes were combined in exactly the same manner as the paths (see Figure 
5.13D) to yield the probability of an amino acid change.  
 
These calculations were performed for each possible amino acid substitution at each of the 
18 target residues, resulting in 342 probability scores for respectively endometrial and 
hepatocellular carcinoma harbouring a mutation in CTNNB1. The probability scores for both 
cancer types poorly correlate (R2 = 0.243), demonstrating that there are substantial 
differences in mutational likelihood between tumour types. 
 
5.2.17. Mutations found in cancers not consistently explained by probability and b-
catenin activity  
The combination of mutational effect scores and amino acid probabilities then allowed us to 
determine the extent to which either of these factors explain the amino acid changes seen 
in cancers. To visualise their particular weights, I extracted amino acid substitution 
frequencies from the same tumour databases from which the probabilities were calculated 







All amino acid changes observed in both liver and endometrial tumours are those that have 
a high likelihood of occurrence based on background substitution rates, and an intermediate 
to large effect on b-catenin signalling. No mutations are found that have a low mutational 
effect score (<0.23, see Figure 5.10), despite this group comprising the majority of possible 
substitutions. Similarly, no mutations are observed with a very low probability (i.e. < 3 x 10-
4). These results indicate that neither the background mutation rate or selectional drive alone 
accounts for the observed pattern of mutations in CTNNB1, which is also supported by the 
similar distributions in mutational scores and likelihood in Figure 5.15.  
 
Several residues are however not consistent with this trend. Substitutions including H36P 
(N=5) and S45P (N=11), which have a high likelihood of occurrence in both tumour types, are 
observed in liver hepatocellular carcinoma, yet are absent in the analysed endometrioid 
carcinomas (Fisher’s exact test, for H36P and S45P respectively p = 0.0118 and p = < 0.0001), 
raising the possibility that these mutations could favour clonal outgrowth in the liver but not 
in the endometrium. Several incidences of S45P in endometrioid carcinomas in the larger 
COSMIC database were observed (see Figure 5.11 and Figure 5.12). As the mutational effect 
score distributions were furthermore broadly similar between both the endometrial cohorts 
(7749 ± 304 (N = 103) vs. 7385 ± 228 (N = 487)) and liver cohorts (6790 ± 779 (N = 79) vs. 
6682 ± 354 (N = 1105)), sample data from clinal samples from COSMIC was included, under 
the assumption that the likelihood scores calculated with the smaller sample sizes can be 
extrapolated to other tumours from the same type (see Figure 5.16).  
 
The larger datasets show that virtually all mutations that have a large mutational effect and 
high likelihood are found in both endometrial and liver cancer. Several mutations at residue 
G34, an essential residue in the b-TrCP binding motif, (e.g. G34I, G34S, G34K, G34D) are 
contrastingly absent in both databases whilst falling in the same range as many other 
mutations that are occurring in endometrial cancer. H36P, which is relatively frequent in 
hepatocellular carcinoma (43/1105) despite a modest effect score (3120), was completely 
absent from endometrial cancer (0/487, Fisher’s exact p = < 0.00001). This is consistent with 
the broader range of effect scores for mutations found in hepatocellular carcinoma 
compared to endometrium. We speculate that H36P may not be sufficiently potent to drive 




in mESCs (Figure 5.10) does not accurately reflect the effect size in both endometrial cells 
and hepatocytes.  
 
Three mutations with intermediate effect scores, H36P, S45P and T41A, were highly enriched 
in liver over endometrial tumour samples (chi-squared p = 1.87 x 10-9, 1.44 x 10-14 and 1.64 x 
10-7), whilst S37F and S37C, both with mutational effect scores above 8500, were more highly 
enriched in endometrial cancer (p = 1.18 x 10-11 and 1.13 x 10-7, i.e. higher in endometrium). 
Supporting these findings, four additional mutations with mutational effect scores below 
7000 were statistically enriched in liver (I35S, S45F, G34V, S45A) and three others with 
mutational effect scores > 0.68 were enriched in endometrium over liver (T41I, G34E, S33F) 
This demonstrates that different cancer types harbour different mutations that are largely 
driven by mutational effect score and not by mutational likelihood. 
 
Notably, the larger sample sizes reveal many mutations with low mutational effect but high 
likelihood of occurrence (i.e. bottom right of the plot) occurring at a low frequency (see 
Figure 5.16). The mutational pattern indeed proved to be the result of both of these factors 
(multiple linear regression, p-value: < 3.5 x 10-21 and 7.9 x 10-16 for liver and endometrium, 
respectively). However, neither likelihood or mutational effect alone can account for the 
mutational pattern in liver (Kruskal-Wallis p = 0.5914 and p = 0.253, respectively) and 
endometrial cancer (Kruskal-Wallis p = 0.5440 and p = 0.253, respectively) cancer and are 
both not different between liver and endometrial tumours (Figure 5.15). This hence provides 
comprehensive evidence for the theory that patterns of mutations found in tumours arise 
from natural selection acting on the available genetic variation. In addition, the data more 






Figure 5.14 Frequency of amino acid substitutions as a result of their probability and 
mutational effect score in endometrial and hepatocellular carcinoma Amino acid 
substitutions were plotted as a result of their probability (calculated from whole exome 
sequencing data) and their mutational effect scores (determined from our assay) for 
endometrial carcinoma (A) and hepatocellular carcinoma (B). The frequency of amino acid 
substitutions in tumours is indicated by the size of the circle, as a proportion of the total 
frequency of missense mutations found in that database (endometrial carcinoma N=103, 
hepatocellular carcinoma N=74), with the largest circle in each plot represents 11 tumours 




tumour types have high probabilities and medium to high mutational effect scores. As was 
shown in figure 5.10, endometrial tumours show a higher average mutational score whereas 
liver tumours show a spread of tumours. Some substitutions with a high probability and high 
mutational effect score, e.g. S36Y, G34I and S45P, are not found in endometrial cancer but 
are frequently observed in hepatocellular tumours. Vice versa, S37P and D32A are solely                                                                                                                                                                                                                                                                                       
observed in endometrial cancer based on these two databases.  
 
 
Figure 5.15 Distribution of mutational effect scores and mutational likelihood across 
endometrium and liver cancer Using the same samples as used in 5.14, distribution plots 
show similar distributions across both cancers types (left) and mutational likelihood (right) 
(NS = not significant). Differences in mutational effect score and mutational likelihood 






Figure 5.16 Frequency of amino acid substitutions as a result of their probability and 
mutational effect score in endometrial and hepatocellular carcinoma, including COSMIC 
Similar to plot 5.14, amino acid substitutions were plotted as a result of their probability 
(calculated from a subset of samples and their mutational effect scores for endometrial 
carcinoma (A) and hepatocellular carcinoma (B). The frequency of amino acid substitutions 
in tumours is indicated by the size of the circle, as a proportion of the total frequency of 
missense mutations found in that database (endometrial carcinoma N=487, hepatocellular 
carcinoma N=1105), with the largest circle in each plot represents 149 tumours in liver (T41A) 




not change the distribution, whilst revealing some mutations with a low mutational effect 
but high likelihood, suggesting that the mutational likelihood has a larger influence on the 
eventual mutational pattern than the mutational effect. 
 
5.3. Discussion 
In this chapter, I analysed experimental data from work performed in the Hohenstein lab and 
assessed whether amino acid substitutions can be introduced into CTNNB1 and their effects 
on b-catenin signalling could be functionally assessed. Initially, I have shown that all possible 
amino acid substitutions can be efficiently integrated over a range of 18 different codons. 
Secondly, I have shown the high reproducibility between biological replicates and the 
combined bins and pool demonstrated the robustness of the editing procedures conducted 
by the Hohenstein lab (section 5.2.8). I demonstrate that a single mutational effect score can 
be derived per amino acid substitution and assess the phenotypic consequences of all 
possible amino acid substitution at a given site (section 5.2.14). The probability of an amino 
acid substitution occurring in different tumour types was calculated and combined this with 
the mutational effect score to show that both of these factors are required to explain 
mutational patterns observed in different tumours (section 5.2.16). This study demonstrates 
that deep mutational scanning can be applied to study the effects of amino acid changes in 
disease genes in their endogenous genomic context.  
 
5.3.1. Genomic variants are efficiently integrated from plasmid into genome 
While codon variants at 2 out of 20 residues (K49 and G50) were shown to be 
underrepresented in both the plasmid and genomic samples (section 5.2.7), our data 
confirmed that all variants at the other sites found in the plasmid are present at 
approximately equal proportions in the genomic pool, indicating that variants were 
incorporated from HDR repair templates in an unbiased manner. The reconstruction of the 
pool from the individual samples and the high correlation with the unsorted pool additionally 
shows that heterogeneity is not lost by binning the samples (section 5.2.8). 
 
Equal representation of codons in the plasmid and unselected cell pool furthermore implies 
that there is no competitive selection for genomic variants during the culture period. By 
culturing cells in the presence of GSK-3b inhibitor until two days prior to analysis by flow 




in clonal expansion while it allows for b-catenin levels to stabilise and alter GFP expression 
accordingly.  
 
5.3.2. Separating cells into multiple bins allows for better assessment of mutational 
consequences 
In the behaviour of codons across the bins, P7 frequently exhibited outliers. In addition, this 
bin showed the lowest correlation between the biological replicates (R2 = 0.653, section 
5.2.8). Since the sequencing depth in each sample is consistently exceeding a 1000X for each 
codon, the sequencing should not introduce any bottleneck that could explain these 
discrepancies. With P7 having the lowest number of sorted cells (respectively 4,075 and 
4,234, see Table 5-1), on average a maximum of 10 cells were sampled per amino acid 
substitution. This is however under the assumption that all cells are represented in the final 
sequencing data, not considering loss of cells or DNA during the processing steps. Therefore, 
this likely explains the variability between the replicates and would hence suggest that these 
proportions are not truly representative of the activity in that bin. However, as the fraction 
of cells binning in P7 is small (0.1% of the total cells is sorted into this bin), its contribution to 
the eventual mutational effect scores is insubstantial and fluctuations in this bin are largely 
obscured by the 99.9% of cells in other bins. Together with the correlation still being high, 
including of this bin was therefore justified.  
 
5.3.3. Perturbations of phospho-residues are context dependent 
We have shown that serine and threonine are interchangeable at phosphorylation sites 
(section 5.2.12), which is supported by our understanding that CKI and GSK-3b can 
phosphorylate both amino acids. The data moreover demonstrates that phosphomimetics 
do not behave consistently across all four phosphorylation sites (section 5.2.13). Whereas 
S45D is the main phosphomimetic used in literature, being minimally effective in 
phosphomimicking (Nejak-Bowen et al., 2010) and one papers used S33/S37/T41E triple 
substitutions to mimic phosphorylation (Huang, Senga and Hamaguchi, 2007), the majority 
of these mutations have not been used in isolation. Whereas substitutions with aspartic or 
glutamic acid impede turnover of b-catenin in all other cases, S33E mutants retain a low 






GSK-3b phosphorylates serines or threonines four residues in the N-terminal direction of 
another phosphorylated serine or threonine (Cohen, 1986; Tuazon, 1991; Fish et al., 1995). 
As all phosphomimetics at sites S37, S41 and S45 enhance activity of b-catenin, this suggests 
that GSK-3b is not able to dock on an aspartic or glutamic acid as it would on a 
phosphorylated serine or threonine. This has not been described before and further supports 
our understanding of the behaviour of this central kinase.  
 
b-TrCP establishes identical hydrogen bonds with pS33 and pS37 upon binding b-catenin (Wu 
et al., 2003). The data presented in this chapter suggests that these bonds can still be formed 
with glutamic acid (S33E), as it retains fairly low levels of TCF/LEF signalling, but not with 
aspartic acid (S33D) (section 5.2.13, figure 5.9). S37E does not follow this trend, but this may 
be due to its inference with the phosphorylation of S33 through the GSK3-3b cascade, 
whereas the reciprocal is not likely as explained in the previous paragraph. Under this 
assumption, a double mutant of S33E/S37E should however be turned over, as these residues 
can both be recognised as phosphorylated residues by b-TrCP. Additional experiments such 
as protein complex immunoprecipitation (Co-IP) for b-TrCP and mutant b-catenin proteins 
would be required to confirm these findings.  
 
As aspartic acid and glutamic acid substitutions at any of the phospho-sites require a 
minimum of respectively two and three nucleotide changes, this, together with the fact that 
all of them requiring at least two nucleotide substitutions (Table s5.1), explains why these 
mutations are not found in tumour databases (COSMIC or TCGA) despite their positive effect 
on b-catenin activity.  
 
5.3.4. Mutational effect score combines multi-dimensional data into a single value 
I have shown that a single mutational effect score can be assigned to each amino acid 
substitution, which incorporates the proportions across all six bins and the pool and the 
relative sizes and fluorescence values of each bin (section 5.2.14). As both a higher number 
of bins and a higher number of HDR reads were obtained, the scores are much more sensitive 





The mutational effect score represents the effect of each amino acid substitution on the 
transcriptional activity of b-catenin. Previous studies have shown that missense substitutions 
in CTNNB1 have a range of effects on b-catenin activity in vitro, but only assessed a small 
number of mutations. This is the first systematic and quantitative interrogation of the 
phenotypic consequences of each possible substitution in this N-terminal region of CTNNB1. 
 
The sensitivity of the scoring system cannot be benchmarked with the data currently 
available. Can anything for example be inferred about the differences between S33H (scoring 
7827) and S33P (scoring 6817)? Future experimental work using clonal cell lines should 
therefore independently evaluate the activity of individual mutations in order to validate 
these findings and establish the sensitivity of the proposed system. Determining b-catenin 
protein concentrations in these clonal cell lines should furthermore confirm the hypothesis 
that mutations directly affect the turnover of this protein. 
 
5.3.5. Mutational effect scores should be benchmarked by in vitro studies  
The mutational effect scores provide a framework that can improve our understanding of the 
phenotypic consequences of mutations observed in CTNNB1 in cancers. However, this 
assumes that mouse ESCs harbouring TCF/LEF::H2B-GFP are a suitable model system to infer 
phenotypes in other cell type and tissues. Firstly, while there could be intrinsic differences 
between the activity of b-catenin in mouse and human, the targeted amino acid residues are 
fully conserved between human and mouse and Wnt/b-catenin signalling itself is thought to 
be highly conserved between the two species (Sato et al., 2004). It was therefore assumed 
that these findings could be extrapolated to the activity in human.  
 
Secondly, whilst ESCs make a good system for the proposed deep mutational scanning 
approach due to their high HDR efficiencies and the ability to conditionally inhibit GSK3b 
signalling to mask the effects, our limited understanding of the differences in b-catenin 
signalling between tissues could obscure predictions on the behaviour of amino acid 
substitutions in specific cancers. Future work should therefore evaluate the activity of amino 
acid changes in different cell types, for example by differentiating earlier mentioned clonal 
cell lines harbouring amino acid substitutions into different lineages. This would be of 




such as H36P and S45P (see Figure 5.14 and Figure 5.16). This should elucidate the extent 
to which the mutational effect scores can be extrapolated to infer anything about b-catenin 
signalling in other cell types.  
 
The distribution of activity scores across all possible amino acid substitutions indicates that 
most mutations do not activate b-catenin signalling. Many of these mutations could disturb 
protein stability altogether, thereby completely stalling b-catenin protein accumulation and 
signalling. It is worthy to note that, taking this in consideration, all of the amino acid 
substitutions at the phosphorylation sites or b-TrCP binding motif are found in the higher 
GFP-expressing populations and these mutations thus cannot destabilise the protein. This is 
possibly because these residues have exposed side chains necessary for binding to one of the 
cofactors, reducing the effect of a substitution at these residues on protein stability. 
 
5.3.6. Mutational effect scores in comparison to previous studies  
When comparing the findings from this study to previous studies on quantifying the effects 
of specific mutations in CTNNB1, several parallels can be drawn. A study investigating 
CTNNB1 mutational patterns in soft tissue tumours by Lazar et al. found that T41A (59%), 
S45F (33%), and S45P (8%) were the most frequently occurring (Lazar et al., 2008). These 
mutations all have intermediate mutational effects (7611, 5969 and 5176, respectively) and 
corresponds with the histogram for soft tissue in Figure 5.11 and mutational effect scores in 
Figure 5.12. This study found that S45F-mutated desmoids have a significantly poorer 
survival than T41A-mutated tumours (65%), which is inconsistent with the former having a 
higher effect score than the latter (5969 vs. 7611). 
 
A study quantifying the effects of several mutations in a hepatocellular cancer cell line (HuH7) 
on TCF/LEF signalling shows some parallels, P44A (their luciferase score 10 versus a 
mutational effect score 656) S45P (15 vs. 5176) S45F (22 vs. 5969), although they found that 
H36P was the strongest mutation (24 vs. 3120) (Austinat et al., 2008). Hence, the findings in 
the screen presented in this chapter are largely consistent with previous studies, but the 
discrepancies confirm that validation of these findings is essential as this could be a source 





5.3.7. Different cancer types have distinct distributions of mutations  
I have shown that different tumour types statistically harbour different mutations with 
specific levels on TCF/LEF activity (section 5.2.15). This is consistent with the ‘just right’ 
signalling model proposed by Albuquerque et al., which states that cells with too high β-
catenin activity might be prone to trigger apoptosis and are hence not clonally expanded 
inside a tumour.  
 
Alternative to a strong selection for mutations of intermediate effect, as is the case with 




Table 5-3) could indicate that some tumours select for high levels of Wnt/b-catenin activity, 
whereas a broader range of activity levels may confer the same effect on proliferation in 
the context of other tumour types. Whilst various tumours harbour mutations with 




Table 5-3), activity levels of these mutations should be addressed in the relevant tissues to 
confirm the extent to which the findings from ESCs can give meaningful information on other 
tissues.  
 
In addition, findings from Austinat et al. suggest that some mutations (H36P) can enhance 
TCF/LEF signalling whilst leaving glutamine synthetase, another important downstream 
target of b-catenin targeting unchanged (Austinat et al., 2008). When relating the mutational 
effect score from our study to cell fitness one should this be aware that b-catenin signalling 
is more complex than just the TCF/LEF activity.  
 
5.3.8. Mutational patterns in CTNNB1 are explained by both probability and activity  
Using endometrial and liver cancer as case studies (section 5.2.16), it was furthermore 
deduced that neither the likelihood of mutations nor activity score alone can fully explain the 
observed difference in mutational patterns between tumours. By quantifying both factors, it 
was shown that both the likelihood and selective pressure are key for the eventual 
occurrence of missense mutations in tumours. This can be expected, as mutational processes 
lay out the mutational diversity that selection can work on. This is best seen in liver cancer 
(with a large number of samples) where many of the mutations with a high likelihood are 
observed, but mutations with a higher effect are most more frequent. 
 
Liver and endometrial cancer were shown to harbour different mutations that are largely 
driven by mutational effect score and not by mutational likelihood (section 5.2.17), i.e. 
mutations that are enriched in liver cancers compared to endometrial are those with 
intermediate effect scores (e.g. H36P, S45P) whereas endometrial cancer is enriched in 
mutations with a high effect score (e.g. S37F, S37C). No difference was observed in the 
overall distribution in mutational effect score or likelihood between liver and endometrial 




Table 5-3), which I expect to be the result of the limited number of mutations with both a 
high enough selective advantage and high likelihood, such that any advantageous mutation 
might be selected for in either of these tissues regardless of specific effect. As more clinical 
data becomes available, the accuracy of these findings should improve. 
 
Calculating the probability of mutations for other tumours is currently limited by the 
availability of whole genome or exome sequencing (WGS/WES) data for samples containing 
CTNNB1 mutations. Additional samples could be included by adding tumours without 
mutations in CTNNB1, although this could lead to confounding effects if CTNNB1 mutant 
tumours have different background mutation frequencies compared to other histologically 
similar tumours.  
 
Finally, whilst the screen demonstrated in this chapter interrogated the effect of genetic 
variants on TCF/LEF signalling, the same strategy of generating a genetic library of cells could 
be applied to perform a survival screen as depicted in Figure 5.2; comparing the prolific 
advantage with the mutational effect score calculated in this study would reveal the extent 
















The main aim of this thesis was to utilise both CRISPR-Cas9 and multiplex HDR to establish a 
deep-mutational scanning (DMS) pipeline for mammalian genomic loci, and to validate this 
approach by assessing the effects of single nucleotide variants in GFP. We furthermore aimed 
to utilise the developed approach to assess the phenotypic consequences of amino acid 
substitutions in b-catenin. 
 
A wide range of targeted genome diversification tools have been developed to date and allow 
for the interrogation of the phenotypic effects of genomic variants. Base editing tools provide 
a powerful way of introducing precise edits into a targeted window (Hess et al., 2016; Komor 
et al., 2016; Rees et al., 2017), but as the targeting window is narrow and base editing often 
only allows one or two nucleotide positions to be modified per sgRNA, its application for DMS 
remains limited. The most fruitful attempts at DMS using CRISPR-Cas9 have been in the use 
of multiplex HDR (Findlay et al., 2014a; Ma et al., 2017; Kotler et al., 2018; Mason et al., 
2018), whereby a repair template library is introduced to a pool of cells, such that each cell 
integrates a unique variant into the genomic locus of interest. Each of the approaches that 
has been developed to achieve this has its own advantages and limitations, as discussed in 
section 1.7.5. The two strategies for DMS presented in this thesis provide parallel approaches 
that unlock the potential of introducing hundreds of genomic variants simultaneously, either 
on the nucleotide or amino acid level. 
 
This pipeline was used to characterise the effect of nucleotide changes that encode for 28 
amino acid substitutions in GFP, which included a range of neutral, hypomorphic and null 
mutations (see Table 4-9), and furthermore characterised all 19 possible amino acid 
substitutions across 18 residues in a mutational hotspot region in b-catenin (see Figure 5.10). 
The latter scores were used to explain the mutational patterns observed in cancer by 
separating its effects from that of mutational signatures in certain tissues (Figure 5.12 and 
Figure 5.14), thereby providing an innovative approach to acquiring novel insights into 





6.1.1 Bioinformatics pipeline prove effective at filtering and analysing predefined 
outcomes 
In chapter 3, a bioinformatics pipeline was developed and optimised using dummy reads 
representing repair outcomes from the GFP experiment. It was subsequently used to filter 
and analyse experimental datasets from different projects including SRSF1, GFP and b-
catenin.  
 
Analysis of the SRSF1 data (section 3.4) and GFP data (chapter 4) demonstrated that the 
pipeline is able to efficiently merge read pairs into a single contig and filter contigs based on 
a predefined editing outcome (e.g. HDR handles). Through this strategy, reads are typically 
sorted into multiple files (e.g. wildtype-like reads, HDR-like reads and other reads). Whilst 
this approach is well tailored to the needs in these projects, it does not allow for the 
detection of unknown outcomes, e.g. the quantification of specific repair outcomes following 
NHEJ, especially because the merging of read pairs only passes contigs that have the same 
length as the reference (i.e. no indels) and up to 6 nt substitutions. Other pipelines are 
however dedicated to the analysis of such read outcomes (Wang et al., 2017). As many DMS 
methods are based on substitutions rather than indels, the pipeline optimised in chapter 3 
would be applicable  for a wide variety of amplicon-based screens, providing a pipeline with 
low memory usage that can be used without (substantial) prior knowledge of bioinformatics.    
 
6.1.2 Selection strategies allow for increased assessment of HDR-derived variants  
One of the limitations in the nucleotide diversification study on GFP was the low HDR 
efficiency from the ssODN pool. As described in Table 4-1, the maximum HDR efficiency 
obtained was 14%, but these proportions did typically not exceed 4 – 8%. As it was shown 
that the most effective analysis processes reads with a single variant (section 4.2.8), the 
proportion of usable reads is even lower than this. Consequently, the bulk of the sequence 
reads were discarded, thereby greatly decreasing the depth of analysis. 
 
DSB repair from ssODNs is typically thought to yield higher insertion rates compared to 
dsDNA donors, especially for shorter stretches of repair (Miura et al., 2015; Yoshimi et al., 
2016; Ferenczi et al., 2017). During the time that this study was conducted, many solutions 





First of all, various small molecules have been shown to skew the ratio of NHEJ to HR towards 
the latter (Pinder, Salsman and Dellaire, 2015; Vartak and Raghavan, 2015), although these 
are species and cell type dependent and are often optimised on the integration of dsDNA 
(e.g. by enhancing Rad51). Much remains to be elucidated about the exact mechanisms 
through which ssODNs are integrated into the genome. Rather than classical homologous 
recombination (HR), the Fanconi Anemia (FA) pathway and Rad51-independent single-strand 
template repair (SSTR) have recently been suggested to be responsible for the introduction 
of nucleotide substitutions from ssODNs after Cas9 cleavage (Richardson et al., 2018). 
Therefore, chemical enhancers of HDR using ssODN developed in the future could focus on 
factors involved in these pathways. As our understanding of the mechanisms involved in 
repair of Cas9-induced breaks develops, so will the ability to enhance integration (either 
through SSDA or direct integration, discussed in section 1.6 and Kan et al., 2017) of donor 
templates.  
 
Another way to increase the proportion of HDR-derived alleles in the pool is by preventing 
the recleavage of alleles that have already undergone HDR by destroying the protospacer 
and/or PAM. This strategy was performed in the targeting of CTNNB1, whereby the entire 
(puDtk) selection cassette, therewith in addition the targeted protospacers and PAM, was 
replaced by the HDR template (see Figure 5.2). As the protospacer and PAM were absent 
from the dsDNA template, this furthermore prevented cleavage of the donor plasmid. In 
addition, the CTNNB1 targeting project employed an FIAU selection step which removed a 
large fraction of cells that had not undergone HDR. Although it was not possible to ascertain 
HDR efficiency prior to this step, the obtained HDR efficiency of 52.4% in the HRM sample 
indicates that the FIAU step is likely to substantially increase the fraction of useful alleles in 
the PCR template (section 5.2.6). However, a drawback of this approach is that it requires a 
laborious genome engineering step to introduce the selection cassette. 
 
To further enhance the eventual proportion of sequencing reads representing HDR-derived 
alleles, repair from the donor plasmid introduced silent mutations in CTNNB1. This creates a 
PCR priming site to enable selective amplification of HDR-derived template strands (Findlay 




increased eventual mapping efficiencies to the HDR template to >98%. In comparison to the 
maximum yield of 15% with the GFP project described in chapter 4, these results 
demonstrate that HDR efficiencies can be largely increased by preventing recleavage of HDR-
derived alleles, by selection against non-targeted cells and through selective PCR of HDR-
derived reads. 
 
6.1.3 Efficacy of the use of a double-stranded template was project-dependent 
The use of a dsDNA donor template proved efficient for the functional assessment of b-
catenin variants. However, the integration of genomic variants into GFP from a long (±820-
bp) dsDNA donor led to a complete loss of GFP expression, making the phenotypic separation 
of genetic variants impossible (section 4.2.17). This discrepancy between both screens could 
be due to several reasons. Previous work has shown that the addition of random (i.e. non-
homologous), linear DNA to editing reactions can increase the rate of error-prone repair (C. 
D. Richardson et al., 2016), providing a possible explanation for the complete loss of GFP 
fluorescence whereby, in contrast to the targeting of b-catenin, linear templates were used. 
This likely provides a likely explanation for the loss in GFP fluorescence.  
 
6.1.4 The advantages of nucleotide versus amino acid substitutions 
Whereas the DMS of GFP was conducted by introducing single nucleotide substitutions from 
doped ssODNs, b-catenin was saturated at the codon level using a rationally designed repair 
template pool. Codon substitutions were not performed on systematic scale (i.e. all amino 
acid substitutions across a long range of residues) until recently (Kotler et al., 2018), as the 
synthesis of such libraries was technically unfeasible, making the scale at which the b-catenin 
study is performed thus relatively novel. Substituting codons rather than nucleotides has an 
advantage considering the equal representation of all possible amino acid variants in the 
eventual pool, without biasing against those requiring multiple nucleotide changes. In 
addition, a protein sequence has functional information that is not directly visible in the 
nucleotide sequence, which is of predominant interest when comparing sequence 
conservation between species, considering that codon bias might obscure sequence 





Contrastingly, while the introduction of variants on the nucleotide level through oligo doping 
predominantly results in amino acid substitutions that can be obtained by a single nucleotide 
change, the advantage is that this more closely reflects the variants that arise naturally in 
biological systems. In addition, when viewing these variants through the scope of codon 
usage bias, silent mutations might affect cell fitness in various ways, elaborately discussed in 
section 1.1.3, which are not assessed by the approach using a single codon per amino acid 
utilised in chapter 5. This was illustrated in section 4.2.13, where the synonymous codons 
encoding T109T in GFP represented different mutational effect scores. This provisional 
finding however needs corroborating evidence through experiments with clonal cell lines. 
This furthermore raises a possible limitation on the ‘one codon, one amino acid’ strategy 
used in the b-catenin, which uses the most frequently used codons in mouse and thereby 
possibly obscuring some codon usage biases when comparing the data to mutational data in 
tumours, where a different codon may underlie the amino acid change.  
 
Whether DMS on the nucleotide or codon level is the best way forward thus depends on the 
hypothesis being tested. Current library synthesis methods however allow for the rational 
design of sequencing libraries encompassing very large numbers of sequence variants, as is 
demonstrated in a recent study (Kotler et al., 2018), which can therefore entail all possible 
single variants on both the nucleotide and amino acid level and thus encompass the best of 
both worlds. In my view, this scale of synthesis will be the gold standard for DMS and will be 
seen more often in the near future.  
 
6.1.5 Mutational effect score encompasses multi-dimensional data in a single value 
The formula derived from Kosuri et al., (2013) was used to assign a single functional value 
per amino acid substitution entailing both its proportionality and the fluorescence value per 
bin. Because of the low number of bins, the scores in GFP were the same for variants at high 
and low frequency, which needed to be weighted by an F score to indicate the power of these 
mutational effect scores. The mutational effect score was more robust in the b-catenin study 
(see Figure 5.10) compared to the GFP study (see Table 4-9) because of (1) the depth of 
analysis (i.e. number of reads) and (2) the larger number of bins, which allowed scoring at a 
higher resolution. Nonetheless, the validity of our GFP study is underscored by the 





In the b-catenin study, the largest difference in frequencies of introduced codons was 
detected between the lower (P2-P4) and higher (P5-P7) segment of TCF/LEF-GFP 
fluorescence (section 0), which is consistent with the upper limit of GFP expression in the 
untargeted cells (see Figure 5.3A). This difference is focussed around residues involved in the 
turnover of b-catenin, i.e. the phosphorylation sites and b-TrCP binding site more frequently 
have mutations in the higher GFP bins, supporting the idea that each of these sites is essential 
for the degradation of the protein. By exploring the individual bins in more detail, it was 
however shown that the behaviour of codon substitutions exhibits differences across the 
bins (see Figure 5.4 and Figure 5.9), confirming that the higher number of bins increases the 
resolution of the screen and is necessary to elucidate subtleties between amino acid 
substitution.   
 
The mutational effect scores calculated provide single values for the relative effect of 
different variants and correspond with the mutational patterns observed in cancers. Future 
efforts could interrogate whether the data from these experiments could be analysed by 
applying different models, for example through regression analysis, principle component 
analysis or a different form of multivariate statistics that reduce the number of dimensions 
in the data and emphasise strong patterns in the dataset. These approaches would be worth 
investigating and should receive a high priority, but have not been performed for this thesis 
due to time constraints. A suitable benchmarking strategy would be necessary to judge which 
model performs best, which is further discussed in the next section. However, as the 
mutational effect scores calculated in this thesis show a distribution as expected and 
correlate with mutations that are occurring frequently in tumours, these scores currently 
provide sufficient detail for our purposes.  
 
 
6.1.6 Validations are essential in determining sensitivity and robustness of 
mutational effect score 
The DMS screen developed in this thesis quantified the phenotypic consequences of genetic 
variants in both GFP and b-catenin. The mutational effect scores determined in GFP were 
compared against in silico predicted effects on protein stability (see Table 4-9). This approach 




unstructured (Xing et al., 2008) and (2) gain-of-function mutations were measured in 
contrast to loss-of-function, which was moreover done with (3) a downstream reporter 
rather than direct functional measurements of the targeted protein. Whilst mutational effect 
scores are consistent with clinical prevalence of substitutions in the mutational region of 
CTNNB1 (see Figure 5.12), it is not clear that the highest possible levels of CTNNB1 signalling 
are always optimal for tumour development (see section 5.1.4). Fluorescence profiles of 
clonal cell lines of at least a subset of the mutations interrogated in b-catenin should ideally 
be generated to validate the sensitivity of the mutational effect screen. However, studies of 
clonal cell lines carrying the same GFP substitutions have been performed by other members 
of the Wood laboratory. In some cases, substantial differences in fluorescence were 
observed, which complicates this approach. 
 
Different cell types reside under specific environmental conditions (e.g. exposure to certain 
growth factors) and have specific gene expression patterns. Whilst the phenotypic 
quantifications in this thesis provide a powerful tool to assess the effects of these mutations 
under these specific conditions, the extent to which anything about their effects in other 
tissues can be inferred from these effect scores is not known. Therefore, the DMS screen of 
b-catenin should be repeated in a different cell type. Indeed, this caveat is broadly applicable 
to studies applying DMS to understand the genetic basis of phenotypic traits in multicellular 
organisms: the findings in one system are not necessarily transferrable to other systems or 
cell lines.  
 
6.1.7 Other applications of DMS using CRISPR-Cas9 and multiplex HDR 
In this thesis, the developed DMS pipeline was utilised to study the effects of genetic variants 
in coding sequences at the codon level. In addition, analysis touched upon the effects of 
synonymous mutations (section 4.2.14), albeit the depth of the GFP screen was not sufficient 
to further elaborate on this. Until recently a bottleneck in laboratory-based studies of 
evolution was the generation of targeted genetic variation in the genome. CRISPR-Cas9 
allows for an increase in variation, and thereby the rate of evolution, in a highly localised 
fashion whilst leaving the rest of the genome relatively unscathed. When studying the effects 
of genetic variants on protein stability, DMS combined with HDR as proposed here is 




introduction and assessment of hypomorphic mutations, something less feasible when 
basing the mutagenesis on indels. 
 
Whilst not utilised to this purpose here, DMS using CRISPR-Cas9 and template libraries can 
interrogate non-coding elements such as upstream open reading frames (uORFs), UTRs or 
other regulating regions including enhancers (Canver et al., 2014). With the ease and 
affordability of next-generation sequencing, vast amounts of genomic data are being 
produced and made publicly available through initiatives including Ensembl (Zerbino et al., 
2017), the 1000 Genomes Project (Auton et al., 2015) and dbSNP (Frazer et al., 2007). A vast 
majority of the variants identified in these projects have not been phenotypically 
characterised, which could be exploited by DMS. Rationally, a future target of DMS should 
hence be a genomic region with a high density of uncharacterised variants, as was aimed to 
do on CTNNB1 mutations from COSMIC in this thesis (Forbes et al., 2018). However, even 
interrogations of non-coding elements require a suitable phenotypic screen, either through 
transcriptional or fluorescent measurement of an element in cis or through a fitness screen, 
and this hence limits the number of suitable targets, as was experienced with analysis of 
Nanog (not shown in this thesis).  
 
Alternatively, as published before (Hess et al., 2016; Ma et al., 2017), DMS can also be 
exploited in cancer drug resistance screens, whereby the heterogeneous pool of cells is 
subjected to a chemotherapeutic agent, by which clones harbouring a variant underlying 
resistance can be identified after survival. Similarly, it can be used to engineer valuable 
therapeutics such as antibodies (Mason et al., 2018). DMS using CRISPR-Cas9 is hence a 
potent tool in analysing the phenotypic consequences in a wide variety of genomic elements 
and in driving directed evolution. Indeed, now we have been able to generate vast amounts 
of genomic data, the next step in genetics is to understand and manipulate alterations in the 







6.2 Closing remarks 
With the relative ease and cost efficiency of both precise genome editing and sequence 
analysis, deep mutational scanning has become a widely used approach to systematically 
study the effects of genetic elements and variations therein. A wide range of approaches to 
this have been developed, each with its limitations and advantages. 
 
The pipeline presented in this thesis provides a means to introduce both nucleotide and 
codon substitutions into a genomic locus using CRISPR-Cas9 and multiplex HDR and to assess 
their phenotypic consequences in parallel. The experimental and bioinformatics pipelines 
can be used to study coding elements. Combined with the analysis of mutational signatures 
found in cancer databases, this pipeline was used to reveal novel insights into b-catenin 
variants that increase our understanding of mutations found in tumours. However, the 
availability of more tumour genome sequences and DMS datasets from clinically relevant cell 
lines will be required to separate the relative contribution of mutational bias and natural 
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